Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution
3008152	ab-ahco3	mmol/l (mmol/l)	18867	99469	0.00%
3008152	ab-shco3	mmol/l (mmol/l)	11056	50988	0.00%
3008152	ab-hco3	mmol/l (mmol/l)	2450	5969	0.00%
3008152	ab-ahco3	— (—)	2179	9569	100.00%	Distribution not available
3008152	ab-aktuaalibikarbonaatti	mmol/l (—)	863	2766	100.00%	Distribution not available
3008152	ab-shco3	— (—)	190	249	100.00%	Distribution not available
3008152	ab-hco3	— (—)	153	206	100.00%	Distribution not available
3008152	abhco3pika	mmol/l (mmol/l)	20	20	0.00%
3008152	ab-chco3	mmol/l (mmol/l)	10	10	0.00%

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

1337

4356

3.27

322.31

8.5

6.5

24.64

24.32

mmol/l

2.04

1260

4023

Spondylopathies

3928

12137

2.05

322.13

7.1

7.3

24.89

24.51

mmol/l

7.94

3656

11307

Symptoms and signs involving cognition, perception, emotional state and behaviour

4616

17564

1.91

322.10

7.6

7.0

24.63

24.58

mmol/l

0.44

4371

16334

Diabetes, insulin treatment (Kela reimbursement)

4842

16199

1.90

320.38

8.5

6.7

24.33

24.75

mmol/l

9.17

4535

15078

Nerve, nerve root and plexus disorders

5092

17837

1.86

318.68

7.3

7.1

24.68

24.57

mmol/l

1.20

4728

16643

General examination and investigation of persons without complaint and reported diagnosis

3329

8401

2.20

316.25

9.2

6.5

24.76

24.47

mmol/l

3.78

3189

7738

Heart failure and coronary heart disease

2054

6210

2.71

314.20

10.0

6.3

24.40

24.66

mmol/l

1.86

1961

5778

Concussion

2183

7886

2.50

313.79

7.4

6.2

24.64

24.31

mmol/l

3.53

2060

7282

Asthma, including avohilmo

5485

18141

1.82

313.73

7.5

6.9

24.89

24.47

mmol/l

12.72

5147

16880

Erysipelas

2886

12518

2.23

312.53

8.6

6.4

24.89

24.63

mmol/l

2.72

2720

11647

Malaise and fatigue

2484

9186

2.38

311.68

7.4

6.6

24.86

24.51

mmol/l

4.28

2362

8518

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

726

1080

5.55

310.24

8.9

6.5

25.11

24.63

mmol/l

2.06

693

1001

Early onset COPD, excluding more controls

1204

3800

3.47

309.88

10.2

6.0

25.86

24.18

mmol/l

31.27

1135

3504

Low back pain

3385

12989

2.09

308.96

7.2

24.77

24.45

mmol/l

5.26

3184

12092

Opioids

4560

12813

1.93

308.65

7.8

6.7

24.61

24.48

mmol/l

1.36

4278

11880

Other dorsopathies, not elsewhere classified

4686

13360

1.91

308.61

7.0

7.2

24.67

24.44

mmol/l

3.88

4367

12440

Lower back pain or/and sciatica

4836

18711

1.86

308.40

7.1

24.72

24.54

mmol/l

2.60

4553

17394

Diabetes medication

4781

16009

1.88

307.93

8.4

6.6

24.34

24.72

mmol/l

7.32

4478

14900

Asthma/COPD (KELA code 203)

4659

16790

2.04

307.65

7.4

6.8

25.04

24.38

mmol/l

25.61

4373

15605

Explicit Sepsis

2809

9247

3.20

307.65

12.1

5.8

24.34

24.55

mmol/l

1.60

2669

8570

STROKE

3097

7863

2.92

307.65

9.7

5.8

24.67

24.82

mmol/l

1.34

2914

7279

Diabetes mellitus

4809

15404

1.93

307.65

8.6

6.6

24.34

24.72

mmol/l

7.54

4516

14331

Type 2 diabetes, wide definition

4279

13349

2.20

307.65

8.5

6.6

24.38

24.77

mmol/l

7.01

4018

12444

Other bacterial diseases

5603

16034

2.58

307.65

9.5

6.3

24.57

24.64

mmol/l

0.53

5251

14905

Heart failure,strict

3489

8737

3.18

307.65

10.3

6.2

24.77

24.54

mmol/l

2.16

3323

8105

Pneumonias (Asthma/COPD co-morbidities)

5854

16082

2.68

307.65

9.9

6.1

25.01

24.42

mmol/l

22.53

5492

14944

Heart failure, strict

3779

10695

2.78

307.65

10.0

6.5

24.77

24.55

mmol/l

2.13

3596

9933

All-cause Heart Failure

3725

10537

2.79

307.65

10.0

6.4

24.79

24.55

mmol/l

2.57

3546

9781

Bacterial Sepsis

3088

9428

3.22

307.65

12.5

5.8

24.63

24.58

mmol/l

0.21

2924

8741

Asthma, unspecified (mode), excluding more controls

2772

7129

3.26

307.65

7.6

5.6

25.05

24.29

mmol/l

18.63

2618

6584

Hypertension

3923

9305

2.50

307.65

8.1

6.5

24.56

24.65

mmol/l

0.66

3704

8577

Antihypertensive medication - note that there are other indications

2397

4886

2.78

307.65

7.3

5.5

24.31

24.47

mmol/l

1.15

2239

4490

Bacterial infection, other or unspecified

2790

11408

2.35

307.65

9.0

6.3

24.44

24.61

mmol/l

1.28

2606

10607

Implicit bacterial Sepsis

2795

8548

3.35

307.65

13.0

5.9

24.66

24.57

mmol/l

0.44

2653

7920

Pure hypercholesterolaemia

3835

12614

2.15

307.65

7.5

6.6

24.49

24.73

mmol/l

3.35

3603

11736

Infections, IBD-co-morbidities

862

1392

4.87

307.65

10.8

6.2

24.37

24.59

mmol/l

0.64

813

1292

Bacterial pneumonia, not elsewhere classified

2693

7722

3.41

307.65

10.8

6.0

25.17

24.31

mmol/l

18.86

2504

7192

ILD medications: prednisolone, methylprednisolone, prednisone

5249

16264

1.89

307.65

7.7

6.8

24.72

24.50

mmol/l

3.58

4936

15109

Inflammatory bowel disease treatment related agents

5577

16959

1.94

307.65

7.5

6.9

24.76

24.48

mmol/l

5.55

5249

15760

Hypertensive diseases

3929

9308

2.51

307.65

8.1

6.5

24.56

24.65

mmol/l

0.67

3710

8580

Insulin medication

3169

12684

2.26

307.65

9.0

6.7

24.07

24.72

mmol/l

13.51

2965

11817

Disorders of lipoprotein metabolism and other lipidaemias

4148

13399

2.04

307.65

7.8

6.6

24.51

24.73

mmol/l

2.92

3903

12455

Asthma (diagnoses ohter than nonallergic)

4297

18403

2.09

307.65

7.7

6.9

24.98

24.48

mmol/l

13.92

4043

17137

Atrial fibrillation and flutter with reimbursement

1503

2138

4.92

307.65

8.6

5.3

24.60

24.83

mmol/l

1.14

1424

1955

Asthma-related infections

3227

13148

2.57

307.65

8.6

6.6

25.14

24.46

mmol/l

17.77

3044

12233

Care involving use of rehabilitation procedures

3419

15001

2.29

307.65

8.6

6.7

24.82

24.57

mmol/l

3.02

3125

13998

Viral Sepsis

1291

3848

3.78

307.65

11.9

5.7

24.88

24.55

mmol/l

1.82

1220

3573

Major coronary heart disease event excluding revascularizations

3676

11784

2.30

307.65

8.7

6.7

24.46

24.74

mmol/l

4.15

3466

10988

Septicaemia

2751

9248

3.16

307.65

12.0

6.3

24.35

24.57

mmol/l

1.77

2609

8603

Presence of cardiac and vascular implants and grafts

2833

9363

2.48

307.65

9.8

6.4

24.42

24.66

mmol/l

2.83

2661

8732

Implicit viral Sepsis

1289

3842

3.78

307.65

11.9

5.7

24.87

24.54

mmol/l

1.83

1218

3567

Substance abuse, excluding more controls

2877

11343

2.34

307.65

9.4

7.1

24.52

24.44

mmol/l

0.46

2738

10497

Asthma, hospital admission 2, infections

3227

13148

2.57

307.65

8.6

6.6

25.14

24.46

mmol/l

17.77

3044

12233

Dyspnoea

5792

16266

2.95

307.65

7.8

6.8

24.80

24.49

mmol/l

6.88

5528

15072

Hypothyroidism, levothyroxine purchases

891

1029

5.18

307.65

8.2

4.1

24.31

24.27

mmol/l

0.09

831

936

Diabetes, varying definitions

4782

15389

1.93

307.65

8.6

6.6

24.35

24.72

mmol/l

7.33

4492

14317

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

4719

16045

2.09

307.65

9.5

6.3

24.38

24.65

mmol/l

4.75

4423

14948

Cardiac arrhythmias

2925

6235

3.27

307.65

7.8

5.4

24.51

24.76

mmol/l

2.76

2740

5727

Excluding asthma or asthma-COPD overlap

3738

8792

2.21

307.65

8.0

5.8

24.77

24.23

mmol/l

12.60

3493

8135

Major coronary heart disease event

4066

12450

2.33

307.65

8.9

6.7

24.48

24.75

mmol/l

4.61

3837

11600

Asthma, hospital admissions 3, pneumonia

2275

8248

3.01

307.65

9.5

6.5

25.40

24.43

mmol/l

22.88

2147

7655

Asthma (mode)

3936

8800

2.58

307.65

7.6

5.8

24.82

24.23

mmol/l

16.99

3697

8141

Heart failure and antihypertensive medication

1784

2435

5.45

307.65

11.5

5.8

24.80

24.84

mmol/l

0.14

1698

2233

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

4622

14922

1.97

307.65

8.6

6.6

24.31

24.75

mmol/l

9.48

4340

13884

Other intervertebral disc disorders

4342

12688

2.19

307.65

7.0

7.3

24.70

24.49

mmol/l

3.16

4023

11809

Hard cardiovascular diseases

4547

12332

2.53

307.65

9.2

6.6

24.60

24.74

mmol/l

1.47

4288

11460

Any reimbursement code in KELA

2362

3856

3.19

307.65

7.5

5.9

24.27

24.41

mmol/l

0.85

2215

3550

Cardiovascular diseases

2525

4132

3.47

307.65

7.7

5.3

24.36

24.35

mmol/l

0.05

2379

3772

Asthma-related pneumonia or sepsis

2275

8248

3.01

307.65

9.5

6.5

25.40

24.43

mmol/l

22.88

2147

7655

COPD/asthma related infections

4996

12663

2.05

307.65

8.4

6.0

24.85

24.37

mmol/l

13.05

4681

11741

ILD differential diagnosis

3700

8800

2.18

307.65

8.0

5.8

24.77

24.23

mmol/l

12.46

3456

8141

Other pulmonary diagnosis

3759

8792

2.22

307.65

8.0

5.8

24.79

24.23

mmol/l

13.49

3513

8135

Myocardial infarction

2754

8688

2.43

307.65

8.9

6.7

24.33

24.73

mmol/l

5.99

2597

8088

Abnormalities of breathing

5337

11357

2.97

307.65

7.5

6.9

24.74

24.43

mmol/l

6.20

5060

10488

Asthma (only as main-diagnosis), excluding more controls

3496

7755

2.83

307.65

7.7

5.6

24.90

24.28

mmol/l

16.23

3292

7154

Fever of other and unknown origin

2905

11027

2.59

307.65

9.4

6.7

24.57

24.50

mmol/l

0.42

2766

10224

Other heart diseases, wide

4808

12054

2.61

307.65

8.7

6.3

24.65

24.61

mmol/l

0.24

4529

11133

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

1829

3610

3.37

307.65

7.7

5.3

24.69

24.66

mmol/l

0.15

1705

3292

General symptoms and signs

5517

13481

2.13

307.65

8.0

6.6

24.59

24.52

mmol/l

0.69

5186

12480

Dorsalgia

4706

13336

1.98

307.65

7.1

7.2

24.68

24.44

mmol/l

4.31

4420

12417

Cardiovascular diseases (excluding rheumatic etc)

2974

4719

3.83

307.65

7.9

5.4

24.39

24.46

mmol/l

0.38

2797

4311

Hypothyroidism (congenital or acquired)

906

1035

5.24

307.65

8.3

4.1

24.31

24.29

mmol/l

0.06

848

942

All pneumoniae

5895

16072

2.69

307.65

9.9

6.1

25.02

24.40

mmol/l

23.83

5522

14945

Hypothyroidism and >3 levothyroxin purchases

891

1029

5.18

307.65

8.2

4.1

24.31

24.27

mmol/l

0.09

831

936

Atrial fibrillation and flutter

1774

2674

4.69

307.65

9.3

5.4

24.52

24.82

mmol/l

2.10

1667

2441

Asthma (only as main-diagnosis)

3601

8718

2.62

307.65

7.7

5.8

24.91

24.23

mmol/l

20.44

3389

8069

Pneumonia, organism unspecified

5111

14991

2.62

307.65

9.9

6.1

25.08

24.42

mmol/l

24.53

4813

13940

Angina pectoris

3638

9765

2.72

307.65

8.5

6.7

24.63

24.75

mmol/l

1.03

3399

9077

Anaemias

1151

941

8.75

307.65

9.9

4.1

24.29

24.34

mmol/l

0.12

1080

862

Other heart diseases

2668

3899

4.87

307.65

9.8

5.4

24.57

24.62

mmol/l

0.18

2508

3558

Chronic lower respiratory diseases

5888

16839

1.96

307.65

7.7

6.8

25.00

24.38

mmol/l

26.32

5536

15648

Other disorders of fluid, electrolyte and acid-base balance

1895

6561

3.07

307.65

11.1

6.4

24.30

24.68

mmol/l

2.60

1805

6091

Bacterial pneumoniae

2811

8153

3.36

307.65

10.8

6.0

25.13

24.32

mmol/l

17.24

2612

7590

Depression medications

1079

1102

5.12

307.65

7.7

4.1

24.52

24.35

mmol/l

0.54

1017

1001

Influenza and pneumonia

6126

15823

2.71

307.65

9.7

6.1

25.00

24.39

mmol/l

24.18

5724

14719

Codeine

4473

12685

2.01

307.65

7.6

6.7

24.65

24.49

mmol/l

1.90

4190

11759

Pain in throat and chest

4384

11081

2.54

307.65

6.9

24.70

24.45

mmol/l

4.10

4097

10233

Intracranial trauma

2712

8038

2.64

307.65

8.4

6.2

24.73

24.32

mmol/l

6.05

2563

7420

Other diseases of pleura

2641

10586

2.38

307.65

11.0

6.6

25.84

24.36

mmol/l

55.12

2511

9858

COPD/asthma/ILD related infections

4996

12663

2.05

307.65

8.4

6.0

24.85

24.37

mmol/l

13.05

4681

11741

Bleeding

4417

15818

2.14

307.65

10.0

6.6

24.56

24.64

mmol/l

0.68

4165

14729

Other septicaemia

2491

8454

3.20

307.65

12.4

6.3

24.33

24.57

mmol/l

1.77

2372

7868

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

5786

16093

2.69

307.65

10.0

6.1

25.02

24.42

mmol/l

22.55

5427

14961

Metabolic disorders

5207

14585

2.34

307.65

8.8

6.6

24.48

24.69

mmol/l

3.11

4902

13532

Renal tubulo-interstitial diseases

4482

16476

2.19

307.65

10.0

6.4

23.95

24.74

mmol/l

27.81

4242

15327

Bacterial pneumonia (organism specified)

2933

9856

2.96

307.65

10.7

6.2

25.09

24.38

mmol/l

14.48

2730

9176

COPD (mode)

1907

5202

3.18

307.65

9.5

5.8

25.82

24.22

mmol/l

43.34

1813

4822

Any gastric operation

3682

8409

2.27

307.65

7.9

5.4

24.34

24.61

mmol/l

3.39

3448

7756

Asthma, unspecified (mode)

2850

8023

3.00

307.65

7.6

5.8

25.06

24.24

mmol/l

22.27

2691

7435

Coronary atherosclerosis

3942

10533

2.59

307.65

8.7

6.7

24.52

24.76

mmol/l

3.47

3728

9792

Oxycodone

2076

8110

2.68

307.65

8.8

6.7

25.08

24.50

mmol/l

8.96

1962

7539

Valvular heart disease excluding rheumatic fever

2787

7316

3.01

307.65

10.1

6.2

24.57

24.66

mmol/l

0.64

2633

6761

Non-invasive ventilation

4394

1959

33.83

307.65

9.0

4.6

25.06

24.62

mmol/l

5.85

4007

1803

5392

12652

2.85

307.65

9.9

6.0

25.03

24.37

mmol/l

24.50

5053

11732

COPD differential diagnosis

3705

8804

2.19

307.65

8.0

5.8

24.78

24.23

mmol/l

12.73

3460

8145

Ischaemic heart disease, wide definition

4468

11624

2.58

307.65

8.6

6.7

24.56

24.79

mmol/l

3.50

4211

10805

Diseases of arteries, arterioles and capillaries (FINNGEN)

1487

2086

5.51

307.65

11.1

5.3

24.36

24.76

mmol/l

2.80

1404

1907

Asthma-related pneumonia

2273

8232

3.02

307.65

9.6

6.5

25.39

24.42

mmol/l

22.83

2145

7640

Complications of surgical and medical care, not elsewhere classified

5344

17700

2.28

307.65

9.7

6.3

24.67

24.57

mmol/l

1.12

5035

16455

First line medication for Crohn's disease

5352

15510

1.95

307.65

7.9

6.7

24.71

24.48

mmol/l

4.11

5017

14398

Non-rheumatic valve diseases

2774

7272

3.01

307.65

10.0

6.2

24.58

24.66

mmol/l

0.55

2620

6720

GASTRO-related operations

3682

8409

2.27

307.65

7.9

5.4

24.34

24.61

mmol/l

3.39

3448

7756

Complications of procedures, not elsewhere classified

4261

17085

2.27

307.65

10.4

6.4

24.70

24.57

mmol/l

1.33

4016

15890

Coronary revascularization (ANGIO or CABG)

2650

7851

2.54

307.65

9.4

6.6

24.53

24.70

mmol/l

1.55

2500

7296

Complications of medical and surgical care

4107

17002

2.44

307.65

9.9

6.5

24.72

24.58

mmol/l

1.48

3863

15833

Cerebrovascular diseases (FINNGEN)

1898

2794

5.32

307.65

10.6

5.3

24.68

24.76

mmol/l

0.37

1791

2553

Ischemic heart diseases

4537

11735

2.59

307.65

8.6

6.7

24.57

24.78

mmol/l

2.98

4281

10904

Hypertension, essential

3972

9166

2.61

307.65

8.3

6.5

24.58

24.65

mmol/l

0.56

3754

8455

Oral corticosteroids

5537

16676

2.10

307.65

7.7

6.9

24.83

24.50

mmol/l

7.85

5218

15493

Condition for Implicit Sepsis (Organ dysfunction codes)

5069

14488

2.72

307.65

10.7

5.8

24.58

24.62

mmol/l

0.24

4802

13433

Implicit Sepsis

4676

13587

2.90

307.65

10.9

5.9

24.64

24.61

mmol/l

0.21

4440

12613

Parasetamol

3926

7862

2.66

307.65

7.6

6.5

24.52

24.44

mmol/l

0.57

3704

7229

Asthma, excluding more controls

4027

7755

2.92

307.65

8.0

5.6

24.93

24.28

mmol/l

19.03

3783

7154

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

4765

17907

1.99

307.65

8.8

6.6

24.48

24.63

mmol/l

1.73

4477

16671

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

3252

14826

2.32

307.65

10.2

6.5

24.71

24.59

mmol/l

1.03

3052

13797

Asthma

4180

8718

2.71

307.65

7.9

5.8

24.94

24.23

mmol/l

23.81

3928

8069

Symptoms and signs involving the circulatory and respiratory systems

4967

11392

2.27

307.65

7.1

6.9

24.57

24.43

mmol/l

1.54

4652

10521

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

5392

12652

2.85

307.65

9.9

6.0

25.03

24.37

mmol/l

24.50

5053

11732

Tramadol

3815

12076

2.12

307.65

7.9

6.8

24.72

24.53

mmol/l

2.38

3586

11194

Hypertensive diseases (excluding secondary)

2677

3881

4.27

307.65

8.3

5.6

24.51

24.66

mmol/l

1.00

2533

3535

Persons encountering health services for specific procedures and health care

5322

17001

2.02

307.65

8.6

6.6

24.66

24.54

mmol/l

1.36

4948

15852

Heart failure, not strict

5111

11970

3.23

307.65

9.9

6.3

24.74

24.57

mmol/l

1.89

4839

11110

Other neurological diseases

3693

15407

2.03

306.76

7.8

7.0

24.61

24.60

mmol/l

0.03

3482

14357

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2929

14195

2.18

306.18

10.1

6.6

24.72

24.59

mmol/l

1.11

2748

13216

ILD medications

5295

16422

1.83

306.03

7.7

6.8

24.71

24.49

mmol/l

3.68

4967

15256

Insulin, intermediate and long-acting

2930

13983

2.18

303.12

8.9

6.9

24.06

24.65

mmol/l

10.26

2739

13036

Type 2 diabetes

4610

14967

1.90

302.81

8.5

6.6

24.43

24.74

mmol/l

5.16

4334

13931

Myocardial infarction, strict

2528

8295

2.37

301.61

8.4

6.7

24.31

24.72

mmol/l

5.89

2374

7714

COPD

2528

9531

2.34

298.87

9.4

6.9

25.63

24.38

mmol/l

38.04

2397

8872

All influenza

1402

4942

3.08

297.48

8.3

6.1

25.05

24.29

mmol/l

10.29

1292

4607

2132

9107

2.45

296.68

8.6

6.7

25.10

24.43

mmol/l

12.52

2017

8481

Endocrine, nutritional and metabolic diseases

3528

8869

2.09

295.46

7.9

6.1

24.36

24.64

mmol/l

3.45

3314

8190

Unstable angina pectoris

2242

8134

2.47

295.31

8.4

6.5

24.61

24.70

mmol/l

0.50

2099

7563

Heart failure and bmi 25plus

2170

6356

2.57

294.80

10.5

6.5

24.94

24.60

mmol/l

2.84

2054

5893

Other CVD (FINNGEN)

642

977

5.78

294.63

8.9

5.5

24.43

24.71

mmol/l

0.81

608

876

Other medical care

2286

9989

2.40

293.72

8.6

6.6

24.84

24.54

mmol/l

3.00

2164

9300

Other special examinations and investigations of persons without complaint or reported diagnosis

3403

8429

2.12

293.47

7.4

6.5

24.54

24.47

mmol/l

0.36

3168

7764

Diseases of arteries, arterioles and capillaries

3522

13591

2.04

292.40

10.0

6.6

24.42

24.64

mmol/l

2.67

3327

12654

Neurological diseases, wide definition

1307

1944

3.51

291.33

8.0

5.8

24.43

24.44

mmol/l

0.01

1222

1791

Sciatica+with lumbago

2431

10563

2.30

290.05

7.5

7.2

24.70

24.52

mmol/l

1.61

2291

9837

Non-ischemic cardiomyopathy

1568

4808

2.90

285.53

9.3

5.9

25.29

24.61

mmol/l

6.46

1489

4444

Other chronic obstructive pulmonary disease

2425

9248

2.34

284.83

9.4

6.9

25.71

24.38

mmol/l

40.91

2305

8608

Insulin, combination of fast acting with intermediate-acting or long-acting

3179

14968

2.06

283.29

9.0

6.9

24.07

24.64

mmol/l

10.70

2975

13956

Neurological diseases

3826

9956

2.00

282.68

7.3

6.6

24.64

24.34

mmol/l

4.59

3576

9214

Valvular operations

941

2714

3.90

282.44

13.6

5.8

24.41

24.48

mmol/l

0.26

888

2499

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

3238

15517

2.04

279.23

7.9

7.1

24.99

24.56

mmol/l

8.47

3041

14483

Pulmonary heart disease, diseases of pulmonary circulation

1854

7815

2.57

276.22

8.6

6.7

24.85

24.55

mmol/l

2.70

1754

7277

Poisoning by drugs, medicaments and biological substances

1232

4204

3.16

275.94

8.4

7.1

24.66

24.41

mmol/l

1.34

1167

3909

Substance abuse

2877

13742

2.10

273.33

9.4

7.1

24.52

24.51

mmol/l

0.02

2738

12754

Mental and behavioural disorders due to psychoactive substance use

2944

14001

2.08

272.48

9.4

7.1

24.51

mmol/l

0.02

2802

13000

Headache

2791

11398

2.13

272.17

7.1

6.5

24.62

24.53

mmol/l

0.67

2628

10544

Paroxysmal tachycardia

917

2148

3.83

271.67

7.1

5.3

24.12

24.64

mmol/l

3.64

864

1951

Codeine or tramadol medication

5286

17166

1.76

270.00

7.6

6.9

24.65

24.55

mmol/l

1.01

4953

15974

Spinal stenosis

2672

10121

2.19

269.62

7.3

24.87

24.52

mmol/l

5.08

2500

9446

Cerebrovascular diseases

3752

14560

1.94

268.18

9.1

6.9

24.74

24.61

mmol/l

1.28

3544

13557

Lumbar disc prolapse

2970

11868

2.08

266.97

7.1

7.5

24.64

24.52

mmol/l

0.95

2749

11039

Other arrhythmias

2728

10155

2.14

265.55

6.4

6.2

24.54

24.62

mmol/l

0.61

2542

9380

Respiratory insufficiency

617

1373

5.26

265.42

12.1

5.6

28.02

23.90

mmol/l

70.08

593

1271

Psychiatric diseases

5003

14426

1.79

265.00

7.7

6.7

24.65

24.51

mmol/l

1.58

4730

13361

Covid-19 confirmed case

1574

6275

2.71

263.27

8.1

7.0

24.57

24.48

mmol/l

0.40

1519

5829

Poisoning by medicine

1117

3713

3.25

262.15

8.7

7.1

24.65

24.39

mmol/l

1.29

1057

3448

Asthma, hospital admissions , main diagnosis only

3743

18458

1.88

260.81

7.6

6.9

24.91

24.52

mmol/l

8.44

3525

17178

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

1564

2795

2.90

260.70

7.4

6.5

24.42

24.39

mmol/l

0.10

1457

2544

Renal failure

2433

10694

2.22

258.63

12.5

6.5

23.07

24.76

mmol/l

54.56

2299

9967

Other postsurgical states

544

1127

5.92

258.62

11.4

6.3

24.64

24.62

mmol/l

0.04

527

1039

Certain infectious and parasitic diseases

4467

12579

1.83

255.56

8.0

6.1

24.51

24.58

mmol/l

0.57

4169

11663

Other diseases of the respiratory system

1319

4926

2.97

255.06

13.9

6.3

26.83

24.36

mmol/l

62.21

1260

4599

Other respiratory disorders and diseases

1319

4926

2.97

255.06

13.9

6.3

26.83

24.36

mmol/l

62.21

1260

4599

Non-allergic asthma (mode), excluding more controls

988

3071

3.43

254.18

8.1

5.6

24.89

24.23

mmol/l

6.53

930

2821

Episodal and paroxysmal disorders

4954

14775

1.77

253.90

7.4

6.7

24.69

24.45

mmol/l

4.02

4656

13675

Emergency coronary revascularization (for ACS)

3027

11231

2.06

252.17

9.1

6.8

24.51

24.59

mmol/l

0.65

2850

10483

Pulmonary embolism

1677

7054

2.58

251.04

8.6

6.8

24.78

24.57

mmol/l

1.52

1581

6568

Pulmonary heart disease

1677

7096

2.56

247.77

8.6

6.8

24.78

24.58

mmol/l

1.37

1581

6611

Pacemaker

1957

8651

2.39

244.48

9.5

6.4

24.52

24.57

mmol/l

0.18

1838

8046

Acute tubulo-interstitial nephritis

2889

13269

2.02

244.38

8.2

6.3

24.40

24.74

mmol/l

4.37

2734

12339

Mental and behavioural disorders due to alcohol

2552

12403

2.10

244.27

9.3

7.1

24.39

24.49

mmol/l

0.62

2423

11521

Any mental disorder

5058

15051

1.73

239.71

7.9

6.7

24.70

24.51

mmol/l

2.52

4780

13959

Diseases of oesophagus, stomach and duodenum

4802

17335

1.74

238.69

8.2

6.8

24.49

24.62

mmol/l

1.45

4495

16142

2846

13612

2.01

238.64

9.3

7.2

24.29

24.54

mmol/l

2.41

2699

12652

Other (not insulin) diabetes medications

4377

15313

1.78

236.94

8.0

6.7

24.49

24.74

mmol/l

3.37

4104

14263

2946

13919

1.98

236.58

9.2

7.2

24.33

24.54

mmol/l

1.97

2794

12937

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

1337

5154

2.75

236.46

8.5

6.9

24.64

24.39

mmol/l

1.45

1260

4791

Type 2 diabetes, definitions combined

4245

14608

1.79

234.22

8.1

6.6

24.52

24.75

mmol/l

3.09

3994

13597

Schizophrenia or delusion, excluding more controls

1415

5588

2.66

233.69

7.9

6.8

25.54

24.49

mmol/l

15.22

1326

5162

DVT of lower extremities and pulmonary embolism

2208

10651

2.20

233.57

8.1

6.8

24.80

24.57

mmol/l

2.12

2077

9938

Other chronic obstructive pulmonary disease, including avohilmo

2801

12172

2.03

231.46

9.2

7.0

25.55

24.45

mmol/l

33.53

2660

11335

Coronary angioplasty

1971

6888

2.35

231.46

8.0

6.5

24.57

24.69

mmol/l

0.67

1855

6405

Type 2 diabetes, strict (exclude DM1)

4254

14705

1.78

231.45

8.1

6.7

24.51

24.75

mmol/l

3.21

4000

13688

Dorsopathies

4506

13386

1.77

230.38

7.0

7.2

24.66

24.44

mmol/l

3.54

4195

12466

Hernia of abdominal wall, postoperative

943

3078

3.32

229.02

11.6

5.7

24.62

24.71

mmol/l

0.30

894

2824

Type 2 diabetes, definitions combined, including avohilmo

4235

14536

1.78

228.74

8.0

6.7

24.49

24.75

mmol/l

3.75

3980

13534

Hypothyroidism, drug reimbursement

493

637

5.80

228.57

7.7

4.2

24.41

24.53

mmol/l

0.24

452

574

Glucagon-like peptide-1 (GLP-1) analogues

2795

12049

2.01

227.87

8.1

6.8

24.14

24.75

mmol/l

11.25

2606

11245

Examination and observation for other reasons

2707

8282

2.06

227.63

8.6

6.5

24.58

24.48

mmol/l

0.72

2605

7630

Obesity related asthma

1648

7186

2.45

225.21

8.9

7.0

25.34

24.49

mmol/l

14.40

1569

6671

Mental and behavioural disorders due to alcohol, excluding acute intoxication

2250

11079

2.14

224.93

9.5

7.3

24.39

24.53

mmol/l

0.82

2136

10309

Alcohol use disorder, Swedish definition

2707

13151

2.00

224.50

9.4

7.2

24.33

24.54

mmol/l

1.68

2565

12230

COPD, hospital admissions

2445

10463

2.10

223.52

9.3

6.9

25.71

24.41

mmol/l

39.78

2324

9747

Other diseases of intestines

4588

15913

1.72

221.66

8.1

6.7

24.48

24.57

mmol/l

0.76

4314

14771

Hypo-osmolality and hyponatraemia

1040

3675

3.12

221.13

11.4

6.3

24.47

24.77

mmol/l

1.35

991

3422

Coronary artery bypass grafting

1561

4997

2.57

220.59

11.0

6.4

24.39

24.63

mmol/l

1.61

1476

4643

Non-allergic asthma (mode)

988

3339

3.14

220.55

8.1

5.7

24.89

24.16

mmol/l

7.75

930

3078

COPD, early/later onset

2448

10517

2.09

219.62

9.4

6.9

25.70

24.41

mmol/l

39.28

2328

9795

Suicide or other Intentional self-harm

1208

4623

2.79

217.92

8.9

7.0

24.77

24.44

mmol/l

2.04

1145

4303

Symptoms and signs involving the digestive system and abdomen

4605

13732

1.73

216.93

7.7

6.9

24.48

24.59

mmol/l

0.98

4326

12690

Haemorrhage from respiratory passages

1680

6916

2.39

216.26

9.0

6.8

24.66

24.45

mmol/l

1.32

1576

6402

Other soft tissue disorders, not elsewhere classified

3962

14184

1.78

215.78

7.2

7.1

24.74

24.50

mmol/l

3.51

3725

13209

Acute renal failure

1260

5004

2.78

215.41

15.7

6.4

22.98

24.71

mmol/l

26.43

1205

4673

Other nutritional deficiencies

2705

14043

1.96

214.63

8.5

7.1

24.99

24.49

mmol/l

8.02

2555

13057

Myocardial infarction, without ST-elevation

2209

10157

2.14

214.17

8.3

6.8

24.16

24.62

mmol/l

6.39

2083

9468

Kela-code for severe mental illness

1748

7958

2.32

213.94

7.6

7.2

25.38

24.51

mmol/l

14.45

1641

7405

Alcohol use disorder, ICD-based

2081

10162

2.16

213.63

9.6

7.3

24.39

24.52

mmol/l

0.66

1978

9455

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

845

2698

3.39

212.74

8.8

7.1

24.57

24.38

mmol/l

0.67

804

2512

Venous thromboembolism

2664

13793

1.97

211.15

7.8

6.9

24.82

24.59

mmol/l

2.48

2493

12865

Abnormal findings on diagnostic imaging of lung

2422

12239

2.04

209.66

8.1

7.0

25.15

24.53

mmol/l

12.82

2272

11421

COPD related to multimorbidity

2152

8963

2.16

209.54

9.8

6.7

25.61

24.35

mmol/l

33.09

2048

8344

4952

16069

1.67

209.41

7.5

6.7

24.83

24.43

mmol/l

10.42

4652

14932

Other antidepressants

4728

14990

1.69

208.56

7.9

6.9

24.75

24.42

mmol/l

7.10

4458

13917

Epilepsy

1527

6635

2.43

207.75

9.9

6.7

24.77

24.40

mmol/l

3.19

1447

6155

Biguanides

4252

15680

1.73

207.11

7.9

6.8

24.52

24.70

mmol/l

2.03

3970

14610

Statin medication

2849

8401

1.96

206.56

7.4

6.7

24.44

24.77

mmol/l

4.02

2671

7767

Insulin, fast-acting

1785

8323

2.27

206.52

9.3

6.9

24.09

24.61

mmol/l

5.13

1662

7756

Abdominal and pelvic pain

4543

13729

1.71

206.32

7.5

6.9

24.52

24.59

mmol/l

0.55

4283

12687

Unspecified mental disorder

1860

8805

2.22

205.70

7.7

7.1

25.31

24.49

mmol/l

13.93

1746

8190

Malignant neoplasm, excluding all cancers (controls excluding all cancers)

3874

13401

1.76

202.49

7.4

7.1

24.75

24.58

mmol/l

1.96

3625

12474

Malignant neoplasm, wide definition for exclusion

3874

13404

1.76

202.30

7.4

7.1

24.75

24.58

mmol/l

1.99

3624

12477

Malignant neoplasm, wide definition for exclusion, excluding all cancers (controls excluding all cancers)

3873

13403

1.76

202.09

7.4

7.1

24.75

24.58

mmol/l

1.98

3623

12476

Calcific aortic valvular stenosis, operated

1717

7846

2.32

201.29

9.2

6.3

24.49

24.53

mmol/l

0.17

1606

7314

Calcific aortic valvular stenosis

1717

7846

2.32

201.29

9.2

6.3

24.49

24.53

mmol/l

0.17

1606

7314

Operations 2 for CAVS

1715

7839

2.32

200.90

9.2

6.3

24.49

24.53

mmol/l

0.19

1604

7307

Calcific aortic valvular stenosis, diagnosis (helper)

1715

7839

2.32

200.90

9.2

6.3

24.49

24.53

mmol/l

0.19

1604

7307

COPD, hospital admission 2, with asthma infections

1802

7239

2.28

200.36

9.9

6.6

25.86

24.30

mmol/l

40.22

1712

6725

Calcific aortic valvular stenosis, including rheumatic fever

1717

7871

2.31

199.17

9.2

6.4

24.49

24.53

mmol/l

0.17

1606

7337

Polyarthropathies

3036

11175

1.87

198.20

8.0

7.1

24.44

24.55

mmol/l

0.76

2842

10429

Diseases of the respiratory system

2762

7230

1.97

197.79

7.4

5.7

24.66

24.19

mmol/l

7.34

2580

6698

Alcohol abuse, main dg, excluding more controls

813

2671

3.32

195.86

8.6

7.0

24.52

24.33

mmol/l

0.55

780

2470

Personality disorders, excluding more controls

1061

4004

2.79

194.91

7.7

6.6

25.05

24.37

mmol/l

6.16

999

3694

Obesity

2545

13589

1.93

193.39

8.5

7.0

25.09

24.49

mmol/l

10.77

2399

12635

Sequelae of external causes of morbidity and mortality

1338

5721

2.52

192.91

9.9

6.9

24.80

24.51

mmol/l

1.64

1265

5327

Obesity and other hyperalimentation

2553

13658

1.92

192.35

8.6

7.0

25.09

24.49

mmol/l

10.79

2407

12702

Pain in limb

3313

13767

1.80

192.35

7.2

7.1

24.83

24.51

mmol/l

5.13

3117

12828

Secondary uncertain malignant neoplasm, excluding all cancers (controls excluding all cancers)

2046

9045

2.10

189.74

7.3

7.1

24.75

24.61

mmol/l

0.87

1926

8416

Dizziness and giddiness

3295

15523

1.78

189.57

6.7

7.0

24.60

24.59

mmol/l

0.06

3113

14441

Stroke, including SAH

3042

12775

1.84

188.19

9.4

6.9

24.72

24.61

mmol/l

0.80

2876

11891

Later onset COPD, excluding more controls

1137

3495

2.75

185.14

8.7

5.4

25.56

24.13

mmol/l

22.00

1092

3203

malignant neoplasm of female genital organs, excluding all cancers (controls excluding all cancers)

948

3439

2.96

185.08

6.6

6.2

24.90

24.89

mmol/l

0.03

907

3174

Paralytic ileus and intestinal obstruction

1371

6022

2.44

184.90

10.5

6.6

24.69

24.65

mmol/l

0.14

1294

5589

Conduction disorders

1355

4849

2.46

182.90

7.5

5.9

24.51

24.60

mmol/l

0.35

1280

4462

Nausea and vomiting

1269

5300

2.50

182.66

8.3

6.2

24.51

24.59

mmol/l

0.30

1202

4916

Malignant neoplasm

3891

13933

1.71

181.81

7.5

7.1

24.77

24.57

mmol/l

2.65

3637

12985

Insulin, fast-acting or short human

1792

8790

2.15

181.48

9.3

7.0

24.09

24.57

mmol/l

4.42

1668

8194

COPD-related respiratory insufficiency

788

2692

3.32

181.34

12.4

6.3

26.83

24.23

mmol/l

43.58

757

2508

Any event in cancer register

3936

14161

1.70

180.14

7.7

6.9

24.73

24.54

mmol/l

2.62

3671

13199

Intestinal stricture

1591

7521

2.26

179.76

10.9

6.8

24.60

24.56

mmol/l

0.11

1512

6996

AV-block

925

3078

2.95

179.02

8.2

5.8

24.37

24.54

mmol/l

0.62

869

2837

Syncope and collapse

2017

9117

2.05

178.17

6.5

6.7

24.51

24.53

mmol/l

0.09

1894

8462

Mood disorders, excluding more controls

3898

14412

1.69

177.70

8.0

6.7

24.79

24.53

mmol/l

3.83

3678

13351

Diseases of the digestive system

2203

11673

1.98

177.62

9.7

6.7

24.23

24.57

mmol/l

3.45

2099

10870

Codes for special purposes

1915

9749

2.05

173.73

7.9

6.8

24.46

24.48

mmol/l

0.05

1841

9075

Convulsions, not elsewhere classified

1066

4223

2.63

173.14

9.1

6.7

24.48

24.41

mmol/l

0.22

1010

3907

Provisional assignment of new diseases of uncertain etiology

1911

9736

2.05

172.99

7.9

6.8

24.46

24.48

mmol/l

0.05

1838

9062

Hypertensive heart and/or renal disease

1271

4207

2.49

172.71

9.9

6.5

24.85

24.59

mmol/l

1.29

1209

3895

Peripheral artery disease

2255

9765

1.96

169.76

9.2

6.4

24.22

24.61

mmol/l

4.39

2125

9076

COPD, hospital admissions 3, with asthma pneumonia sepsis

1532

6154

2.28

169.36

10.3

6.5

25.94

24.28

mmol/l

39.03

1458

5716

Shoulder lesions

3511

12912

1.72

168.82

7.1

7.2

24.68

24.58

mmol/l

0.89

3282

12035

Misadventures to patients during surgical and medical care

793

2809

3.11

168.64

12.3

6.0

24.76

24.56

mmol/l

0.78

758

2612

Schizophrenia or delusion

1415

6514

2.28

168.43

7.9

7.1

25.54

24.50

mmol/l

15.24

1326

6072

Schizophrenia, schizotypal and delusional disorders

1419

6565

2.27

166.81

7.9

7.2

25.54

24.51

mmol/l

14.85

1329

6121

Injuries to the head

4567

19154

1.59

166.50

8.0

6.9

24.62

24.56

mmol/l

0.44

4331

17788

Deforming dorsopathies

1265

5597

2.39

166.09

7.2

7.0

24.89

24.50

mmol/l

3.35

1184

5209

Early onset COPD

1204

5256

2.47

165.85

10.2

7.2

25.86

24.38

mmol/l

25.58

1135

4882

Osteopathies and chondropathies

2413

12728

1.87

165.75

7.5

6.9

24.88

24.60

mmol/l

2.94

2256

11874

Other headache syndromes

1713

8527

2.09

164.97

7.0

6.6

24.69

24.51

mmol/l

1.38

1618

7879

Pain (limb, back, neck, head abdominally)

3230

9439

1.76

163.20

7.1

24.46

24.48

mmol/l

0.07

3023

8709

Benign neoplasm of colon, rectum, anus and anal canal

2435

9608

1.89

162.75

7.3

7.1

24.58

24.61

mmol/l

0.14

2293

8956

Bronchitis

4456

18868

1.59

160.77

7.7

6.9

24.85

24.49

mmol/l

7.95

4209

17534

Autoimmune diseases excluding thyroid diseases

4459

15860

1.60

160.50

8.0

6.9

24.47

24.57

mmol/l

0.91

4151

14777

Obesity due to excess calories

1886

9814

2.00

160.49

8.6

7.1

25.02

24.49

mmol/l

6.49

1780

9108

Secondary malignant neoplasm of respiratory and digestive organs, excluding all cancers (controls excluding all cancers)

971

3923

2.71

159.75

7.4

7.2

24.76

24.58

mmol/l

0.74

917

3640

Hernia

3979

17043

1.63

159.49

8.1

6.9

24.61

24.64

mmol/l

0.18

3746

15834

Abnormal findings on examination of blood, without diagnosis

2238

11554

1.90

158.99

7.5

24.40

24.52

mmol/l

0.72

2089

10805

Focal epilepsy

1073

4524

2.54

158.89

10.1

6.7

24.69

24.47

mmol/l

1.03

1013

4203

Dentinal caries

1121

4788

2.48

158.53

10.0

7.1

24.48

24.56

mmol/l

0.28

1053

4457

Intestinal infectious diseases

3869

19025

1.62

158.17

8.2

6.8

24.42

24.60

mmol/l

1.97

3665

17676

Use of hypnotics and sedatives

4545

17047

1.58

157.04

7.7

7.1

24.76

24.53

mmol/l

3.67

4260

15865

Disorders of gallbladder, biliary tract and pancreas

4219

17435

1.60

157.01

8.2

6.9

24.50

24.64

mmol/l

1.64

3966

16247

Aneurysms, operations, SAH

918

3645

2.75

156.15

12.0

6.6

24.86

24.61

mmol/l

1.28

869

3380

Cervicobrachial syndrome

1017

4210

2.56

155.64

6.9

7.3

24.88

24.49

mmol/l

3.43

967

3923

Soft tissue disorders

4324

14338

1.60

155.59

6.8

7.1

24.54

24.50

mmol/l

0.22

4034

13355

Viral pneumonia

676

2299

3.22

153.99

10.2

6.0

25.21

24.21

mmol/l

7.16

615

2152

Other and unspecified nerve root and plexus disorders, also in other diseases

928

3713

2.69

153.97

6.3

7.2

24.83

24.55

mmol/l

1.55

841

3459

Dental caries

1222

5451

2.35

153.88

9.7

7.0

24.48

24.55

mmol/l

0.22

1148

5074

Autoimmune diseases excluding thyroid diseases, strict definition

4308

15421

1.59

153.52

7.8

6.9

24.45

24.56

mmol/l

1.06

4013

14374

Other functional intestinal disorders

1976

10094

1.94

152.28

7.3

6.5

24.77

24.60

mmol/l

1.03

1845

9380

Cardiac arrest

355

649

5.21

151.91

15.0

6.0

24.13

24.58

mmol/l

0.86

338

580

Sequelae with surgical and medical care as external cause

1054

4521

2.53

151.56

9.6

6.7

24.91

24.58

mmol/l

1.79

1000

4204

Symptoms and signs involving the nervous and musculoskeletal systems

2474

14288

1.80

150.24

7.6

7.0

24.92

24.54

mmol/l

5.80

2322

13314

Gastrointestinal diseases

2338

6341

1.89

150.20

7.4

6.0

24.27

24.61

mmol/l

3.40

2172

5853

Transient ischemic attack

2468

11745

1.82

150.02

7.1

6.9

24.54

24.63

mmol/l

0.61

2321

10931

Allergic asthma (mode), excluding more controls

857

3239

2.70

149.75

7.6

5.6

24.59

24.15

mmol/l

2.77

798

2971

ILD, hospital admission 2, with pulmonary infections

584

1872

3.51

149.11

9.8

5.9

25.20

24.19

mmol/l

7.48

557

1744

Diarrhoea and gastroenteritis of presumed infectious origin

2883

15713

1.72

149.04

8.4

6.7

24.41

24.59

mmol/l

1.64

2737

14603

Hypertensive Heart Disease

1118

3967

2.45

148.43

10.1

6.4

25.10

24.57

mmol/l

3.67

1064

3671

GI-bleeding

1612

8210

2.08

148.25

9.7

6.6

24.13

24.59

mmol/l

4.06

1540

7647

Intracranial injury

2485

13914

1.79

148.07

8.5

6.8

24.65

24.50

mmol/l

1.17

2357

12925

Malignant neoplasm of digestive organs, excluding all cancers (controls excluding all cancers)

2080

8867

1.92

147.44

8.4

7.1

24.49

24.61

mmol/l

0.73

1969

8270

Atherosclerosis, excluding cerebral and coronary sclerosis

2087

9172

1.92

146.57

8.8

6.4

24.20

24.61

mmol/l

4.45

1968

8525

Osteoporosis

1268

5652

2.29

146.54

7.6

6.1

24.97

24.72

mmol/l

1.40

1191

5259

Other acute lower respiratory infections

2307

12528

1.82

146.30

8.3

6.8

25.29

24.43

mmol/l

21.30

2178

11677

Volume depletion

558

1759

3.54

145.84

11.5

6.5

24.10

24.57

mmol/l

1.45

541

1642

Alcohol dependence

1337

6405

2.21

145.17

9.6

7.4

24.54

24.46

mmol/l

0.25

1280

5961

Vocal cord dysfunction

528

1460

3.55

144.43

8.9

5.0

25.13

24.75

mmol/l

1.65

480

1345

Endovascular or surgical operations to intracerebral aneurysms

448

1245

4.18

144.22

11.7

7.3

24.92

24.67

mmol/l

0.76

435

1149

Focal epilepsy, strict definition

992

4224

2.52

143.97

10.1

6.6

24.71

24.48

mmol/l

1.02

937

3928

Benign neoplasm: Colon

2141

9091

1.88

143.96

7.3

7.0

24.58

24.61

mmol/l

0.12

2017

8458

Other symptoms and signs involving cognitive functions and awareness

2051

10645

1.89

143.88

7.9

6.9

24.69

24.56

mmol/l

0.82

1944

9907

Finngen Rheumatological endpoints

3964

14477

1.60

143.61

7.3

7.1

24.63

24.52

mmol/l

0.97

3668

13488

Alcohol abuse, main dg

813

3165

2.78

143.20

8.6

7.6

24.52

24.42

mmol/l

0.24

780

2962

Other diseases of the digestive system

1587

8144

2.06

142.84

9.6

6.7

24.10

24.60

mmol/l

4.77

1518

7585

Stroke, excluding SAH

2757

12241

1.74

142.05

8.7

7.0

24.73

24.62

mmol/l

0.78

2600

11411

Other disorders of teeth and supporting structures

1079

4790

2.41

142.04

10.2

7.0

24.65

24.63

mmol/l

0.06

1014

4469

Fall on same level

4706

17524

1.53

141.89

8.1

6.9

24.70

24.51

mmol/l

2.59

4419

16294

Neoplasms

2958

9427

1.72

141.44

7.3

7.1

24.42

24.41

mmol/l

0.04

2762

8754

Anxiety disorders, excluding more controls

3159

12845

1.67

141.23

8.1

6.6

24.77

24.54

mmol/l

2.62

2987

11888

Abnormalities of heart beat

1380

6664

2.14

140.75

6.4

6.6

24.43

24.45

mmol/l

0.07

1307

6147

Focal epilepsy, mode (most common among epilepsy diagnosis)

939

3952

2.55

139.88

10.2

6.6

24.63

24.48

mmol/l

0.54

892

3670

COPD, hospital admissions 1, only main diagnosis

1785

8112

1.98

139.70

9.1

6.8

25.86

24.35

mmol/l

40.79

1703

7548

Peripheral arterial reconstruction

996

4361

2.50

137.93

10.8

6.3

24.14

24.46

mmol/l

1.70

936

4070

Other respiratory diseases principally affecting the interstitium

994

4343

2.49

137.79

10.3

6.7

25.15

24.54

mmol/l

5.18

947

4047

Acute alcohol intoxication

1232

5840

2.23

137.26

8.5

7.3

24.52

24.42

mmol/l

0.33

1177

5436

Rotator cuff syndrome

2730

12177

1.72

136.95

6.8

7.3

24.64

24.60

mmol/l

0.25

2560

11357

Pain, not elsewhere classified

1100

4978

2.32

136.25

6.9

6.6

24.89

24.56

mmol/l

2.20

1041

4600

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

582

1972

3.31

135.32

10.7

6.9

24.72

24.48

mmol/l

0.76

548

1833

Carpal tunnel syndrome

2480

13277

1.74

134.47

7.3

7.0

24.80

24.65

mmol/l

1.25

2293

12387

Aplastic and other anaemias

2088

11260

1.84

134.16

9.0

6.7

24.33

24.57

mmol/l

1.69

1974

10483

ILD medications: immunosuppressive drugs

2406

13614

1.75

133.49

7.9

7.0

24.39

24.56

mmol/l

1.39

2245

12652

Allergic asthma (mode)

857

3425

2.55

133.47

7.6

5.8

24.59

24.12

mmol/l

3.09

798

3152

Type 1 diabetes, wide definition, subgroup 1

896

3752

2.51

132.87

9.3

6.4

23.70

24.65

mmol/l

7.80

828

3470

malignant neoplasm of female genital organs

758

2996

2.76

130.27

6.7

6.4

24.93

24.97

mmol/l

0.11

724

2790

Personality disorders

1061

4836

2.30

129.05

7.7

7.2

25.05

24.37

mmol/l

6.17

999

4500

Oedema, not elsewhere classified

1325

6554

2.11

128.94

9.1

6.4

25.21

24.55

mmol/l

6.45

1248

6081

Diverticular disease of intestine

3102

12910

1.65

128.81

7.4

6.8

24.56

24.66

mmol/l

0.82

2933

12008

Disorders of adult personality and behaviour

1100

5090

2.26

128.74

8.0

7.2

25.12

24.36

mmol/l

8.02

1031

4736

Specific personality disorders

934

4059

2.41

127.44

7.8

7.2

25.19

24.33

mmol/l

8.35

881

3780

ILD, hospital admissions 3, with pneumonia sepsis

505

1638

3.48

126.85

10.6

6.0

25.31

24.16

mmol/l

7.87

481

1523

Mood disorders

4083

17894

1.53

126.73

8.0

6.9

24.78

24.55

mmol/l

3.23

3852

16627

Supplementary factors related to causes of morbidity and mortality classified elsewhere

1332

6690

2.09

126.50

8.3

7.0

24.83

24.51

mmol/l

2.25

1260

6236

Mood [affective] disorders

4069

17863

1.53

126.15

8.0

6.9

24.78

24.56

mmol/l

3.22

3839

16597

Other symptoms and signs involving the nervous and musculoskeletal systems

1746

9595

1.89

125.82

7.9

7.0

24.97

24.50

mmol/l

6.73

1637

8950

Other or unspecified ileus, impaction or obstruction

950

4228

2.41

124.63

10.1

6.7

24.87

24.66

mmol/l

0.81

902

3922

Short Achilles tendon (acquired)

227

416

6.67

123.60

7.3

7.8

24.84

24.69

mmol/l

0.20

208

386

Constipation

3616

17017

1.56

123.30

7.4

7.1

24.86

24.54

mmol/l

5.29

3405

15862

Chronic kidney disease

1454

7589

2.02

123.16

10.6

6.3

22.83

24.70

mmol/l

42.11

1362

7085

Substance use, excluding alcohol

829

3478

2.52

123.09

10.4

7.3

25.23

24.53

mmol/l

4.98

792

3231

Other disorders of skin and subcutaneous tissue

2849

16423

1.64

122.85

8.4

6.9

24.48

24.63

mmol/l

1.17

2662

15311

Benzodiazepine use

4055

19434

1.52

122.28

7.6

7.0

25.00

24.50

mmol/l

13.26

3842

18058

Persons encountering health services for examination and investigation

2772

8429

1.69

121.48

7.5

6.5

24.51

24.47

mmol/l

0.15

2580

7764

Nutritional anaemias

2099

11962

1.77

121.29

9.0

6.5

24.37

24.59

mmol/l

1.58

1978

11150

Iron deficiency anaemia

1796

9978

1.86

121.22

9.4

6.5

24.40

24.59

mmol/l

1.23

1696

9282

Type 1 diabetes

1058

4936

2.24

121.15

9.2

6.6

23.67

24.63

mmol/l

9.29

979

4573

Acute alcohol intoxication, ICD10

936

4182

2.38

121.15

8.8

7.7

24.31

24.47

mmol/l

0.55

899

3907

Depression

3696

16846

1.54

120.07

8.1

6.9

24.77

24.56

mmol/l

2.59

3487

15647

Conductive and sensorineural hearing loss

3400

15350

1.58

119.93

6.9

7.2

24.59

24.66

mmol/l

0.48

3184

14343

Disorders of lens

2911

11517

1.64

119.33

7.8

7.4

24.52

24.67

mmol/l

1.08

2702

10757

Other disorders of urethra and urinary system

2794

13086

1.64

119.13

7.4

6.7

24.77

24.51

mmol/l

2.80

2630

12151

Schizophrenia

755

3102

2.59

118.02

8.0

7.6

26.16

24.40

mmol/l

20.51

705

2883

Used for control exclusion in common control thyroid runs

4328

14906

1.50

116.48

7.8

6.9

24.40

24.56

mmol/l

1.68

4031

13894

External causes of morbidity and mortality

2681

8178

1.68

115.63

7.5

6.0

24.45

24.49

mmol/l

0.21

2507

7589

Spondylosis

2161

11031

1.74

114.81

6.5

7.3

24.93

24.54

mmol/l

5.80

2028

10289

Other and unspecified anaemias

1885

10546

1.81

114.73

8.9

6.6

24.38

24.56

mmol/l

0.96

1790

9824

Benign neoplasms

2846

10055

1.64

114.25

7.3

7.1

24.37

24.43

mmol/l

0.36

2671

9333

Type 1 diabetes, wide definition

922

4171

2.31

114.18

9.2

6.5

23.72

24.63

mmol/l

7.59

851

3868

Spondylolisthesis/Spondylolysis

832

3630

2.44

113.80

7.0

7.3

24.64

24.52

mmol/l

0.41

781

3380

Autoimmune diseases

4521

15910

1.48

113.44

7.9

6.9

24.39

24.57

mmol/l

2.10

4216

14821

Direct fill therapy

645

2514

2.76

113.21

9.6

7.2

24.71

24.42

mmol/l

1.05

604

2353

Sensorineural hearing loss

3243

14857

1.57

112.76

6.9

7.2

24.57

24.66

mmol/l

0.71

3036

13884

Other anaemias

1892

10625

1.79

112.48

8.9

6.6

24.39

24.56

mmol/l

0.89

1797

9898

Gastroduodenal ulcer

1305

6786

2.03

112.25

9.7

6.6

24.25

24.58

mmol/l

2.17

1229

6334

ILD, hospital admissions

809

3545

2.49

111.74

8.8

6.6

25.07

24.50

mmol/l

4.16

771

3304

Nephropathy related operations

662

2649

2.74

111.41

17.3

6.8

22.63

24.59

mmol/l

24.76

629

2477

Postprocedural musculoskeletal disorders, not elsewhere classified

441

1432

3.52

111.30

8.6

6.8

25.08

24.50

mmol/l

2.29

403

1335

Ischaemic Stroke, excluding all haemorrhages

2511

11807

1.67

111.11

8.0

7.0

24.67

24.62

mmol/l

0.27

2370

10996

Other interstitial pulmonary diseases

816

3602

2.47

110.72

8.7

6.6

25.08

24.49

mmol/l

4.37

778

3357

Interstitial lung disease endpoints

816

3609

2.46

110.23

8.7

6.6

25.08

24.48

mmol/l

4.46

778

3365

Interstitial lung disease

816

3609

2.46

110.23

8.7

6.6

25.08

24.48

mmol/l

4.46

778

3365

Cervical disc disorders

1513

8327

1.89

108.59

7.0

7.4

24.77

24.52

mmol/l

2.21

1426

7758

Other disorders of ear

3730

16831

1.51

108.53

6.8

7.2

24.61

24.64

mmol/l

0.19

3497

15715

Hypokalaemia

586

2231

2.85

108.38

10.6

6.7

25.46

24.72

mmol/l

2.69

558

2077

Mycoses

1152

5829

2.08

107.70

9.4

7.0

24.68

24.52

mmol/l

0.68

1081

5434

Missing teeth due to accident, extraction or parodontitis

626

2480

2.75

107.30

10.2

6.9

24.76

24.69

mmol/l

0.18

594

2304

Problems related to lifestyle

532

1936

2.97

106.92

9.3

6.9

24.80

24.31

mmol/l

1.78

505

1793

Chronic periapical parodontitis

969

4618

2.22

106.82

10.0

7.2

24.52

24.58

mmol/l

0.18

910

4301

Unspecified acute lower respiratory infection

731

3113

2.51

106.17

10.3

7.1

25.57

24.38

mmol/l

12.03

690

2899

Infections of the skin and subcutaneous tissue

2207

13507

1.67

105.60

8.9

7.1

24.70

24.52

mmol/l

1.31

2085

12576

Other reaction to severe stress, and adjustment disorders

1267

6647

1.97

104.56

8.9

6.8

24.67

24.49

mmol/l

1.01

1214

6140

Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)

363

1081

3.77

104.26

8.0

6.6

24.60

25.04

mmol/l

1.47

349

988

Gonarthrosis [arthrosis of knee](FG)

3234

12563

1.55

104.23

6.6

7.2

24.79

24.61

mmol/l

1.88

3010

11724

Other/unspecified dorsalgia

1447

7902

1.89

104.09

7.1

24.89

24.46

mmol/l

4.26

1361

7365

Benign neoplasm of colon, rectum, anus and anal canal

2643

15356

1.61

103.87

7.3

7.1

24.56

24.66

mmol/l

0.64

2493

14311

Migraine

1545

7310

1.84

102.62

6.3

6.5

24.47

24.42

mmol/l

0.23

1448

6746

Falls/tendency to fall

4372

15273

1.46

102.33

7.9

6.8

24.57

24.51

mmol/l

0.47

4094

14207

ILD, hospital admissions 1, main diag only

729

3178

2.51

102.18

8.5

6.6

25.07

24.48

mmol/l

3.87

697

2956

Other CVD

967

4705

2.20

102.04

8.8

6.4

24.47

24.50

mmol/l

0.07

912

4390

Pain in thoracic spine

644

2628

2.60

101.87

6.9

7.1

24.96

24.42

mmol/l

3.77

614

2447

Cough

1460

7743

1.87

101.74

6.7

6.8

24.80

24.50

mmol/l

2.47

1382

7151

Cerebral aneurysm, nonruptured

481

1719

3.10

101.29

10.5

7.1

24.82

24.66

mmol/l

0.49

455

1592

Cardiomyopathy

757

3333

2.41

101.19

9.9

6.1

24.28

24.51

mmol/l

0.83

721

3069

Hernia of abdominal wall

1923

11583

1.72

100.90

9.4

7.1

24.77

24.57

mmol/l

1.53

1808

10819

Drugs, medicaments and biological substances causing adverse effects in therapeutic use

456

1583

3.15

100.58

8.9

6.0

24.84

24.49

mmol/l

1.00

432

1469

Sleep disorders (combined)

3892

17669

1.47

100.45

7.7

7.1

25.02

24.50

mmol/l

13.97

3689

16403

Factors influencing health status and contact with health services

1388

3639

1.97

99.73

7.5

5.8

24.45

24.46

mmol/l

0.02

1301

3335

Diagnoses used for exclusion with ILD

1186

6239

2.00

99.25

9.8

6.9

25.06

24.49

mmol/l

5.42

1102

5819

Gonarthrosis

2785

10315

1.59

98.61

6.7

7.2

24.78

24.62

mmol/l

1.51

2586

9630

Diseases of the skin and subcutaneous tissue

4176

14598

1.46

98.31

8.1

6.6

24.52

24.56

mmol/l

0.25

3910

13566

Type of accident

1176

6181

1.99

97.93

8.0

6.9

24.94

24.51

mmol/l

3.35

1114

5760

Disorders of thyroid, IBD co-morbidities

559

1512

2.79

97.76

6.5

5.9

24.50

24.47

mmol/l

0.06

520

1398

Diseases of pulp and periapical tissues

1444

8091

1.85

97.69

9.6

7.0

24.52

24.58

mmol/l

0.24

1355

7531

Other and unspecified nonorganic psychotic disorders

737

3249

2.38

97.37

8.6

7.2

25.33

24.32

mmol/l

8.02

684

3018

Dermatitis

2383

15234

1.61

97.07

8.2

6.9

24.66

24.62

mmol/l

0.20

2245

14192

Arthrosis

3001

10840

1.56

97.05

7.1

7.2

24.68

24.60

mmol/l

0.51

2772

10111

Acute sinusitis

1890

10603

1.71

96.92

8.2

7.0

24.62

24.53

mmol/l

0.50

1768

9843

Anxiety disorders

3280

15713

1.51

96.89

8.2

6.9

24.73

24.59

mmol/l

1.30

3101

14577

Gout

1288

6364

1.94

96.88

9.6

7.3

24.03

24.55

mmol/l

4.08

1222

5953

Neurotic, stress-related and somatoform disorders

3236

15528

1.51

96.29

8.2

6.9

24.73

24.59

mmol/l

1.21

3058

14411

Acute bronchitis

1678

9650

1.76

96.10

8.0

6.7

25.32

24.43

mmol/l

16.30

1583

8987

Senile cataract

2645

10588

1.60

95.90

7.8

7.5

24.56

24.67

mmol/l

0.72

2451

9880

Dialysis, with operation codes

647

2745

2.55

95.66

17.6

6.6

22.57

24.72

mmol/l

28.24

614

2560

Emotionally unstable personality disorder

465

1667

2.95

94.88

7.9

7.2

24.96

24.18

mmol/l

3.83

444

1552

Gastric ulcer

898

4369

2.19

94.36

10.1

6.5

24.46

24.59

mmol/l

0.42

856

4084

Any operation in hilmo

150

11.12

94.15

10.3

2.6

24.29

24.31

mmol/l

0.01

139

Idiopathic pulmonary fibrosis

465

1710

3.06

93.95

7.5

6.6

25.11

24.43

mmol/l

3.15

443

1589

Benign neoplasms

3876

15069

1.46

93.89

7.3

7.1

24.41

24.53

mmol/l

1.06

3633

14009

Other and unspecified drugs and medicaments

439

1564

3.09

92.76

9.0

7.1

24.92

24.47

mmol/l

1.50

416

1458

Extreme obesity with alveolar hypoventilation

281

772

4.27

92.59

11.5

7.6

28.53

24.49

mmol/l

32.25

271

719

Diseases of the musculoskeletal system and connective tissue

2010

6033

1.70

92.46

6.2

7.5

24.43

mmol/l

0.00

1859

5615

Obesity, other/unspecified

1222

6629

1.91

91.58

8.5

6.9

25.01

24.49

mmol/l

4.71

1151

6158

Injuries to the abdomen, lower back, lumbar spine and pelvis

1596

9323

1.76

91.19

9.1

6.7

24.98

24.50

mmol/l

5.33

1514

8673

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

344

1073

3.52

91.00

7.6

7.4

24.59

24.42

mmol/l

0.31

332

999

Injuries to the thorax

1868

11462

1.69

90.96

8.7

7.1

24.83

24.50

mmol/l

3.26

1750

10698

Anxiety (asthma-related co-morbidities)

1931

9301

1.67

90.41

8.4

6.7

24.68

24.52

mmol/l

1.06

1830

8612

Organic, including symptomatic, mental disorders

2165

9857

1.65

90.16

7.4

7.0

24.58

24.60

mmol/l

0.06

2065

9163

Ventral hernia

1063

5570

2.01

90.03

11.0

6.7

24.76

24.60

mmol/l

0.70

1000

5174

Other symptoms and signs involving the circulatory and respiratory systems

338

1051

3.53

89.88

7.1

6.7

24.68

24.49

mmol/l

0.39

321

966

Traumatic subdural haemorrhage

619

2591

2.51

89.77

10.6

6.1

24.68

24.17

mmol/l

2.42

594

2392

ILD-related respiratory insufficiency

258

693

4.57

89.25

12.4

6.5

25.35

24.44

mmol/l

2.81

243

651

Enterocolitis due to Clostridium difficile

561

2304

2.64

89.15

10.7

6.3

24.43

24.58

mmol/l

0.35

531

2147

Schizoaffective disorder

377

1259

3.26

88.75

7.3

7.7

25.96

24.43

mmol/l

7.64

354

1171

Undetermined asthma, excluding more controls

482

1826

2.78

88.34

6.7

5.6

24.85

24.22

mmol/l

2.83

460

1674

Nontraumatic intracranial haemmorrhage

957

4881

2.08

88.07

12.6

6.5

24.81

24.51

mmol/l

1.58

907

4539

Fungal Sepsis

247

643

4.48

87.55

16.6

5.7

24.84

24.59

mmol/l

0.36

237

595

Other bacterial intestinal infections

813

3917

2.20

87.28

9.5

6.5

24.33

24.62

mmol/l

1.15

772

3635

L04AD Calcineurin inhibitors

499

1953

2.76

87.26

10.8

7.6

23.47

24.56

mmol/l

7.30

464

1823

Transplanted organ and tissue status

459

1742

2.85

85.43

11.4

6.8

23.11

24.60

mmol/l

10.91

428

1614

Viral and other specified intestinal infections

720

3238

2.25

84.66

7.4

6.3

24.33

24.36

mmol/l

0.07

680

3007

Cholelithiasis, broad definition with cholecystitis

3389

16225

1.46

84.49

7.3

6.8

24.57

24.65

mmol/l

0.58

3186

15110

Disorders of eyelid, lacrimal system and orbit

3265

17868

1.46

83.84

7.0

7.1

24.76

24.57

mmol/l

2.37

3048

16669

Other arthrosis

2146

9806

1.61

83.46

7.4

7.3

24.80

24.63

mmol/l

1.28

1992

9163

Symptoms and signs concerning food and fluid intake

461

1767

2.79

83.42

9.6

6.2

24.79

24.51

mmol/l

0.70

429

1640

Chronic ulcer of skin, not elsewhere classified

397

1426

3.11

83.39

11.1

7.1

24.52

24.53

mmol/l

0.01

373

1330

Implicit fungal Sepsis

228

581

4.60

83.32

15.7

5.7

24.77

24.52

mmol/l

0.34

219

536

Viral hepatitis, IBD co-morbidity

199

446

4.74

82.86

10.0

6.6

24.72

24.29

mmol/l

0.64

188

416

Symptoms and signs involving the urinary system

3060

16364

1.48

82.30

7.4

7.1

24.64

24.60

mmol/l

0.25

2880

15264

Other cataract

1783

8517

1.68

81.68

6.8

7.4

24.42

24.63

mmol/l

1.38

1676

7921

Other and unspecified iron deficiency

1308

7518

1.81

81.47

8.8

6.5

24.43

24.55

mmol/l

0.49

1242

7003

Explicit bacterial Sepsis

482

1920

2.70

81.09

10.8

5.6

24.42

24.53

mmol/l

0.21

451

1784

Delirium, not induced by alcohol and other psychoactive substances

574

2488

2.49

80.76

11.2

6.4

24.54

24.52

mmol/l

0.04

555

2313

Sequelae of cerebrovascular disease

1556

8224

1.73

80.72

8.6

6.5

24.57

24.50

mmol/l

0.28

1470

7635

Vascular disorders of the intestines

392

1423

3.06

80.59

10.5

6.4

23.89

24.62

mmol/l

2.49

370

1318

Abnormal serum enzyme levels

1381

8011

1.78

80.45

7.1

7.8

24.42

24.48

mmol/l

0.25

1272

7490

Coxarthrosis

2123

9237

1.60

80.45

6.9

7.2

24.71

24.63

mmol/l

0.44

1975

8640

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

978

5170

1.98

80.39

7.6

7.3

24.42

24.72

mmol/l

1.68

923

4811

Secondary hypertension

276

793

3.66

80.37

10.7

5.8

24.37

24.43

mmol/l

0.07

257

718

All influenza (not pneumonia)

611

2706

2.38

80.33

7.5

6.3

24.88

24.26

mmol/l

3.81

568

2529

Benign neoplasm: Colon

2189

14065

1.58

80.25

7.4

7.1

24.59

24.65

mmol/l

0.27

2065

13109

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

882

4433

2.03

79.85

7.6

6.5

24.72

24.23

mmol/l

3.54

828

4126

Hypotension

802

3992

2.15

79.73

8.2

6.4

24.47

24.49

mmol/l

0.04

759

3726

Depression or dysthymia

2696

10107

1.52

79.66

8.0

7.0

24.65

24.46

mmol/l

1.72

2543

9342

Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)

465

1845

2.75

79.60

5.6

6.1

24.99

25.02

mmol/l

0.06

448

1704

Other diseases of urinary system

3948

15999

1.41

79.53

7.5

7.0

24.59

24.50

mmol/l

0.75

3688

14888

Hyperkalaemia

313

1009

3.48

79.42

13.1

6.9

22.67

24.51

mmol/l

6.90

303

938

Lung diseases due to external agents

692

3262

2.27

79.35

11.2

6.5

25.30

24.37

mmol/l

7.61

646

3051

Other retinal disorders

2586

14048

1.52

79.14

8.4

7.0

24.36

24.65

mmol/l

2.98

2420

13105

Mental and behavioural disorders due to multiple drug use and use of multiple drugs and use of other psychoactive substances

305

960

3.42

78.89

8.4

25.01

24.37

mmol/l

1.87

294

892

Streptococcal septicaemia

422

1602

2.87

78.84

10.0

6.1

24.44

24.49

mmol/l

0.07

392

1484

Subarachnoid haemorrhage

533

2263

2.55

78.75

14.0

6.6

24.87

24.61

mmol/l

0.79

508

2097

L04AA Selective immunosuppressants

853

4333

2.06

78.74

9.3

7.3

23.89

24.62

mmol/l

6.15

798

4023

Coxarthrosis [arthrosis of hip](FG)

2269

10781

1.57

78.25

6.9

7.2

24.72

24.62

mmol/l

0.60

2115

10074

Visual disturbances

1784

11233

1.64

77.98

7.4

6.9

24.63

24.59

mmol/l

0.14

1653

10482

Undetermined asthma

482

1951

2.60

77.23

6.7

5.7

24.85

24.21

mmol/l

2.97

460

1800

Cutaneous abscess, furuncle and carbuncle

985

5279

1.94

77.21

9.9

7.1

24.66

24.50

mmol/l

0.57

930

4907

Acute upper respiratory infections

3984

18170

1.40

76.76

7.6

6.9

24.65

24.55

mmol/l

0.85

3754

16901

Malignant neoplasm of digestive organs

1666

10222

1.67

76.75

8.7

6.8

24.51

24.56

mmol/l

0.23

1570

9521

Acute upper respiratory infections of multiple and unspecified sites

2679

13692

1.49

76.43

7.5

6.9

24.63

24.51

mmol/l

0.88

2544

12711

Injury, poisoning and certain other consequences of external causes

2046

6501

1.61

75.17

7.5

5.9

24.42

24.49

mmol/l

0.28

1920

6008

Temporomandibular joint disorders

560

2452

2.38

75.01

6.8

6.7

24.65

24.63

mmol/l

0.06

526

2250

Colorectal cancer, excluding all cancers (controls excluding all cancers)

1192

6620

1.82

74.81

8.3

7.0

24.47

24.61

mmol/l

0.65

1132

6167

Post-traumatic stress disorder

283

876

3.41

74.56

6.9

6.1

24.37

24.08

mmol/l

0.69

262

809

Non-selective monoamine reuptake inhibitors

1539

9158

1.68

74.52

7.2

6.8

25.15

24.52

mmol/l

8.52

1449

8502

Peripheral artery operations in Hilmo

631

2941

2.29

74.33

11.9

6.0

23.89

24.45

mmol/l

2.62

598

2742

Sub-endpoint used in defining T1D endpoints

1174

6594

1.81

74.20

8.9

6.9

23.77

24.51

mmol/l

6.71

1087

6148

Other degenerative diseases of the nervous system

1047

4325

1.90

73.99

5.8

6.0

24.45

24.31

mmol/l

0.55

993

3986

Congenital malformations, deformations and chromosomal abnormalities

1973

12279

1.57

73.85

8.8

7.0

24.69

24.49

mmol/l

1.54

1837

11427

Visual disturbances and blindness

1903

12316

1.59

73.78

7.5

6.8

24.65

24.58

mmol/l

0.34

1765

11498

Gonarthrosis,primary

3619

16459

1.41

73.49

6.6

7.3

24.77

24.61

mmol/l

1.94

3370

15388

Cardiomyopathies, Primary/intrinsic

531

2311

2.44

73.33

9.9

6.2

24.15

24.46

mmol/l

0.90

502

2131

Complications of internal orthopaedic prosthetic devices, implants and grafts

979

5346

1.93

73.32

7.4

6.1

25.04

24.63

mmol/l

2.53

924

4972

Other complications of surgical and medical care, not elsewhere classified

432

1718

2.70

72.93

10.1

6.1

24.62

24.55

mmol/l

0.12

417

1579

All anxiety disorders

1953

10164

1.58

72.55

8.3

6.9

24.66

24.54

mmol/l

0.72

1852

9437

Cholelithiasis

3201

15971

1.43

72.45

6.9

6.8

24.59

24.65

mmol/l

0.39

3011

14869

Unspecified misadventure during surgical and medical care

313

1068

3.30

72.41

14.8

7.6

25.07

24.47

mmol/l

1.99

300

996

Arthropathies

3360

12121

1.43

72.35

6.5

7.1

24.41

24.50

mmol/l

0.66

3114

11301

Genitourinary diseases

2381

7914

1.54

72.10

8.2

6.9

24.31

24.62

mmol/l

3.13

2220

7355

Sleep apnoea

3493

17121

1.41

71.81

7.8

7.2

25.10

24.54

mmol/l

14.61

3312

15905

Other mental disorders due to brain damage and dysfunction and to physical disease

561

2542

2.38

71.47

7.8

6.3

24.30

24.57

mmol/l

0.96

536

2369

Other gastritis (incl. Duodenitis)

979

5394

1.90

70.89

8.7

6.8

24.54

24.60

mmol/l

0.18

929

5033

Disorders of choroid and retina

3177

16535

1.43

70.82

8.1

7.0

24.40

24.66

mmol/l

3.28

2970

15440

Disorders of other endocrine glands

1577

9695

1.65

70.76

7.9

6.7

24.65

24.59

mmol/l

0.28

1481

9016

Bacterial intestinal infections, IBD co-morbidities

797

4123

2.04

70.33

9.5

6.5

24.33

24.57

mmol/l

0.87

755

3845

Diseases of the eye and adnexa

2993

10466

1.45

69.73

7.5

6.9

24.35

24.51

mmol/l

1.31

2787

9750

Other disorders of the musculoskeletal system and connective tissue

656

3186

2.19

69.49

8.1

6.8

24.88

24.57

mmol/l

1.39

605

2963

Other and unspecified dermatitis

1881

12318

1.57

69.01

8.0

6.8

24.59

mmol/l

0.02

1775

11472

Ulcer of oesophagus

396

1567

2.78

68.77

9.9

6.6

24.71

24.51

mmol/l

0.45

377

1463

Bipolar affective disorders

650

3135

2.15

68.59

6.9

6.7

24.89

24.38

mmol/l

2.55

610

2902

Other diseases of pericardium

234

688

3.79

68.58

13.3

6.8

24.77

24.50

mmol/l

0.51

222

633

Sleep apnoea, including avohilmo

3652

17361

1.39

68.49

7.6

7.2

25.07

24.53

mmol/l

14.88

3461

16125

Cardiomyopathy (excluding other)

541

2453

2.34

67.82

10.0

6.0

24.12

24.47

mmol/l

1.13

512

2259

Hyperlipidaemia, other/unspecified

1539

9177

1.64

67.04

7.4

6.6

24.52

24.68

mmol/l

1.00

1461

8546

Status epilepticus

211

593

4.01

66.42

20.4

6.2

25.03

24.35

mmol/l

1.66

193

557

Toxic effects of substances chiefly nonmedicinal as to source

480

2090

2.44

66.25

6.7

7.3

24.39

24.43

mmol/l

0.07

459

1950

Azathioprine

569

2649

2.25

66.23

7.5

6.8

24.35

24.34

mmol/l

0.01

537

2452

Autoimmune diseases related-to ILD

3079

19540

1.41

66.23

8.1

6.9

24.65

24.57

mmol/l

0.62

2890

18179

Chronic pancreatitis

579

2736

2.26

66.16

12.2

7.0

24.16

24.58

mmol/l

1.52

550

2547

Migraine with aura

705

3541

2.05

66.14

7.4

6.1

24.28

24.33

mmol/l

0.14

665

3266

Myocarditis

183

460

4.26

65.93

6.3

6.6

24.44

24.38

mmol/l

0.08

171

420

ILD medications: azathioprine

569

2655

2.24

65.85

7.5

6.8

24.35

24.40

mmol/l

0.11

537

2455

Other joint disorders

3173

12108

1.42

64.98

6.5

7.1

24.48

24.50

mmol/l

0.13

2957

11289

Accidents

3230

11614

1.42

64.68

7.3

6.7

24.51

mmol/l

0.01

3015

10803

Disorders of synovium and tendon

1885

11231

1.55

64.66

7.1

24.55

24.56

mmol/l

0.04

1770

10451

Vascular syndromes of brain in cerebrovascular disorders

280

961

3.30

64.43

7.5

6.6

24.77

24.38

mmol/l

0.79

270

892

Emphysema

368

1448

2.78

64.33

9.5

6.7

24.51

24.24

mmol/l

0.63

341

1345

Gout, FINNGEN

1288

7888

1.70

64.30

9.6

7.0

24.03

24.55

mmol/l

4.21

1222

7376

Other external causes of accidental injury

3217

11614

1.41

62.93

7.4

6.7

24.52

24.51

mmol/l

0.04

3007

10803

Unintentional cut, puncture, perforation or haemorrhage during surgical and medical care

376

1510

2.70

62.86

10.9

6.8

24.57

24.53

mmol/l

0.07

362

1404

Diseases of peritoneum

479

2140

2.40

62.84

13.5

6.8

23.70

24.65

mmol/l

4.53

451

1987

Rheumatoid arthritis

1239

6822

1.70

62.51

7.6

7.0

24.75

24.64

mmol/l

0.47

1139

6378

Cervicalgia

768

4076

1.96

62.12

6.5

7.0

24.87

24.48

mmol/l

2.41

727

3810

Secondary malignant neoplasm of other and unspecified sites, excluding all cancers (controls excluding all cancers)

941

5355

1.84

61.52

6.2

7.2

24.71

24.60

mmol/l

0.41

887

4977

Acute peritonitis

337

1300

2.85

61.50

16.5

7.2

23.38

24.57

mmol/l

4.36

323

1210

Serous carcinoma of ovary, excluding all cancers (controls excluding all cancers)

196

555

4.03

61.40

8.9

6.3

24.54

24.80

mmol/l

0.45

191

506

Intestinal adhesions without obstruction

408

1721

2.56

61.30

12.4

6.5

24.53

24.71

mmol/l

0.36

391

1590

Candidiasis

536

2522

2.24

61.27

11.0

6.7

24.85

24.47

mmol/l

1.36

506

2339

Fracture of rib(s), sternum and thoracic spine

1217

7431

1.70

61.08

9.1

7.1

24.81

24.51

mmol/l

2.03

1149

6927

Parkinson's disease, excluding more controls

556

2584

2.21

61.01

5.7

6.1

25.72

24.26

mmol/l

17.00

518

2384

Exclusions for E4_PCOS_BROAD

633

3169

2.09

60.82

9.1

6.8

24.71

24.48

mmol/l

0.82

591

2941

Glaucoma suspect

1432

9106

1.63

60.80

6.3

7.0

24.52

24.68

mmol/l

0.84

1313

8476

Glomerular diseases

765

4103

1.96

60.67

10.3

7.1

23.08

24.58

mmol/l

17.92

718

3822

Other pleural conditions

496

2286

2.33

60.57

9.5

6.1

25.16

24.17

mmol/l

6.41

474

2124

Iron deficiency anaemia secondary to blood loss (chronic)

701

3660

2.02

60.42

10.5

6.4

24.36

24.62

mmol/l

0.98

659

3406

Kyphosis

115

221

6.57

60.27

9.6

6.1

26.16

24.62

mmol/l

2.74

107

212

Amputation

489

2247

2.34

60.14

12.3

6.4

23.92

24.47

mmol/l

1.84

460

2100

Enlarged lymph nodes

587

2871

2.13

60.06

6.8

7.0

24.76

24.54

mmol/l

0.76

543

2650

Selective serotonin reuptake inhibitors

3810

15009

1.36

59.59

7.4

6.9

24.82

24.42

mmol/l

8.48

3575

13935

Abnormal findings on diagnostic imaging of other body structures

536

2569

2.21

58.75

7.1

6.8

24.72

24.58

mmol/l

0.36

507

2376

Pneumonitis due to solids and liquids

406

1744

2.52

58.66

14.0

6.6

25.43

24.32

mmol/l

5.64

377

1631

Gastro-oesophageal reflux disease

2472

15562

1.44

58.49

7.4

6.8

24.51

24.64

mmol/l

1.00

2306

14516

Colorectal adenocarcinoma, excluding all cancers (controls excluding all cancers)

840

4696

1.88

58.44

8.2

6.8

24.47

24.57

mmol/l

0.36

799

4370

Unspecified fall

1792

11937

1.53

58.43

8.4

6.8

24.66

24.56

mmol/l

0.51

1688

11124

Nonorganic sleeping disorders, excluding more controls

581

2856

2.11

58.27

7.9

6.3

24.75

24.30

mmol/l

2.15

550

2624

Migraine without aura

533

2534

2.16

58.00

5.9

6.0

24.34

24.29

mmol/l

0.15

500

2341

Leisure time condition

696

3670

1.98

57.84

7.3

6.8

24.99

24.45

mmol/l

2.97

646

3425

Abnormal findings on antenatal screening of mother

225

709

3.31

57.38

4.7

6.7

23.11

23.87

mmol/l

2.48

209

657

Hydrocephalus

380

1602

2.57

57.38

10.6

6.7

24.68

24.47

mmol/l

0.46

363

1483

Psychotic depression

267

937

3.05

57.35

9.1

6.6

25.03

24.30

mmol/l

2.64

252

859

Benign neoplasm of other and ill-defined parts of digestive system

694

3675

1.98

57.19

8.1

6.8

24.56

24.64

mmol/l

0.22

654

3401

Polyarthrosis

792

4182

1.89

57.03

5.8

6.8

25.18

24.76

mmol/l

2.54

754

3920

Pain in joint

1949

8725

1.51

56.90

6.9

7.2

24.57

24.52

mmol/l

0.24

1818

8042

Artrosis, including avohilmo

3252

13154

1.38

56.81

6.8

7.5

24.64

24.55

mmol/l

0.71

3016

12244

Lung cancer and mesothelioma

726

3307

1.96

56.76

7.4

5.7

25.64

24.10

mmol/l

24.05

681

3045

Retention of urine

1452

7917

1.60

56.60

7.7

7.3

24.39

24.47

mmol/l

0.35

1375

7373

Other specific joint derangements/joint disorders

2449

11625

1.44

56.27

6.9

7.2

24.57

24.51

mmol/l

0.38

2277

10829

Familial hypercholesterolemia, with ischemic heart disease

433

1949

2.38

55.95

8.6

6.1

24.41

24.61

mmol/l

0.53

417

1808

Mental and behavioural disorders due to opioids

169

455

4.05

55.92

9.0

8.3

25.78

24.34

mmol/l

4.52

160

421

Extrapyramidal and movement disorders

1437

9327

1.59

55.67

6.3

7.0

25.24

24.55

mmol/l

9.98

1356

8686

Later onset COPD

1267

6239

1.66

55.66

8.5

6.2

25.53

24.28

mmol/l

20.25

1213

5795

Other anxiety disorders

1333

7486

1.61

55.18

8.2

6.7

24.71

24.46

mmol/l

1.63

1268

6925

Transport accidents

1593

9318

1.55

55.15

8.1

6.7

24.64

24.50

mmol/l

0.76

1465

8657

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

3614

17792

1.34

55.14

7.4

7.1

24.72

24.58

mmol/l

1.45

3385

16570

Combinations of oral blood glucose lowering drugs

1131

6966

1.69

54.98

7.5

7.1

24.05

24.71

mmol/l

6.31

1071

6504

Alzheimer’s disease (Atypical or mixed), excluding more controls

374

1359

2.55

54.84

4.7

5.8

24.46

24.18

mmol/l

0.69

354

1260

Colectomy operation

735

4030

1.92

54.73

11.3

6.8

24.05

24.60

mmol/l

3.58

696

3755

Dental operations

2654

9752

1.42

54.70

7.1

6.8

24.61

24.59

mmol/l

0.11

2474

9105

Phobic anxiety disorders

398

1725

2.39

54.59

9.1

6.3

24.37

24.20

mmol/l

0.36

374

1598

Secondary and unspecified malignant neoplasm of lymph nodes, excluding all cancers (controls excluding all cancers)

628

3276

2.02

54.43

7.6

7.3

25.00

24.55

mmol/l

2.06

587

3036

Pleural effusion

673

3594

1.98

54.43

9.6

6.3

25.33

24.24

mmol/l

9.94

637

3351

Diseases of the ear and mastoid process

4281

16698

1.31

53.91

6.8

7.2

24.51

24.58

mmol/l

0.56

4004

15563

Malignant neoplasm of corpus uteri

388

1701

2.47

53.77

5.7

6.0

25.03

24.94

mmol/l

0.22

374

1582

Diaphragmatic hernia

1378

8932

1.59

53.63

7.6

6.6

24.57

24.66

mmol/l

0.37

1303

8287

Injuries to the hip and thigh

1799

11248

1.50

53.46

7.7

6.7

24.96

24.52

mmol/l

4.99

1698

10476

Noninfective enteritis and colitis

1621

10852

1.53

53.25

8.2

7.0

24.25

24.56

mmol/l

2.71

1530

10101

Serous carcinoma of ovary

196

610

3.65

53.18

8.9

6.2

24.54

24.88

mmol/l

0.67

191

568

Panic disorder

452

2091

2.24

53.09

10.0

6.2

24.72

24.24

mmol/l

1.83

427

1936

Injuries to the shoulder and upper arm

3052

19116

1.36

52.62

7.3

7.1

24.64

24.61

mmol/l

0.19

2857

17813

Neuromuscular dysfunction of bladder

417

1895

2.35

52.60

7.6

7.1

25.00

24.59

mmol/l

1.43

385

1757

Dysphagia

919

5420

1.76

52.45

7.9

6.6

25.12

24.61

mmol/l

3.55

865

5027

Symptoms and signs involving the skin and subcutaneous tissue

2405

17304

1.41

52.30

7.2

7.0

24.64

24.59

mmol/l

0.25

2259

16121

Fracture of lumbar spine and pelvis

877

5117

1.79

52.20

9.1

6.4

25.20

24.57

mmol/l

4.97

835

4770

Diabetic retinopathy, excluding more controls

1067

3607

1.74

52.09

10.8

7.1

24.11

24.46

mmol/l

1.55

997

3356

Diseases of liver

1274

8166

1.61

52.08

10.1

7.2

23.81

24.62

mmol/l

9.48

1186

7615

Aortic aneurysm

985

5839

1.73

52.00

12.5

6.5

24.73

24.44

mmol/l

1.65

932

5435

Kidney transplant status

254

925

3.01

51.80

10.4

8.0

22.20

24.59

mmol/l

14.20

240

866

Other systemic involvement of connective tissue (FG)

924

5447

1.74

51.24

6.6

24.88

24.58

mmol/l

1.64

870

5087

Colorectal cancer

992

6034

1.72

51.03

8.7

6.9

24.45

24.57

mmol/l

0.48

939

5610

Parkinson's disease, strict definition, excluding more controls

501

2418

2.13

50.70

5.6

6.1

25.68

24.29

mmol/l

15.15

466

2229

Use of disulfiram, acamprosate or naltrexone

386

1726

2.39

50.49

9.0

8.3

24.82

24.52

mmol/l

0.75

376

1613

Other pulmonary heart/vessel disease

250

919

3.02

50.47

10.8

6.6

25.30

24.52

mmol/l

1.61

243

857

Deposits [accretions] on teeth

301

1158

2.68

50.40

10.7

6.5

24.31

24.39

mmol/l

0.13

283

1082

Medical observation and evaluation for suspected diseases and conditions

2320

8426

1.43

50.10

7.8

6.5

24.45

24.47

mmol/l

0.08

2178

7761

Disorders of lacrimal system

1468

9778

1.54

50.07

7.1

6.8

24.81

24.65

mmol/l

0.98

1369

9090

Secondary right heart disease

232

827

3.13

49.74

11.1

6.7

25.35

24.50

mmol/l

1.75

225

769

Certain disorders involving the immune mechanism

731

4118

1.85

49.29

9.1

7.0

24.56

24.60

mmol/l

0.11

673

3834

Insulin, fast-acting (human)

523

2637

2.06

49.24

9.7

6.7

23.67

24.52

mmol/l

4.16

488

2451

Other sleep disorders

437

2074

2.22

48.91

6.4

6.6

24.88

24.34

mmol/l

2.18

418

1919

Occupational exposure to risk-factors

197

648

3.44

48.87

6.7

7.8

24.37

24.44

mmol/l

0.10

188

603

Superficial injury of head

824

4810

1.77

48.69

7.3

6.7

24.62

24.51

mmol/l

0.37

796

4457

Other disorders of lacrimal gland

1185

7587

1.61

48.55

7.3

6.8

24.81

24.68

mmol/l

0.66

1105

7054

Familial hypercholesterolemia

665

3667

1.90

48.47

7.9

6.8

24.66

24.64

mmol/l

0.06

646

3411

Dermatophytosis

548

2843

2.04

48.40

7.9

6.9

24.58

24.50

mmol/l

0.18

508

2655

Left ventricular outflow tract obstruction (LVOTO), broad definition

422

1991

2.25

48.31

13.4

7.8

24.51

mmol/l

0.01

402

1858

Gout, idiopatic and unspecified

1040

6501

1.67

48.11

9.7

7.1

24.09

24.50

mmol/l

2.37

995

6068

Alzheimer disease, excluding more controls

697

2545

1.90

48.05

5.5

5.9

24.63

24.31

mmol/l

1.30

664

2348

Soft tissue disorders related to use, overuse and pressure

970

5944

1.68

47.75

6.9

7.2

24.69

24.61

mmol/l

0.26

906

5540

Benign neoplasm of meninges

396

1831

2.30

47.68

8.8

6.9

24.91

24.79

mmol/l

0.29

381

1685

Neuralgia and neuritis, unspecified

238

873

2.96

47.63

7.6

7.7

24.79

24.61

mmol/l

0.33

224

808

Endocarditis

177

550

3.56

47.62

17.3

6.9

24.03

24.50

mmol/l

0.78

172

503

Other disorders of adrenal gland

210

721

3.18

47.59

10.9

7.6

24.14

24.54

mmol/l

0.67

205

682

Viral pneumonia (known virus, not influenza)

150

426

4.08

47.23

10.4

7.3

25.38

24.22

mmol/l

2.15

139

405

Recurrent or chronic depression

1218

5616

1.60

47.22

8.4

7.0

24.61

24.50

mmol/l

0.49

1156

5178

Special screening examination for infectious and parasitic diseases

2738

0.23

47.20

4.3

6.6

24.33

24.32

mmol/l

0.01

2524

Pneumonia due to Streptococcus pneumoniae

208

716

3.17

46.90

10.0

7.1

24.28

24.21

mmol/l

0.09

189

668

Behavioural syndromes associated with physiological disturbances and physical factors

954

5827

1.68

46.90

7.5

6.8

24.69

24.33

mmol/l

2.07

917

5406

Fentanyl

439

2125

2.18

46.79

8.2

5.7

25.48

24.37

mmol/l

6.72

406

1978

Diabetic nephropathy, excluding more controls

627

2852

1.94

46.40

10.7

7.3

23.41

24.35

mmol/l

5.93

587

2653

Use of biperiden

266

1050

2.76

46.36

7.7

7.5

25.91

24.52

mmol/l

6.01

250

984

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

563

2882

1.97

45.93

12.5

6.9

24.52

24.43

mmol/l

0.24

525

2675

Second line medication for Crohn's disease

1904

13531

1.43

45.93

7.3

7.2

24.59

24.61

mmol/l

0.09

1775

12611

L04AX Other immunosuppressants

1868

13233

1.44

45.91

7.3

7.2

24.60

24.62

mmol/l

0.06

1740

12334

Aortic valve malfunction, age under 60 years

398

1876

2.26

45.81

13.3

7.7

24.52

24.50

mmol/l

0.05

378

1755

Cerebral cysts

239

897

2.86

45.59

14.0

7.7

24.09

24.38

mmol/l

0.49

226

833

Infective dermatitis

476

2407

2.08

45.12

8.2

6.7

24.70

24.51

mmol/l

0.50

445

2243

Somatoform disorder

559

2973

1.95

45.08

7.8

6.5

24.76

24.50

mmol/l

0.95

524

2757

Injuries to the knee and lower leg

4253

19253

1.28

44.98

8.1

6.8

24.67

24.55

mmol/l

1.30

3982

17931

Care involving dialysis

343

1536

2.39

44.90

13.5

6.4

22.38

24.57

mmol/l

15.88

321

1445

Reimbursement for rheumatic diseases

1998

14344

1.42

44.89

7.4

7.0

24.74

24.65

mmol/l

0.55

1861

13381

Disorders of mineral metabolism

332

1464

2.41

44.88

8.4

6.8

24.89

24.70

mmol/l

0.33

318

1359

Shock, not elsewhere classified

145

6.88

44.53

39.7

7.6

23.29

24.65

mmol/l

1.37

136

Assault

439

2160

2.11

44.27

8.9

7.7

24.39

24.38

mmol/l

0.01

417

2011

Cholecystectomy

2518

16619

1.36

44.18

7.3

6.9

24.56

24.64

mmol/l

0.53

2368

15472

Other blood glucose lowering drugs, excl. Insulins

693

3978

1.82

44.16

7.0

6.6

24.57

24.73

mmol/l

0.48

644

3697

Malignant neoplasm of ovary

222

823

2.97

43.98

9.0

6.6

24.68

24.86

mmol/l

0.32

211

768

Speech and linguistic disorders, excluding more controls

213

709

2.94

43.97

7.0

6.2

24.21

24.07

mmol/l

0.18

194

649

Disorders of calcium metabolism

264

1063

2.67

43.83

8.3

6.7

24.86

24.61

mmol/l

0.38

251

985

severe traumatic brain injury, does not include concussion

901

5559

1.68

43.70

11.5

6.7

24.81

24.45

mmol/l

1.95

859

5188

Glomerular disorders in diseases classified elsewhere

485

2503

2.05

43.57

12.2

7.1

22.70

24.55

mmol/l

16.03

459

2336

Seropositive rheumatoid arthritis

922

5695

1.67

43.55

7.3

7.0

24.72

24.61

mmol/l

0.36

846

5324

Glaucoma

2129

13643

1.40

43.55

6.4

6.9

24.46

24.66

mmol/l

1.64

1984

12728

Elevated blood glucose level

351

1608

2.32

43.41

8.4

7.1

23.88

24.57

mmol/l

2.13

338

1493

Diseases of the myoneural junction and muscle

501

2619

2.02

43.32

9.9

6.9

24.76

24.53

mmol/l

0.57

477

2435

Other symptoms and signs involving the digestive system and abdomen

560

3018

1.92

43.32

8.6

6.2

24.56

24.78

mmol/l

0.77

533

2806

Acidosis

132

366

4.23

43.23

15.8

7.1

20.11

24.20

mmol/l

9.45

124

341

Brachial plexus disorders

323

1424

2.38

43.19

5.3

7.4

24.54

24.46

mmol/l

0.18

300

1325

Colorectal adenocarcinoma

840

5117

1.72

43.19

8.2

6.9

24.47

24.54

mmol/l

0.22

799

4759

Tobacco use

235

902

2.82

43.18

10.0

7.9

25.19

24.43

mmol/l

1.74

221

843

Dialysis

205

736

3.07

43.17

14.7

7.2

22.20

24.74

mmol/l

12.73

194

686

Diseases of oral cavity, salivary glands and jaws

3487

13840

1.31

43.09

7.5

6.7

24.45

24.58

mmol/l

1.12

3249

12876

Cervicocranial syndrome

394

1888

2.19

42.92

6.7

7.3

24.81

24.53

mmol/l

0.95

370

1761

Primary gonarthrosis, bilateral

1909

12008

1.42

42.86

6.4

7.2

24.82

24.62

mmol/l

1.60

1774

11212

Osteoporosis with pathological fracture (FG)

303

1316

2.48

42.85

8.1

5.9

25.55

24.84

mmol/l

2.46

285

1226

Sequelae of other external causes

245

965

2.74

42.72

11.6

7.4

24.33

24.36

mmol/l

0.03

227

894

Other metabolic disorders

426

2104

2.11

42.60

7.1

6.6

24.82

24.72

mmol/l

0.25

395

1949

Early lumbar disc prolapse, operated

294

1250

2.44

42.37

7.0

8.5

24.51

24.45

mmol/l

0.11

266

1175

Benign neoplasm: Cerebral meninges

356

1656

2.28

42.31

9.0

7.0

24.96

24.80

mmol/l

0.42

342

1516

Systemic connective tissue disorders

1239

8263

1.54

42.19

7.2

6.6

24.70

24.63

mmol/l

0.25

1169

7697

Other condition

504

2655

1.98

42.15

9.4

6.9

24.86

24.45

mmol/l

1.67

490

2475

Dental caries 2 and operation codes, only avohilmo

1354

12301

0.67

42.14

6.7

7.4

24.65

24.57

mmol/l

0.41

1273

11444

Inguinal hernia

2264

11227

1.38

42.10

7.3

7.2

24.47

24.54

mmol/l

0.40

2125

10444

Fracture of lower leg, including ankle

1910

13742

1.41

41.96

9.5

6.8

24.73

24.62

mmol/l

0.62

1776

12788

Ascites

320

1437

2.39

41.73

9.9

6.8

23.84

24.77

mmol/l

3.58

304

1340

Acute and transient psychotic disorders

425

2117

2.10

41.69

8.0

7.3

25.70

24.40

mmol/l

7.66

391

1967

Other arthritis (FG)

1047

6747

1.59

41.59

6.9

7.1

24.64

24.55

mmol/l

0.32

987

6308

Asthma and allergy, excluding more controls

320

1399

2.32

41.57

6.7

5.4

24.51

24.09

mmol/l

1.17

302

1288

Brain meningioma, excluding all cancers (controls excluding all cancers)

229

888

2.80

41.30

9.2

7.3

25.24

24.57

mmol/l

2.90

223

817

Postprocedural disorders of digestive system, not elsewhere classified

178

608

3.27

41.26

11.9

7.6

24.32

24.59

mmol/l

0.33

171

575

Malignant neoplasm of urinary organs, excluding all cancers (controls excluding all cancers)

507

2713

1.97

40.99

6.8

6.9

24.20

24.52

mmol/l

1.20

482

2516

Benign neoplasm of other and ill-defined parts of digestive system

694

4072

1.78

40.95

8.1

6.8

24.56

24.64

mmol/l

0.23

654

3790

Polyneuropathies and other disorders of the peripheral nervous system

866

5386

1.67

40.82

10.8

7.1

24.78

24.52

mmol/l

1.12

827

5007

Malignant neoplasm of colon, excluding all cancers (controls excluding all cancers)

754

4527

1.73

40.77

8.2

6.7

24.22

24.60

mmol/l

2.15

718

4207

Sleep disorders

687

4012

1.76

40.51

7.6

6.9

24.81

24.40

mmol/l

2.17

655

3722

Suppurative and necrotic conditions of lower respiratory tract

272

1159

2.56

40.48

15.2

7.2

25.72

24.49

mmol/l

5.13

257

1077

Acute gastritis

341

1592

2.28

40.29

8.4

6.3

24.78

24.63

mmol/l

0.29

325

1482

Malignant neoplasm of brain, excluding all cancers (controls excluding all cancers)

229

898

2.75

40.29

13.5

7.2

25.25

24.57

mmol/l

2.02

211

846

Oxicams

1071

3896

1.61

40.06

6.7

7.6

24.58

24.42

mmol/l

0.69

1014

3628

Arthropod-borne viral fevers and viral haemorrhagic fevers

409

2050

2.11

40.03

8.3

7.4

24.41

24.47

mmol/l

0.12

382

1905

Dermatitis and eczema

3832

19961

1.27

39.99

8.0

6.9

24.61

24.57

mmol/l

0.28

3597

18583

Other noninfective gastroenteritis and colitis

839

5183

1.67

39.87

8.7

6.6

24.14

24.56

mmol/l

2.31

790

4824

Benign neoplasm: Colon, unspecified

900

5652

1.64

39.70

7.6

7.0

24.51

24.58

mmol/l

0.20

839

5257

Malignant neoplasm of kidney, except renal pelvis, excluding all cancers (controls excluding all cancers)

450

2347

2.03

39.41

6.9

24.30

24.53

mmol/l

0.70

428

2179

Chronic periodontitis

589

3335

1.84

39.34

10.4

7.1

24.55

24.63

mmol/l

0.17

555

3105

Acute pancreatitis

754

4567

1.71

39.27

9.9

6.9

24.33

24.60

mmol/l

1.06

708

4239

Congenital malformations of heart and great arteries

436

2166

2.03

39.10

12.6

7.0

24.98

24.38

mmol/l

3.09

407

2022

Vascular diseases of the intestine

197

731

2.97

39.07

12.7

6.5

23.58

24.54

mmol/l

2.06

189

686

Open wound of head

1838

13154

1.40

39.01

7.4

7.1

24.56

24.53

mmol/l

0.11

1743

12212

Postprocedural endocrine and metabolic disorders, not elsewhere classified

390

1934

2.10

38.64

7.3

6.6

24.79

24.65

mmol/l

0.34

362

1790

TMD related operations

540

2990

1.87

38.41

6.8

7.2

24.77

24.49

mmol/l

1.14

498

2790

Malignant neoplasm of urinary organs

440

2302

2.03

38.35

7.1

6.7

24.16

24.44

mmol/l

0.86

416

2145

Disorders of ocular muscles, binocular movement, accommodation and refraction

1448

10050

1.46

38.04

8.6

6.8

24.66

24.50

mmol/l

0.93

1357

9360

Viral haemorrhagic fevers, not elsewhere classified/unspecified

341

1630

2.23

38.02

8.7

7.7

24.41

24.47

mmol/l

0.13

316

1515

Dissociative [conversion] disorders

148

470

3.37

37.95

7.3

6.8

24.64

24.16

mmol/l

0.77

140

438

Gonarthrosis, primary, with knee surgery

2110

12829

1.37

37.86

6.7

7.2

24.76

24.63

mmol/l

0.96

1979

11983

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

1084

7190

1.55

37.84

7.3

6.8

24.76

24.63

mmol/l

0.58

995

6704

Asthma and allergy

320

1456

2.23

37.79

6.7

5.4

24.51

24.06

mmol/l

1.28

302

1350

Abnormal involuntary movements

498

2714

1.92

37.70

7.1

7.0

24.89

24.46

mmol/l

1.88

474

2529

Benign neoplasm of other and unspecified endocrine glands

455

2411

1.97

37.56

8.6

6.9

25.22

24.63

mmol/l

2.91

425

2228

Lesion of ulnar nerve

511

2809

1.90

37.50

8.4

7.3

24.56

24.53

mmol/l

0.06

482

2610

Pyothorax

220

884

2.74

37.38

16.3

7.4

25.92

24.49

mmol/l

5.96

208

819

Other and unspecified polyneuropathies, also in other diseases

763

4706

1.69

37.35

9.8

7.2

24.71

24.52

mmol/l

0.65

732

4370

Causalgia

226

4.71

36.91

6.9

10.5

25.45

24.68

mmol/l

1.19

213

Polycystic ovarian syndrome, consortium definition

2033

9021

1.38

36.72

6.9

6.1

24.90

24.63

mmol/l

2.53

1898

8380

Disorders of skin appendages

1478

10450

1.44

36.68

7.6

7.0

24.54

24.51

mmol/l

0.08

1380

9722

Artificial opening status

241

1015

2.57

36.67

20.1

6.7

24.46

24.56

mmol/l

0.13

232

934

Cellulitis

757

4665

1.67

36.66

9.3

7.2

24.82

24.50

mmol/l

1.31

714

4347

Correction of physiology of bite - demanding therapy visit

251

1069

2.48

36.61

6.9

8.0

24.51

24.52

mmol/l

0.03

232

993

Other specified and unspecified personality disorders

317

1486

2.23

36.60

7.0

7.6

25.34

24.34

mmol/l

3.90

308

1387

Other disorders of glucose regulation and pancreatic internal secretion

332

1592

2.20

36.45

7.6

6.9

24.04

24.50

mmol/l

0.97

316

1480

Other and unspecified myopathies

368

1842

2.12

36.35

10.0

6.9

24.59

24.51

mmol/l

0.11

353

1717

Dentofacial anomalies [including malocclusion]

813

5034

1.63

36.34

6.7

6.5

24.58

mmol/l

0.01

759

4662

Procreative management

917

4954

1.59

36.27

6.7

7.3

24.57

24.60

mmol/l

0.07

836

4607

Flat foot [pes planus] (acquired)

346

1686

2.15

36.26

7.2

7.4

24.93

24.76

mmol/l

0.41

317

1570

Cholecystitis

561

3209

1.82

36.22

10.0

6.3

24.54

24.62

mmol/l

0.18

534

2980

Unspecified kidney failure

422

2218

2.01

36.14

10.6

6.0

22.86

24.74

mmol/l

12.27

399

2072

Gout, strict definition

749

4645

1.69

36.14

10.4

7.0

24.10

24.47

mmol/l

1.50

725

4321

Fracture of femur

1025

6193

1.56

36.10

8.1

6.2

24.98

24.53

mmol/l

2.87

972

5768

Problems related to social environment

140

447

3.43

36.04

7.6

7.2

25.53

24.30

mmol/l

2.13

130

419

Impingement syndrome of shoulder

880

5645

1.60

35.99

7.6

24.74

24.61

mmol/l

0.54

802

5248

Insomnia

505

2801

1.86

35.72

8.1

7.1

24.80

24.41

mmol/l

1.49

481

2611

Extracorporeal dialysis

272

1224

2.40

35.58

15.0

7.4

22.53

24.49

mmol/l

10.13

254

1144

Mental and behavioural disorders due to sedatives or hypnotics

259

1134

2.42

35.55

8.9

7.8

25.03

24.41

mmol/l

1.56

246

1059

Primary_lymphoid and hematopoietic malignant neoplasms

860

5512

1.61

35.42

9.1

7.0

24.73

24.56

mmol/l

0.61

801

5125

Other diseases of pancreas

324

1565

2.21

35.32

10.4

6.5

23.89

24.60

mmol/l

2.26

309

1452

Strabismus

849

5408

1.61

35.31

9.2

6.9

24.72

24.50

mmol/l

0.93

794

5040

Paracetamol of NSAID medication

618

1759

1.80

35.18

7.3

7.0

24.31

24.21

mmol/l

0.24

575

1624

Somnolence, stupor and coma

202

798

2.73

35.08

11.3

7.3

24.91

24.45

mmol/l

0.81

194

745

DVT of lower extremities

731

4528

1.67

34.96

7.5

7.0

24.73

24.54

mmol/l

0.66

686

4220

Injuries to the neck

730

4506

1.67

34.95

7.6

7.1

24.91

24.38

mmol/l

3.42

686

4194

Amputation of toe

324

1575

2.21

34.93

11.5

6.8

23.87

24.53

mmol/l

1.79

303

1465

Benign neoplasm: Transverse colon

405

2126

2.02

34.88

9.2

7.0

24.59

24.58

mmol/l

0.03

384

1969

Unspecified haematuria

1585

9799

1.42

34.85

7.3

7.4

24.46

24.53

mmol/l

0.32

1477

9143

Malignant neoplasm of brain

166

598

3.05

34.80

14.6

7.4

25.33

24.41

mmol/l

2.20

152

561

Adenocarcinoma, papilloma adenocarcinoma and mucinous carcinomas of rectum, excluding all cancers (controls excluding all cancers)

420

2232

1.99

34.78

8.8

6.8

24.75

24.49

mmol/l

0.82

396

2070

Nonorganic sleeping disorders

581

3385

1.77

34.63

7.9

6.9

24.75

24.40

mmol/l

1.43

550

3149

Total colectomy operation

191

740

2.80

34.62

13.5

7.5

23.75

24.46

mmol/l

1.31

180

693

Total colectomy

191

740

2.80

34.62

13.5

7.5

23.75

24.46

mmol/l

1.31

180

693

Sulfasalazine

947

6221

1.56

34.54

7.3

7.0

24.79

24.47

mmol/l

1.90

874

5769

Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium

1164

6939

1.49

34.49

6.4

6.7

24.45

24.70

mmol/l

1.55

1082

6430

Other diseases of blood and blood-forming organs, wide

770

4843

1.64

34.44

9.2

7.1

24.74

24.64

mmol/l

0.29

734

4512

Disturbances of skin sensation

843

5404

1.60

34.36

6.9

7.0

24.60

24.53

mmol/l

0.26

792

5038

Intracerebral haemorrhage

509

2877

1.85

34.34

11.8

6.2

24.79

24.52

mmol/l

0.86

478

2674

Malignant neoplasm of kidney, except renal pelvis

399

2099

2.02

34.29

7.2

6.9

24.24

24.46

mmol/l

0.60

378

1950

Ovarian cyst

1101

4236

1.53

34.29

6.5

6.6

24.43

24.64

mmol/l

1.04

1042

3926

Other viral diseases

854

5480

1.59

34.05

8.2

7.1

24.40

24.42

mmol/l

0.07

800

5114

Presence of other functional implants

2023

10724

1.36

34.03

6.7

6.3

24.56

24.72

mmol/l

1.00

1882

9991

Functional dyspepsia

882

5730

1.58

34.00

6.9

6.6

24.69

24.65

mmol/l

0.12

817

5330

Benign neoplasm: Stomach

369

1893

2.05

33.81

7.0

6.7

24.73

24.72

mmol/l

0.01

349

1751

Exclusions for E4_PCOS_CONSORTIUM

2164

10219

1.34

33.68

7.3

6.4

24.77

24.62

mmol/l

1.15

2034

9488

Left ventricular outflow tract obstruction, narrow definition

202

813

2.67

33.68

18.0

7.9

24.90

24.51

mmol/l

0.87

194

756

Alcohol-induced chronic pancreatitis

294

1396

2.26

33.62

12.7

7.4

24.08

24.46

mmol/l

0.78

278

1308

Umbilical hernia

944

6249

1.55

33.54

7.6

7.2

24.81

24.52

mmol/l

1.60

889

5814

Myocardial infarction, with ST-elevation

745

4694

1.65

33.46

8.3

6.8

24.24

24.41

mmol/l

0.61

699

4378

Other diseases of anus and rectum

1032

6965

1.52

33.10

7.6

6.6

24.68

24.62

mmol/l

0.17

975

6466

Other disorders of skin and subcutaneous tissue, not elsewhere classified

542

3152

1.79

33.04

10.1

6.7

24.68

24.57

mmol/l

0.21

504

2938

Coxarthrosis, primary

2215

14720

1.33

33.01

6.7

7.1

24.66

24.65

mmol/l

0.04

2068

13740

Malignant neoplasm of eye, brain and central nervous system, excluding all cancers (controls excluding all cancers)

284

1334

2.25

33.01

12.4

6.5

25.24

24.46

mmol/l

3.13

261

1243

Cardiac murmurs and other cardiac sounds

279

1277

2.24

32.94

8.3

6.7

24.96

24.44

mmol/l

1.69

259

1183

Malignant neoplasm of rectum, excluding all cancers (controls excluding all cancers)

501

2857

1.84

32.92

8.6

7.0

24.72

24.54

mmol/l

0.55

473

2650

Glomerulonephritis

389

2054

1.99

32.69

8.7

7.1

23.44

24.50

mmol/l

5.09

359

1914

Abdominal aortic aneurysm (AAA)

446

2440

1.90

32.66

11.6

5.8

24.51

24.32

mmol/l

0.47

422

2286

Pneumonia due to other infectious organisms, not elsewhere classified

147

512

3.14

32.66

12.1

7.3

24.46

24.31

mmol/l

0.18

140

476

Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere

295

1412

2.22

32.66

7.5

6.4

24.61

24.55

mmol/l

0.09

280

1305

Benign neoplasm of meninges

396

2108

1.98

32.61

8.8

7.2

24.91

24.72

mmol/l

0.59

381

1951

Migraine with aura and triptan purchases

392

2063

1.95

32.49

7.4

6.7

23.99

24.38

mmol/l

1.57

374

1920

Brain meningioma

225

973

2.50

32.35

9.2

7.4

25.23

24.60

mmol/l

2.71

219

910

Other extrapyramidal and movement disorders in other diseases

799

5149

1.60

32.31

6.5

7.0

25.01

24.56

mmol/l

2.79

760

4805

Other viral diseases, not elsewhere classified

577

3412

1.74

32.30

7.1

7.2

24.58

24.38

mmol/l

0.63

547

3187

Fall involving bed

164

615

2.98

32.25

8.7

6.0

25.51

24.38

mmol/l

2.54

151

576

Congenital malformations of the circulatory system

455

2443

1.87

32.22

13.3

6.9

24.99

24.35

mmol/l

3.47

430

2278

Clear cell adenocarcinoma of kidney, excluding all cancers (controls excluding all cancers)

215

916

2.56

32.21

6.3

7.1

24.17

24.54

mmol/l

0.75

203

855

Viral infections characterized by skin and mucous membrane lesions

1354

9656

1.43

32.21

7.9

7.1

24.56

24.57

mmol/l

0.03

1276

8999

Rheumatoid arthritis, including avohilmo

1324

9424

1.44

32.17

7.4

6.9

24.74

24.67

mmol/l

0.30

1220

8780

Other specified/unspecified arthritis

874

5735

1.56

32.14

6.9

7.2

24.71

24.62

mmol/l

0.27

825

5367

Lyme disease

295

5835

0.49

32.14

7.3

7.2

24.94

24.63

mmol/l

1.03

282

5434

Acute pancreatitis (for exclusion)

754

4803

1.62

32.12

9.9

7.0

24.33

24.55

mmol/l

0.78

708

4478

Unknown and unspecified causes of morbidity

258

1175

2.30

32.07

8.2

6.8

24.41

24.62

mmol/l

0.38

253

1089

Corns and callosities

287

1373

2.22

32.02

8.1

7.1

24.37

24.59

mmol/l

0.37

269

1270

Disorders of parathyroid gland

759

4788

1.62

31.83

6.8

6.4

24.63

24.77

mmol/l

0.46

709

4454

Hypothyroidism, strict autoimmune

2477

12710

1.31

31.80

6.8

24.59

24.55

mmol/l

0.22

2325

11841

Agranulocytosis

408

2209

1.93

31.71

9.4

7.1

24.66

24.57

mmol/l

0.15

390

2050

Adenocarcinoma and papilloma adenocarcinoma of rectum, excluding all cancers (controls excluding all cancers)

399

2150

1.96

31.69

8.6

6.8

24.83

24.46

mmol/l

1.35

377

1994

Pregnancy hypertension

1025

6251

1.50

31.67

6.5

6.6

24.44

24.66

mmol/l

1.19

950

5794

Artificial joint operation, meniscal resection

3335

17857

1.26

31.61

6.7

7.2

24.79

24.62

mmol/l

2.08

3118

16656

Preparation and fitting of bite rail to mouth

432

2376

1.88

31.55

6.5

7.5

24.72

24.44

mmol/l

0.96

397

2217

Cytomegalovirus infection, IBD co-morbidity

118

373

3.55

31.32

13.8

8.9

23.43

24.63

mmol/l

2.25

108

348

Other systemic involvement of connective tissue

933

6252

1.53

31.26

6.5

24.86

24.63

mmol/l

1.09

879

5819

Congenital malformations of aortic and mitral valves

177

695

2.75

31.21

18.9

7.9

24.97

24.45

mmol/l

1.25

169

650

Visual field defects

348

1803

2.04

31.14

8.7

7.0

24.73

24.57

mmol/l

0.36

320

1673

Arterial embolism and thrombosis

256

1185

2.30

31.06

12.7

6.0

24.20

24.51

mmol/l

0.59

237

1109

Mental retardation, excluding more controls

128

412

3.24

31.03

8.3

6.8

25.88

24.49

mmol/l

2.97

123

379

Cytomegaloviral disease

118

375

3.51

30.96

13.8

8.8

23.43

24.66

mmol/l

2.34

108

351

Benign neoplasm: Sigmoid colon

647

4014

1.67

30.87

7.1

6.9

24.57

24.56

mmol/l

0.03

612

3729

Cardiomyopathy, other and unspecified

285

1374

2.18

30.87

10.3

6.4

24.40

24.48

mmol/l

0.12

276

1271

Abnormal spermatozoa

120

3275

0.35

30.64

4.5

7.8

24.53

24.36

mmol/l

0.17

110

3053

Sequelae of injuries, of poisoning and of other consequences of external causes

784

5084

1.58

30.60

10.9

7.2

24.89

24.57

mmol/l

1.49

719

4736

Acute alcohol intoxication ICD-9

181

729

2.71

30.54

7.7

6.7

25.27

24.50

mmol/l

1.47

171

678

121

392

3.38

30.48

8.2

9.2

24.75

mmol/l

0.00

114

367

Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523

563

3389

1.73

30.48

11.1

7.3

23.54

24.55

mmol/l

5.94

530

3173

Decubitus ulcer and pressure area

256

1198

2.29

30.42

18.0

6.7

24.62

24.51

mmol/l

0.13

246

1116

Recurring oral aphthae, including avohilmo

465

2654

1.82

30.20

6.9

7.0

24.52

24.55

mmol/l

0.05

433

2467

Appendectomy

2030

14972

1.32

30.13

7.7

7.2

24.58

24.59

mmol/l

0.06

1910

13928

Other spirochaetal diseases

309

5892

0.51

30.02

7.2

24.99

24.64

mmol/l

1.31

296

5487

Gestational [pregnancy-induced] hypertension

597

3623

1.68

30.02

6.8

6.5

24.33

24.50

mmol/l

0.57

557

3357

Any dementia, excluding more controls

1326

6584

1.43

30.00

5.3

6.4

24.59

24.50

mmol/l

0.34

1260

6117

Gout, unspecified

801

5269

1.58

29.89

9.8

7.0

24.13

24.51

mmol/l

1.62

766

4916

Alzheimer’s disease (Atypical or mixed)

380

2054

1.95

29.74

4.6

5.5

24.47

24.52

mmol/l

0.08

360

1915

Focal brain injury

242

1109

2.29

29.74

12.0

5.9

24.88

24.12

mmol/l

2.48

233

1025

Colon adenocarcinoma, excluding all cancers (controls excluding all cancers)

466

2683

1.82

29.72

7.9

6.6

24.13

24.57

mmol/l

1.68

444

2483

Benign neoplasm: Rectum

628

3907

1.67

29.68

7.2

7.1

24.50

24.60

mmol/l

0.29

588

3635

Other embolism and thrombosis

488

2846

1.78

29.53

8.5

6.8

24.73

24.55

mmol/l

0.48

459

2645

Hypopituitarism

250

1168

2.25

29.39

11.0

7.9

24.74

24.44

mmol/l

0.67

233

1090

Other skin changes

622

3873

1.67

29.30

7.5

6.8

24.64

24.54

mmol/l

0.30

583

3623

Hypoglycaemia, other or unspecified

263

1257

2.21

29.28

7.9

7.0

23.97

24.42

mmol/l

0.75

250

1167

Other other unspecified disorders of the circulatory system

175

708

2.69

29.27

11.6

7.5

24.51

24.44

mmol/l

0.10

163

661

Noninfectious colitis NAS

469

2708

1.80

29.23

8.2

6.5

23.91

24.53

mmol/l

2.63

444

2517

Benign neoplasm: Cerebral meninges

356

1900

1.97

29.17

9.0

6.9

24.96

24.63

mmol/l

1.30

342

1757

Other symptoms and signs involving general sensations and perceptions

170

677

2.71

29.16

8.2

7.1

24.92

24.41

mmol/l

1.00

162

627

Other diseases of intestine

458

2634

1.81

29.15

12.7

6.9

24.42

24.72

mmol/l

0.84

436

2440

Other and unspecified effects of external causes

794

5210

1.56

29.15

7.7

6.8

24.29

24.45

mmol/l

0.56

751

4829

Malignant neoplasm of other and unspecified female genital organs, excluding all cancers (controls excluding all cancers)

126

433

3.22

28.92

7.8

6.1

25.06

24.90

mmol/l

0.19

120

396

Hydronephrosis

419

2354

1.86

28.89

8.4

6.2

23.47

24.72

mmol/l

7.37

389

2196

Paralytic ileus

181

748

2.62

28.85

13.1

6.9

24.79

24.67

mmol/l

0.12

171

689

Pulmonary oedema

108

342

3.58

28.74

18.2

5.1

25.32

24.36

mmol/l

1.17

103

316

Benign neoplasm: Rectum, anus and anal canal

694

4455

1.61

28.66

7.0

24.53

24.58

mmol/l

0.14

649

4147

Assault by bodily force

245

1144

2.23

28.65

9.5

7.9

24.55

24.37

mmol/l

0.30

232

1070

Alcohol withdrawal state with delirium

304

1554

2.08

28.50

10.9

7.7

24.34

24.48

mmol/l

0.25

290

1452

Early lumbar disc prolapse operation

305

1549

2.03

28.30

7.0

8.0

24.54

24.43

mmol/l

0.22

276

1439

Diplopia

476

2792

1.77

28.25

7.2

7.0

24.69

24.57

mmol/l

0.30

447

2602

Malignant neoplasm of eye, brain and central nervous system

188

798

2.53

28.17

13.5

7.5

25.38

24.45

mmol/l

2.61

172

748

Hypothyreosis and Thyroxine purchase for inclusion criteria

3129

16704

1.25

28.16

7.1

7.0

24.62

24.55

mmol/l

0.53

2919

15566

Behavioural disorders, excluding more controls

146

4.79

28.16

7.5

6.4

24.63

23.91

mmol/l

0.73

135

Drug-induced neutropenia

273

1346

2.15

28.15

9.7

7.6

24.78

24.52

mmol/l

0.46

262

1256

Cystitis

2814

13731

1.27

28.12

7.4

6.7

24.61

24.49

mmol/l

0.90

2651

12745

Non-allergic asthma

346

1848

1.96

28.11

7.0

6.9

24.73

24.56

mmol/l

0.38

324

1709

Radiculopathy

572

3518

1.68

28.09

6.4

7.2

24.81

24.46

mmol/l

1.45

541

3295

Other epidermal thickening

185

781

2.54

28.02

8.6

7.3

23.66

24.47

mmol/l

1.83

174

726

Other disorders of binocular vision

166

4.72

27.95

4.8

8.7

23.68

24.55

mmol/l

0.91

155

Rheumatism, unspecified

451

2606

1.79

27.95

6.0

7.1

25.11

24.73

mmol/l

1.43

419

2422

Injury of intra-abdominal organs

115

382

3.29

27.81

21.3

8.4

24.24

24.36

mmol/l

0.10

108

355

Ulcer of lower limb, not elsewhere classified

537

3275

1.71

27.67

9.8

6.8

24.15

24.57

mmol/l

1.28

507

3070

Postmenopausal osteoporosis with pathological fracture

256

1246

2.20

27.66

7.8

5.7

25.48

24.86

mmol/l

1.82

242

1161

Disorders of continuity of bone

319

1665

2.00

27.64

7.4

25.11

24.52

mmol/l

1.96

296

1554

Bicuspidal aortic valve syndrome

162

649

2.71

27.58

20.0

8.0

24.99

24.51

mmol/l

1.18

155

607

Hypothyroidism, other/unspecified

3038

16221

1.25

27.37

7.1

7.0

24.61

24.54

mmol/l

0.52

2831

15119

Fibromyalgia

251

1206

2.16

27.19

6.0

7.1

24.85

24.51

mmol/l

0.80

235

1114

Cholangitis (primary sclerosing, PSC)

241

1150

2.22

27.09

10.1

6.5

23.80

24.58

mmol/l

2.32

227

1064

Acute posthaemorrhagic anaemia

163

662

2.66

26.97

9.6

7.1

24.38

24.65

mmol/l

0.34

150

620

Mental and behavioural disorders due to tobacco

313

1642

2.00

26.94

13.6

7.3

25.57

24.47

mmol/l

4.28

300

1522

Other problems related to primary support group, including family circumstances

297

1480

2.01

26.84

8.1

7.0

24.84

24.36

mmol/l

1.69

276

1381

Type 1 diabetes, strict definition, subgroup 1

178

741

2.47

26.82

7.0

6.5

22.55

24.32

mmol/l

4.59

161

685

Smoking dependency

313

1645

2.00

26.80

13.6

7.2

25.57

24.49

mmol/l

4.13

300

1527

Stomatitis and related lesions

289

1474

2.04

26.79

8.6

6.4

24.54

24.46

mmol/l

0.15

268

1377

Chronic viral hepatitis

179

755

2.49

26.78

10.1

8.7

24.79

24.44

mmol/l

0.52

169

701

Duodenal ulcer

442

2582

1.78

26.73

9.1

6.4

23.85

24.49

mmol/l

2.42

410

2415

Adenocarcinoma, papilloma adenocarcinoma and mucinous carcinomas of rectum

403

2301

1.84

26.67

8.9

6.7

24.78

24.49

mmol/l

0.97

380

2145

Family history of malignant neoplasm

300

1550

2.00

26.58

6.3

24.69

24.59

mmol/l

0.22

271

1433

Fall on same level involving ice and snow

1834

14120

1.32

26.56

7.4

7.0

24.65

24.61

mmol/l

0.19

1722

13144

Elevated erythrocyte sedimentation rate and abnormality of plasma viscosity

319

1695

1.98

26.56

7.3

6.6

24.49

24.55

mmol/l

0.10

302

1583

Other and unspecified local infections of skin and subcutaneous tissue

341

1848

1.93

26.49

9.0

7.0

24.71

24.45

mmol/l

0.55

319

1714

Ulcerative colitis, NAS

452

2659

1.75

26.30

8.3

6.8

23.94

24.45

mmol/l

2.15

427

2476

Maltreatment syndromes

161

651

2.59

26.29

6.9

9.1

24.34

24.28

mmol/l

0.07

154

602

Other aneurysm

232

1112

2.22

25.97

12.7

6.9

24.66

24.58

mmol/l

0.11

220

1041

Dental operations, only avohilmo

2680

10969

1.27

25.92

6.7

7.1

24.58

24.57

mmol/l

0.04

2510

10232

Sulfonylureas

1369

8077

1.38

25.89

7.5

6.5

24.18

24.70

mmol/l

4.43

1279

7532

Other/unspecified cytomegaloviral diseases

301

3.57

25.86

13.9

9.3

23.61

24.53

mmol/l

1.27

283

Disorders of oesophagus in diseases classified elsewhere

113

392

3.24

25.79

13.7

6.7

24.30

24.52

mmol/l

0.21

106

367

Benign neoplasm: Transverse colon

405

2341

1.82

25.75

9.2

6.6

24.59

24.53

mmol/l

0.13

384

2178

Type 1 diabetes, definitions combined

258

1272

2.08

25.72

6.9

6.5

22.79

24.46

mmol/l

5.87

235

1184

Dissocial personality disorder

233

3.91

25.58

8.3

9.8

25.40

24.50

mmol/l

1.30

215

Coagulation defects, purpura and other haemorrhagic conditions

623

4003

1.60

25.52

10.1

6.8

24.65

24.49

mmol/l

0.41

584

3738

Superficial injury of thorax

518

3188

1.68

25.51

8.2

7.0

25.08

24.46

mmol/l

3.51

481

2969

Benign neoplasm of other and unspecified endocrine glands

455

2713

1.74

25.50

8.6

6.9

25.22

24.56

mmol/l

3.67

425

2513

Sarcoidosis

475

2864

1.72

25.45

7.4

6.9

24.76

24.54

mmol/l

0.61

434

2663

Haemorrhage, not elsewhere classified

157

644

2.62

25.37

9.8

6.0

24.75

24.51

mmol/l

0.27

150

592

Cardiodefibrillation

1375

10250

1.37

25.30

7.5

7.2

24.43

24.60

mmol/l

0.95

1299

9561

798

5129

1.52

25.28

6.4

6.0

24.58

24.62

mmol/l

0.10

748

4763

Type 1 diabetes, strict (exclude DM2)

255

1260

2.08

25.28

6.9

22.76

24.44

mmol/l

5.89

233

1174

Seborrhoeic keratosis

789

5351

1.52

25.27

6.6

6.8

24.63

24.65

mmol/l

0.07

738

4991

Idiopathic gout

380

2171

1.85

25.24

9.2

7.0

23.78

24.51

mmol/l

2.81

365

2025

Diseases of salivary glands

632

4084

1.59

25.17

7.2

6.7

24.57

24.69

mmol/l

0.37

596

3798

Other/unspecified seropositive rheumatoid arthritis

914

6373

1.47

25.17

7.3

6.8

24.71

24.66

mmol/l

0.14

838

5949

Parodontitis or operation codes

3105

18749

1.23

25.16

7.6

7.1

24.55

24.64

mmol/l

0.71

2896

17463

Excessive, frequent and irregular menstruation

1110

4369

1.43

25.12

7.1

6.5

24.67

24.60

mmol/l

0.19

1039

4052

Diseases of male genital organs

1968

7690

1.31

25.00

7.5

8.3

24.53

24.47

mmol/l

0.29

1831

7202

Benign neoplasm: Adrenal gland

266

1357

2.07

24.97

8.3

6.6

25.51

24.59

mmol/l

3.61

255

1255

Dementia

1541

8028

1.35

24.96

5.2

6.6

24.56

24.60

mmol/l

0.15

1460

7467

Scoliosis

252

1253

2.08

24.94

8.3

7.1

25.08

24.40

mmol/l

2.27

237

1178

Myalgia

658

4292

1.57

24.94

6.6

7.0

24.85

24.54

mmol/l

1.34

612

3998

Pleural plaque

414

2431

1.79

24.91

6.3

6.5

24.92

24.03

mmol/l

5.31

396

2266

137

5.23

24.87

6.9

6.7

25.26

24.23

mmol/l

1.11

127

Chronic periodontitis, including avohilmo

3087

18743

1.23

24.82

7.7

7.1

24.55

24.64

mmol/l

0.71

2879

17459

Disorders of muscles

344

1905

1.87

24.81

8.3

7.4

24.39

24.48

mmol/l

0.17

326

1771

Seropositive rheumatoid arthritis, wide

922

6457

1.46

24.80

7.3

6.8

24.72

24.65

mmol/l

0.22

846

6025

Other disorders of nervous system

254

1279

2.10

24.77

7.4

6.9

25.21

24.62

mmol/l

2.01

243

1188

Parodontitis

3098

18750

1.23

24.75

7.6

7.1

24.54

24.65

mmol/l

0.80

2889

17465

Other fall from one level to another

705

4680

1.54

24.73

9.7

7.1

24.81

24.38

mmol/l

2.25

657

4367

Benign neoplasm: Stomach

369

2098

1.84

24.70

7.0

6.7

24.73

24.64

mmol/l

0.18

349

1951

Other disorders of eyelid

1543

11334

1.34

24.68

6.8

24.93

24.65

mmol/l

2.45

1440

10551

Ulcerative colitis

772

5225

1.51

24.63

7.7

6.9

24.23

24.54

mmol/l

1.61

724

4858

Hyperparathyroidism

654

4239

1.57

24.55

6.6

6.4

24.49

24.79

mmol/l

1.21

614

3944

Benign neoplasm: Colon, unspecified

900

6300

1.47

24.52

7.6

7.2

24.51

24.60

mmol/l

0.29

839

5863

Cerebral palsy and other paralytic syndromes

390

2250

1.80

24.51

10.0

6.8

24.93

24.48

mmol/l

1.30

357

2094

Other disorders of kidney and ureter

469

2852

1.71

24.48

10.1

6.7

24.20

24.58

mmol/l

1.24

436

2660

Parodontitis and operation codes

2914

18522

1.24

24.46

7.6

7.2

24.53

24.65

mmol/l

0.96

2711

17265

Clear cell adenocarcinoma of kidney

215

1031

2.26

24.43

6.3

7.4

24.17

24.50

mmol/l

0.67

203

961

Social phobias

208

967

2.22

24.43

8.5

6.8

24.12

24.11

mmol/l

0.01

191

897

Use of pramipexole

764

5185

1.52

24.39

6.7

6.9

24.94

24.60

mmol/l

1.83

713

4835

Primary_lymphoid and hematopoietic malignant neoplasms

860

5978

1.48

24.24

9.1

7.1

24.73

24.53

mmol/l

0.75

801

5565

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

892

6240

1.46

24.16

7.3

6.9

24.72

24.67

mmol/l

0.15

818

5822

Irregular menses

1144

6718

1.40

24.15

7.2

6.3

24.60

24.55

mmol/l

0.20

1070

6233

Inflammatory bowel disease

978

6943

1.44

24.14

8.1

7.1

24.30

24.53

mmol/l

1.18

920

6453

Asthma mixed form (mode), excluding more controls

164

696

2.45

24.06

4.9

5.5

25.50

24.10

mmol/l

4.17

155

637

Diseases of pulp and periapical tissues, including avohilmo

3812

16535

1.21

24.00

7.2

6.9

24.49

24.58

mmol/l

0.74

3540

15435

Migraine without aura and triptan purchases

373

2126

1.79

24.00

6.1

6.6

24.19

24.36

mmol/l

0.45

352

1975

Dental pulpitis 4

3818

16563

1.21

23.99

7.1

6.9

24.50

24.58

mmol/l

0.69

3547

15459

Trochanteric bursitis

437

2615

1.73

23.98

6.0

6.9

24.76

24.74

mmol/l

0.04

411

2437

Speech and linguistic disorders

214

970

2.18

23.97

7.1

7.0

24.21

24.20

mmol/l

0.02

194

903

Postprocedural disorders of nervous system

207

971

2.21

23.94

6.0

7.5

24.44

24.29

mmol/l

0.25

194

902

Malignant neoplasm of colon

572

3675

1.62

23.86

8.5

6.5

24.18

24.55

mmol/l

1.61

543

3429

Disorders of the thyroid gland

3233

17451

1.22

23.83

7.2

7.1

24.60

24.53

mmol/l

0.49

3015

16277

Car occupant injured in other and unspecified transport accidents

557

3541

1.61

23.76

9.1

6.9

24.60

24.36

mmol/l

0.77

510

3292

Recurring oral aphthae

182

820

2.36

23.73

8.4

7.8

24.57

24.49

mmol/l

0.12

170

770

Carcinoma in situ of endometrium

7.03

23.67

5.7

8.0

24.60

26.06

mmol/l

1.86

Hyperplasia of prostate

1470

6302

1.36

23.65

7.1

8.2

24.52

24.40

mmol/l

0.51

1371

5929

Other local infections of skin and subcutaneous tissue

351

1988

1.84

23.63

8.9

7.1

24.72

24.50

mmol/l

0.47

329

1846

Examination and encounter for administrative purposes

172

758

2.41

23.59

8.4

6.5

24.53

24.40

mmol/l

0.18

161

707

Dental pulpitis 1

3813

16569

1.21

23.59

7.1

6.9

24.50

24.58

mmol/l

0.71

3542

15465

Other and unspecified injuries of head

228

1124

2.14

23.51

7.2

7.8

24.57

24.43

mmol/l

0.26

222

1042

Purpura and other haemorrhagic conditions

453

2755

1.70

23.48

9.2

6.7

24.65

24.50

mmol/l

0.31

426

2571

Obsessive-compulsive disorder

166

715

2.40

23.47

7.0

6.5

24.59

24.00

mmol/l

1.08

158

660

Adenocarcinoma and papilloma adenocarcinoma of rectum

380

2215

1.80

23.45

8.6

6.7

24.87

24.48

mmol/l

1.45

360

2068

Methotrexate

468

2865

1.68

23.45

7.3

6.6

24.68

24.56

mmol/l

0.30

437

2650

Type 1 diabetes, strict definition

188

851

2.26

23.39

6.8

22.71

24.35

mmol/l

4.32

169

786

Normal-pressure hydrocephalus

228

1138

2.16

23.23

5.9

6.1

24.68

24.54

mmol/l

0.23

218

1057

Dental caries 1

2941

12283

1.24

23.19

7.0

24.54

24.60

mmol/l

0.34

2748

11437

Malignant neoplasm of rectum

378

2207

1.80

23.18

8.5

6.7

24.77

24.52

mmol/l

0.71

355

2055

Dental caries, including avohilmo

2937

12269

1.24

23.16

7.0

24.54

24.60

mmol/l

0.34

2745

11423

Other strabismus

623

4072

1.56

23.15

8.8

6.5

24.58

24.45

mmol/l

0.39

583

3780

Other/unspecified rheumatoid arthritis

463

2848

1.69

23.08

8.2

6.6

24.64

24.72

mmol/l

0.17

430

2645

1084

7003

1.41

22.90

6.6

6.2

24.50

24.62

mmol/l

0.47

1016

6521

Other viral hepatitis

202

960

2.20

22.76

10.4

8.4

24.67

24.46

mmol/l

0.29

191

898

Other diseases of lip and oral mucosa

544

3483

1.61

22.76

8.2

6.7

24.43

24.67

mmol/l

0.76

511

3253

Injury of other and unspecified intrathoracic organs

251

1298

2.04

22.74

13.8

7.3

25.08

24.43

mmol/l

2.02

236

1207

Colon adenocarcinoma

466

2891

1.68

22.64

7.9

6.5

24.13

24.52

mmol/l

1.43

444

2692

Pneumothorax

271

1439

1.98

22.63

12.5

6.8

25.58

24.19

mmol/l

6.99

255

1336

Fibrosis and cirrhosis of liver

287

1556

1.94

22.59

10.1

7.0

23.77

24.62

mmol/l

2.51

265

1455

Disorders of psychological development

264

1271

1.97

22.56

6.8

7.2

24.31

24.15

mmol/l

0.25

242

1182

Osteomyelitis

244

1253

2.05

22.55

10.7

7.7

24.67

24.52

mmol/l

0.21

226

1167

Lesion of lateral popliteal nerve

197

936

2.23

22.55

11.8

7.4

24.54

24.52

mmol/l

0.02

184

866

Any dementia

1404

7485

1.35

22.52

5.2

6.5

24.59

24.56

mmol/l

0.10

1331

6966

Poisoning by and exposure to other and unspecified chemicals and noxious substances, undetermined intent

186

4.09

22.52

8.2

9.8

24.96

24.18

mmol/l

0.66

173

Disorders of sclera, cornea, iris and ciliary body

1718

13419

1.30

22.37

7.4

7.1

24.62

24.60

mmol/l

0.06

1608

12513

Other diseases of biliary tract

318

1784

1.86

22.28

10.7

6.4

23.80

24.70

mmol/l

3.46

303

1658

Hypothermia

100

352

3.18

22.27

12.0

8.2

23.34

24.22

mmol/l

0.85

328

Carcinoma in situ of endometrium

6.59

22.22

5.7

7.9

24.60

25.70

mmol/l

1.37

Right hemicolectomy

248

1291

2.04

22.21

12.4

7.0

24.13

24.56

mmol/l

0.92

230

1198

Calcific tendinitis of shoulder

208

1012

2.16

22.17

7.2

8.1

24.67

24.62

mmol/l

0.06

189

943

Other diseases of spinal cord

131

527

2.68

22.17

10.0

7.9

26.05

24.49

mmol/l

5.14

125

495

Varicose veins

2198

13320

1.26

22.16

6.8

6.9

24.83

24.59

mmol/l

2.40

2049

12398

Amiodarone users

401

2413

1.74

22.08

8.0

6.9

24.21

24.51

mmol/l

0.85

377

2256

Mixed and other personality disorders

241

1234

2.02

22.08

7.8

7.9

25.27

24.38

mmol/l

2.72

228

1152

Haemorrhoids and perianal venous thrombosis

991

7165

1.41

22.08

6.2

6.5

24.62

24.65

mmol/l

0.08

928

6660

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

1674

12782

1.30

21.98

7.7

7.4

24.91

24.57

mmol/l

3.37

1549

11911

Fracture of skull and facial bones

664

4466

1.52

21.96

10.7

7.2

24.64

24.54

mmol/l

0.26

631

4132

Other enthesopathies

902

6421

1.43

21.96

6.3

7.3

24.74

24.59

mmol/l

0.70

837

5987

Thoracic aortic aneurysm

503

3200

1.63

21.95

13.4

6.6

24.85

24.52

mmol/l

1.35

474

2976

Mental retardation

128

508

2.65

21.89

8.3

25.88

24.32

mmol/l

3.62

123

470

Outcome of delivery

1265

0.30

21.87

2.3

6.7

23.85

24.31

mmol/l

0.65

1169

Other diseases of oesophagus

361

2110

1.78

21.87

7.3

6.4

25.02

24.52

mmol/l

1.61

338

1969

Dental pulpitis 2

2643

11006

1.24

21.86

6.9

24.56

24.61

mmol/l

0.22

2477

10252

Malignant neoplasm of pancreas, excluding all cancers (controls excluding all cancers)

318

1799

1.85

21.73

9.3

6.3

24.34

24.46

mmol/l

0.23

304

1675

Primary coxarthrosis, bilateral

1030

7535

1.40

21.72

6.7

6.8

24.83

24.63

mmol/l

0.99

959

7039

Pneumonia derived septicemia

141

593

2.55

21.64

10.7

7.6

24.69

24.50

mmol/l

0.19

127

548

Dental caries 3

3045

12857

1.22

21.59

6.9

7.0

24.52

24.59

mmol/l

0.37

2847

11976

Zoster [herpes zoster]

612

4074

1.55

21.56

8.1

6.7

24.90

24.59

mmol/l

1.17

576

3799

Other disorders affecting eyelid function

149

4.61

21.39

5.6

7.0

24.76

24.56

mmol/l

0.16

139

Intussusception

341

3.10

21.38

6.2

7.2

24.62

24.75

mmol/l

0.14

319

Oesophagitis

215

1080

2.10

21.20

9.9

6.5

24.15

24.55

mmol/l

0.78

201

1011

Pericarditis

132

542

2.58

21.19

7.9

7.0

25.08

24.45

mmol/l

1.11

127

499

Mental retardation, wide definition

138

578

2.51

21.07

8.1

8.3

25.82

24.50

mmol/l

2.98

132

536

Tubulo-interstitial nephritis, not specified as acute or chronic

245

1287

1.99

21.01

6.2

6.1

24.68

24.69

mmol/l

0.01

232

1195

Arterial embolism and thrombosis of lower extremity artery

156

696

2.41

21.00

13.1

5.7

24.07

24.44

mmol/l

0.54

144

650

Dental caries 3 and operation codes

3287

14071

1.21

20.99

7.1

24.54

24.58

mmol/l

0.21

3071

13114

Bronchiectasis

291

1620

1.88

20.98

7.4

6.5

25.56

24.26

mmol/l

5.86

266

1511

Persistent mood disorders

586

3884

1.54

20.81

8.2

6.5

25.01

24.56

mmol/l

1.88

551

3598

Other misadventures during surgical and medical care

101

374

2.97

20.38

11.3

6.8

24.90

24.51

mmol/l

0.36

350

Convergence insufficiency and excess

170

4.00

20.34

7.2

7.6

23.83

24.75

mmol/l

1.08

160

Hyperkinetic disorders, excluding more controls

166

737

2.23

20.22

5.3

6.0

24.25

23.89

mmol/l

0.72

157

681

Other diseases of hard tissues of teeth

2030

12145

1.26

20.21

7.9

6.9

24.63

24.61

mmol/l

0.10

1917

11299

Fracture of neck

232

1219

2.01

20.20

11.0

6.9

25.43

24.42

mmol/l

3.46

221

1137

Immunodeficiencies

173

815

2.24

20.20

14.1

7.5

24.92

24.45

mmol/l

0.83

159

760

Childhood asthma (age<16), excluding more controls

222

884

2.02

20.19

8.2

5.5

23.95

23.80

mmol/l

0.25

205

820

Benign neoplasm: Caecum

358

2139

1.75

20.17

8.2

6.8

24.74

24.63

mmol/l

0.25

344

1989

Superficial injury of hip and thigh

492

3172

1.60

20.01

7.0

6.4

24.95

24.47

mmol/l

2.18

470

2953

Viral warts

308

1762

1.81

19.99

6.6

7.2

24.17

24.41

mmol/l

0.47

288

1639

Dementia, including avohilmo

1612

8706

1.30

19.99

5.3

6.8

24.60

mmol/l

0.01

1527

8110

D07AA Corticosteroids, weak (group I)

430

2682

1.64

19.86

7.8

6.9

24.92

24.32

mmol/l

2.12

401

2497

Impotence

229

1207

2.01

19.86

6.0

7.8

24.26

24.30

mmol/l

0.06

211

1134

Disorders of vestibular function (Vertigo)

1527

11866

1.30

19.82

5.9

6.9

24.74

24.66

mmol/l

0.39

1439

11059

Asthma mixed form (mode)

164

758

2.25

19.79

4.9

5.7

25.50

24.06

mmol/l

4.44

155

699

Erythema intertrigo

110

432

2.78

19.77

10.8

6.9

25.37

24.60

mmol/l

1.00

105

405

Alzheimer’s disease (Late onset), excluding more controls

511

2190

1.60

19.77

4.5

5.9

24.44

24.26

mmol/l

0.53

495

2016

Degeneration of macula and posterior pole

1669

10869

1.29

19.74

7.0

6.7

24.54

24.66

mmol/l

0.63

1571

10142

Pre-existing hypertension complicating pregnancy, childbirth and the puerperium

181

870

2.14

19.66

9.0

7.2

24.52

24.43

mmol/l

0.13

169

810

Artificial joint re-operation

273

1527

1.89

19.62

6.6

6.5

25.24

24.63

mmol/l

1.90

260

1418

Dental pulpitis 2, only avohilmo

2679

11299

1.23

19.54

6.8

7.0

24.57

24.60

mmol/l

0.12

2510

10527

Diseases of inner ear

1790

13996

1.27

19.50

6.0

7.0

24.72

24.64

mmol/l

0.40

1682

13055

Childhood asthma (age<16)

222

896

1.99

19.49

8.2

5.7

23.95

23.81

mmol/l

0.23

205

834

Exposure to unspecified smoke, fire and flames

154

4.24

19.43

4.3

10.2

24.45

24.18

mmol/l

0.22

142

Dental pulpitis 3

208

740

2.06

19.43

6.2

6.0

23.72

23.35

mmol/l

0.68

194

689

Dental caries 1 and operation codes

3166

13612

1.20

19.32

7.1

24.53

24.58

mmol/l

0.30

2964

12684

Benign neoplasm of brain and other parts of central nervous system

218

1135

2.01

19.31

9.2

6.9

25.33

24.61

mmol/l

2.26

209

1049

Paralytic strabismus

260

1437

1.90

19.26

10.1

7.0

25.00

24.45

mmol/l

1.65

242

1337

Temporomandibular joint disorders, including avohilmo

1061

7903

1.36

19.25

6.1

6.8

24.54

24.50

mmol/l

0.16

995

7323

Conduct disorder

194

3.59

19.25

7.4

10.7

24.71

24.43

mmol/l

0.20

178

Other congenital malformations of the digestive system

140

611

2.39

19.24

8.4

7.4

23.88

24.46

mmol/l

1.01

133

569

Coxarthrosis, primary, with hip surgery

1643

12345

1.28

19.21

6.7

7.0

24.66

24.65

mmol/l

0.05

1538

11517

Subjective visual disturbances

730

5136

1.45

19.20

7.5

6.8

24.63

24.61

mmol/l

0.05

677

4789

Traumatic subarachnoid haemorrhage

132

569

2.46

19.12

14.1

5.9

24.93

24.29

mmol/l

1.11

126

525

Behavioural disorders

195

3.57

19.11

7.5

10.2

24.63

24.34

mmol/l

0.23

179

Intestinal malabsorption

166

788

2.22

19.05

13.6

7.4

23.82

24.48

mmol/l

1.07

155

738

Heartburn

313

1825

1.77

18.99

6.6

24.70

24.64

mmol/l

0.12

298

1691

False labour

603

2528

1.52

18.96

5.1

6.4

23.95

24.32

mmol/l

1.73

559

2335

Other and unspecified mood [affective] disorders

181

883

2.11

18.93

6.6

7.1

24.23

24.35

mmol/l

0.13

175

814

Parkinson's disease, including avohilmo

586

3984

1.52

18.87

5.9

6.8

25.70

24.50

mmol/l

13.21

545

3724

Superficial injury of abdomen, lower back and pelvis

452

2896

1.60

18.85

6.6

6.9

24.71

24.39

mmol/l

1.07

424

2695

Fitting and adjustment of other devices

655

8692

0.69

18.84

5.6

6.6

24.39

24.54

mmol/l

0.45

612

8104

Type1 diabetes, definitions combined, early onset

147

659

2.28

18.78

7.5

7.8

22.93

24.24

mmol/l

2.36

131

611

Unspecific neurodegenerative disorder

1466

7887

1.31

18.75

4.9

6.5

24.55

24.57

mmol/l

0.09

1385

7339

Toxic effect of ethanol

144

649

2.33

18.72

8.3

8.0

24.16

24.43

mmol/l

0.28

131

605

Unspecified nephritic syndrome

104

408

2.77

18.71

10.5

8.5

23.88

24.56

mmol/l

1.12

384

Trigger finger

438

2794

1.61

18.66

7.8

7.2

24.66

24.64

mmol/l

0.03

409

2586

Other and unspecified abdominal hernia

167

804

2.21

18.66

9.2

6.9

24.99

24.70

mmol/l

0.42

155

744

Pneumocystosis

332

3.06

18.62

15.0

8.5

24.49

24.56

mmol/l

0.06

309

Fracture of shoulder and upper arm

1123

8501

1.34

18.59

7.4

6.9

24.79

24.60

mmol/l

0.87

1059

7919

Nonischemic cardiomyopathy

199

1019

2.05

18.57

10.3

7.0

24.40

24.61

mmol/l

0.26

185

944

Inflammatory diseases of the central nervous system

278

1581

1.83

18.57

10.9

7.2

24.93

24.45

mmol/l

1.44

261

1464

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)

240

1311

1.92

18.53

7.6

6.2

23.63

24.45

mmol/l

2.63

225

1224

Benign neoplasm: Sigmoid colon

647

4501

1.48

18.43

7.1

7.0

24.57

24.60

mmol/l

0.09

612

4187

Iridocyclitis

704

4961

1.45

18.40

7.2

7.0

24.46

24.60

mmol/l

0.47

652

4621

Hypothyroidism, strict autoimmune, 3 medication purchases required

2705

15376

1.21

18.39

6.7

6.8

24.62

24.55

mmol/l

0.39

2538

14325

5-aminosalicylic acid

596

4065

1.49

18.37

7.5

7.0

24.14

24.38

mmol/l

0.83

560

3771

Benign neoplasm: Ascending colon

434

2785

1.61

18.28

8.2

6.9

24.67

24.59

mmol/l

0.14

415

2576

ICD-8 DM (Sub-endpoint used for defining DM endpoints)

127

549

2.43

18.17

12.9

8.6

23.58

24.78

mmol/l

1.77

115

509

Injuries to the elbow and forearm

2118

15658

1.24

18.15

7.1

7.0

24.68

24.61

mmol/l

0.36

1987

14602

Pruritus

334

2009

1.71

18.13

9.9

6.3

24.33

24.55

mmol/l

0.51

316

1847

Communicating hydrocephalus

105

422

2.72

18.08

15.4

8.0

24.65

24.34

mmol/l

0.29

404

Other benign neoplasms of skin

1109

8259

1.34

18.03

6.8

24.56

24.59

mmol/l

0.10

1035

7668

Pre-eclampsia

461

2990

1.57

18.02

5.5

6.6

24.48

24.60

mmol/l

0.31

419

2765

394

2471

1.64

18.02

8.4

6.7

24.73

24.47

mmol/l

0.67

366

2289

Anaemia in chronic diseases classified elsewhere

113

471

2.62

18.00

11.7

7.7

22.59

24.56

mmol/l

4.67

103

443

Cluster headache, wide

126

545

2.43

18.00

7.1

6.3

24.59

24.39

mmol/l

0.24

120

506

Invasive ventilation

260

1468

1.85

17.95

18.6

7.2

25.65

24.40

mmol/l

3.96

240

1361

Benign lipomatous neoplasm

872

6397

1.39

17.92

6.5

7.0

24.64

24.63

mmol/l

0.03

815

5952

Meniscus derangement

1866

10283

1.26

17.92

6.7

7.2

24.84

24.61

mmol/l

2.00

1750

9596

Dental caries 2, only avohilmo

1457

14550

0.78

17.82

6.7

7.3

24.60

24.57

mmol/l

0.15

1372

13530

Other obstructive and reflux uropathy

146

675

2.27

17.81

9.9

6.2

23.49

24.56

mmol/l

2.03

140

630

Benign neoplasm: Rectum

628

4376

1.48

17.77

7.2

7.1

24.50

24.59

mmol/l

0.26

588

4083

Dislocation, sprain and strain of joints and ligaments at neck level

408

2588

1.61

17.72

6.1

7.1

24.56

24.33

mmol/l

0.69

378

2409

Other diseases of upper respiratory tract

3915

17547

1.17

17.71

7.4

7.1

24.60

24.54

mmol/l

0.50

3665

16364

Malignant neoplasm of endocrine gland, excluding all cancers (controls excluding all cancers)

249

1389

1.86

17.70

6.1

7.2

25.08

24.64

mmol/l

1.22

232

1272

Other bursopathies

433

2794

1.60

17.67

7.3

24.86

24.65

mmol/l

0.50

408

2601

Dental caries 1, only avohilmo

2953

12685

1.20

17.65

6.9

7.1

24.51

24.60

mmol/l

0.54

2762

11818

Asthma and opportunity respiratory infection

180

910

2.10

17.63

8.2

6.8

25.55

24.31

mmol/l

3.67

165

838

Pneumococcal septicemia

133

598

2.37

17.63

10.4

7.8

24.80

24.54

mmol/l

0.27

119

553

Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

542

2334

1.52

17.63

7.0

5.9

23.68

24.00

mmol/l

1.35

509

2162

Other factor of the environment

204

3.55

17.61

9.0

6.9

24.47

24.36

mmol/l

0.08

188

Diabetic retinopathy

1316

6452

1.32

17.53

9.9

7.9

24.16

24.40

mmol/l

1.17

1231

6043

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

363

2030

1.65

17.47

6.8

24.27

24.02

mmol/l

0.62

339

1891

Brain glioblastoma and astrocytoma, excluding all cancers (controls excluding all cancers)

280

3.11

17.36

7.6

9.0

24.84

24.65

mmol/l

0.23

266

Congenital malformations and deformations of the musculoskeletal system

216

1150

1.92

17.33

7.3

7.6

24.96

24.18

mmol/l

2.49

204

1067

Diabetic nephropathy

633

4392

1.47

17.33

10.6

8.2

23.40

24.26

mmol/l

5.24

593

4103

Secondary parkinsonism+Parkinsonism in other disease

128

573

2.42

17.32

6.1

7.3

25.99

24.33

mmol/l

4.22

123

540

Other ulcerative colitis

193

1001

2.01

17.31

6.9

7.2

23.80

24.43

mmol/l

1.61

177

934

Oter anti-inflammatory and antirheumatic agents, non-steroids

912

3707

1.39

17.30

7.0

7.6

24.58

24.45

mmol/l

0.46

856

3453

220

1188

1.92

17.29

6.4

5.9

24.94

24.51

mmol/l

0.88

214

1107

Heterophoria

231

1269

1.88

17.22

6.9

24.68

24.35

mmol/l

0.81

211

1175

Benign neoplasm: Connective and other soft tissue of upper limb, including shoulder

153

732

2.20

17.21

8.2

7.9

24.15

24.58

mmol/l

0.80

143

683

Other dialysis

126

561

2.41

17.20

9.8

8.1

22.53

24.49

mmol/l

5.41

119

523

Persons encountering health services for other counselling and medical advice, not elsewhere classified

2831

19112

0.84

17.11

7.7

7.0

24.66

24.55

mmol/l

0.72

2678

17748

Hypertensive Renal Disease

132

598

2.33

17.06

8.7

6.9

22.86

24.47

mmol/l

3.20

122

551

Multiple myeloma, Monoclonal gammopathy of undetermined significance (MGUS), excluding all cancers (controls excluding all cancers)

298

1777

1.75

17.03

7.1

6.4

24.74

24.47

mmol/l

0.46

275

1648

Disorder of lipoprotein metabolism, unspecified

459

3028

1.56

17.02

8.3

6.9

24.25

24.63

mmol/l

1.48

431

2815

Cirrhosis of liver, NAS

201

1070

1.99

17.01

9.8

7.3

23.57

24.54

mmol/l

2.28

191

996

Cluster headache, strict

114

484

2.47

17.00

7.6

6.7

24.52

24.38

mmol/l

0.17

108

447

Parkinson's disease

556

3821

1.50

17.00

5.7

6.8

25.72

24.49

mmol/l

13.03

518

3567

Evidence of alcohol involvement determined by level of intoxication

139

4.05

16.97

9.5

11.1

24.04

24.12

mmol/l

0.04

130

Other follicular disorders

218

1185

1.91

16.89

7.4

7.7

24.78

24.36

mmol/l

0.81

204

1108

Benign neoplasm: Adrenal gland

266

1543

1.80

16.84

8.3

6.9

25.51

24.54

mmol/l

4.06

255

1440

Anterior Iridocyclitis

630

4428

1.45

16.79

7.4

7.0

24.51

24.56

mmol/l

0.13

581

4128

Hepatic failure, not elsewhere classified

147

703

2.23

16.79

17.9

8.0

23.29

24.67

mmol/l

3.16

139

662

Abnormal results of function studies

269

1563

1.78

16.70

7.4

7.3

24.24

24.50

mmol/l

0.52

250

1456

Vitreous haemorrhage

347

2163

1.66

16.59

9.4

6.9

24.16

24.57

mmol/l

1.14

323

2016

Other (seronegative) rheumatoid arthritis, wide

624

4393

1.45

16.57

8.5

6.8

24.73

24.69

mmol/l

0.11

578

4093

Female infertility, associated with anovulation

150

716

2.14

16.55

6.0

5.9

24.18

23.96

mmol/l

0.34

141

664

Papilloedema, unspecified

325

2.84

16.55

6.4

8.4

22.78

24.55

mmol/l

2.60

304

Dental caries 2

1514

14861

0.79

16.50

6.8

7.3

24.60

24.57

mmol/l

0.09

1423

13819

Volvulus

114

495

2.47

16.47

10.6

6.3

24.57

24.68

mmol/l

0.11

109

456

Acute and subacute iridocyclitis

595

4157

1.46

16.40

7.2

6.9

24.59

24.56

mmol/l

0.06

551

3869

Other obstetric conditions, not elsewhere classified

555

2442

1.49

16.38

7.0

5.9

23.73

24.03

mmol/l

1.28

521

2263

Alzheimer’s disease, wide definition, excluding more controls

516

2358

1.52

16.36

5.4

5.9

24.45

24.28

mmol/l

0.49

498

2176

Phlebitis and thrombophlebitis (not including DVT)

708

5104

1.42

16.34

6.7

7.1

24.67

24.57

mmol/l

0.30

664

4739

Benign neoplasm: Rectum, anus and anal canal

694

4997

1.43

16.32

7.0

24.53

24.59

mmol/l

0.16

649

4651

Hallux valgus (acquired)

1032

5660

1.34

16.31

6.1

6.9

24.75

24.70

mmol/l

0.17

967

5281

Pre-eclampsia or eclampsia

496

3341

1.51

16.29

5.6

6.6

24.47

24.65

mmol/l

0.49

452

3091

Other hearing loss

933

6906

1.35

16.25

6.4

6.7

24.52

24.59

mmol/l

0.21

867

6421

Hidradenitis suppurativa

109

463

2.47

16.25

7.7

9.5

24.69

24.42

mmol/l

0.27

104

432

Other or ill-defined heart diseases

159

787

2.10

16.19

8.6

6.6

24.78

24.44

mmol/l

0.50

151

726

Dental caries 3, only avohilmo

3050

13241

1.19

16.17

6.8

7.1

24.51

24.58

mmol/l

0.45

2852

12343

Failure and rejection of transplanted organs and tissues

199

3.44

16.16

12.6

7.6

23.16

24.44

mmol/l

1.55

186

Spondyloarthritis

558

3861

1.48

16.12

7.7

6.6

24.85

24.50

mmol/l

1.46

523

3594

Foreign body in alimentary tract

193

1028

1.97

16.12

12.4

7.4

24.73

24.40

mmol/l

0.59

180

964

Amputation of ankle bones

104

440

2.58

16.10

14.1

6.6

23.92

24.31

mmol/l

0.36

410

Pyogenic arthritis

238

1352

1.83

16.08

9.2

7.3

24.76

24.51

mmol/l

0.46

226

1271

Benign neoplasm: Duodenum

111

485

2.48

15.96

11.3

6.7

24.04

24.56

mmol/l

0.62

106

451

Early complications of trauma

154

762

2.13

15.95

11.7

7.7

24.91

24.52

mmol/l

0.51

141

704

!Aliquae complicationes praecoces traumatis

154

762

2.13

15.95

11.7

7.7

24.91

24.52

mmol/l

0.51

141

704

Orchitis and epididymitis

335

2091

1.66

15.92

9.3

7.8

24.43

24.32

mmol/l

0.21

313

1956

Unspecified jaundice

182

955

2.00

15.89

8.5

6.5

23.81

24.67

mmol/l

2.09

167

890

Adhesive capsulitis of shoulder

530

3653

1.48

15.74

7.8

7.4

24.75

24.64

mmol/l

0.31

494

3396

Benign neoplasm: Small intestine

153

762

2.13

15.70

9.5

6.7

24.12

24.56

mmol/l

0.57

144

709

Dermatitis due to substances taken internally

182

960

1.98

15.58

8.2

6.6

24.55

24.51

mmol/l

0.06

171

887

Benign neoplasm: Descending colon

234

1339

1.83

15.58

9.2

6.4

24.26

24.53

mmol/l

0.50

221

1242

Hypersensitivity pneumonitis due to organic dust

315

2.87

15.57

6.7

7.1

24.91

24.50

mmol/l

0.46

296

Oesophageal varices

159

806

2.09

15.53

9.4

6.9

23.39

24.31

mmol/l

1.90

150

743

Sequelae of injuries of neck and trunk

116

521

2.37

15.45

14.2

7.6

25.71

24.38

mmol/l

3.11

109

484

Other disorders of optic [2nd] nerve and visual pathways

210

1165

1.88

15.41

7.8

7.1

23.99

24.50

mmol/l

0.99

191

1087

Melanocytic naevi

754

5539

1.38

15.35

7.4

6.9

24.44

24.48

mmol/l

0.10

703

5124

Schizotypal disorder

308

2.78

15.31

7.2

8.9

25.89

24.52

mmol/l

1.73

289

Other disorders involving the immune mechanism, not elsewhere classified

116

523

2.36

15.30

9.6

8.0

23.36

24.40

mmol/l

1.59

110

489

Follow-up examination after treatment for malignant neoplasms

336

2117

1.63

15.27

8.0

6.2

24.91

24.56

mmol/l

0.86

312

1961

Budesonide

375

2419

1.59

15.26

6.4

6.8

24.07

24.37

mmol/l

0.88

351

2239

Exposure to other specified factors

2215

17372

1.21

15.24

8.1

7.1

24.77

24.55

mmol/l

2.29

2090

16159

Open wound of lower leg

452

3044

1.52

15.15

10.5

6.9

24.76

24.50

mmol/l

0.68

427

2841

Non-follicular lymphoma, hilmo, excluding all cancers

324

2033

1.65

15.15

10.9

6.7

24.87

24.52

mmol/l

0.79

302

1891

Lesion of radial nerve

137

662

2.18

15.14

7.7

7.9

25.53

24.54

mmol/l

1.95

126

614

Preterm labour and delivery

599

4242

1.43

15.14

6.8

6.7

24.73

24.77

mmol/l

0.12

561

3910

Malnutrition

342

2.73

15.12

8.9

8.0

24.28

24.44

mmol/l

0.10

321

Menorrhagia

972

4055

1.34

15.11

6.4

6.7

24.90

24.74

mmol/l

0.59

904

3756

Cauda equina syndrome

213

3.27

15.11

15.2

9.1

25.82

24.60

mmol/l

1.66

199

Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)

443

2978

1.53

15.10

9.8

6.9

24.91

24.54

mmol/l

1.08

410

2756

Malignant neoplasm of thyroid gland, excluding all cancers (controls excluding all cancers)

221

1250

1.83

15.10

6.1

7.2

24.95

24.58

mmol/l

0.87

207

1145

Dipeptidyl peptidase 4 (DPP-4) inhibitors

409

2710

1.56

15.03

7.5

6.8

24.30

24.69

mmol/l

1.18

380

2518

Viral hepatitis

215

1207

1.84

15.03

10.1

8.2

24.62

24.42

mmol/l

0.30

203

1131

Malignant neoplasm of respiratory system and intrathoracic organs, excluding all cancers (controls excluding all cancers)

829

5195

1.37

15.01

7.4

7.1

25.61

24.54

mmol/l

13.96

772

4840

Embolic stroke with flimmer

106

465

2.43

14.93

7.4

5.9

24.48

24.43

mmol/l

0.04

435

Other secondary coxarthrosis

134

648

2.20

14.89

6.9

7.8

24.31

24.55

mmol/l

0.30

127

609

Other diseases of arteries and capillaries

297

1830

1.68

14.88

9.5

6.5

24.49

24.55

mmol/l

0.10

275

1708

Acute nasopharyngitis (common cold)

361

2311

1.59

14.83

7.7

7.5

24.72

24.55

mmol/l

0.39

343

2158

Dental pulpitis 3, only avohilmo

180

683

1.95

14.78

5.6

5.9

23.70

23.33

mmol/l

0.64

167

638

Retinal vascular occlusion

433

2915

1.53

14.78

6.1

6.4

24.42

24.58

mmol/l

0.36

406

2722

Event of undetermined intent

191

1041

1.90

14.76

9.0

8.1

24.64

24.38

mmol/l

0.35

178

971

Inflammatory diseases of female pelvic organs

1540

9366

1.25

14.72

6.5

6.3

24.58

24.70

mmol/l

0.75

1442

8706

Embedded teeth, including avohilmo

204

1133

1.84

14.60

6.4

7.6

24.59

24.06

mmol/l

0.96

184

1060

Malignant neoplasm of rectosigmoid junction, excluding all cancers (controls excluding all cancers)

122

576

2.27

14.52

10.0

6.9

24.31

24.51

mmol/l

0.26

115

540

Chronic sinusitis

1279

10171

1.27

14.51

7.4

7.1

24.63

24.58

mmol/l

0.19

1190

9482

Spondylopathies in diseases classified elsewhere

208

3.27

14.50

5.4

6.5

25.56

24.87

mmol/l

0.62

200

Papulosquamous disorders

1213

9601

1.28

14.49

7.5

7.3

24.88

24.59

mmol/l

1.86

1130

8951

Gingivitis and periodontal diseases

3094

13704

1.17

14.45

7.6

6.8

24.50

24.59

mmol/l

0.61

2877

12749

Dental caries 2 and operation codes

1492

14609

0.80

14.44

6.8

7.3

24.59

24.57

mmol/l

0.10

1401

13587

Superficial injury of lower leg

679

4960

1.39

14.40

7.4

6.6

24.73

24.51

mmol/l

0.75

638

4619

Retinal vascular disorders

438

2971

1.52

14.40

6.2

6.4

24.44

24.59

mmol/l

0.33

411

2776

Disorders of speech understanding and production

115

516

2.28

14.39

7.3

7.1

24.22

24.40

mmol/l

0.16

478

Other and unspecified tonsillitis

815

5169

1.35

14.37

6.6

7.1

24.46

24.34

mmol/l

0.44

756

4802

Manic episode

101

440

2.41

14.33

8.6

7.7

26.11

24.54

mmol/l

2.67

407

Other benign neoplasms of connective and other soft tissue

287

1768

1.67

14.32

7.8

7.1

24.40

24.61

mmol/l

0.47

271

1632

Lateral epicondylitis

378

2480

1.56

14.30

6.1

7.2

24.56

24.58

mmol/l

0.04

347

2296

Anankastic personality disorder

111

503

2.30

14.29

5.4

8.8

24.71

24.41

mmol/l

0.36

101

468

Dental pulpitis 4, only avohilmo

3771

17158

1.16

14.27

6.8

7.1

24.53

24.57

mmol/l

0.29

3508

16018

Attention to artificial openings

146

740

2.08

14.26

11.7

6.5

24.96

24.58

mmol/l

0.45

138

693

Urticaria and erythema

979

7563

1.31

14.09

7.3

6.8

24.62

24.53

mmol/l

0.35

916

7038

Weight loss

309

1951

1.64

14.06

7.1

6.8

24.92

24.53

mmol/l

0.78

281

1814

Acute appendicitis, no complications

1616

13205

1.23

13.96

7.1

7.4

24.61

24.54

mmol/l

0.34

1518

12266

Brain glioblastoma and astrocytoma

315

2.75

13.94

7.6

8.4

24.84

24.50

mmol/l

0.51

297

Persistent delusional disorders

249

1492

1.73

13.94

7.6

7.1

25.62

24.33

mmol/l

5.00

239

1380

Benign neoplasm: Pituitary gland, craniopharyngeal duct

157

823

1.99

13.75

9.2

7.1

24.64

24.45

mmol/l

0.30

141

763

Diabetic retinopathy, strict definition

664

4290

1.40

13.74

10.9

7.9

23.85

24.30

mmol/l

1.77

617

4019

Amenorrhoea

144

728

2.02

13.73

9.1

6.4

24.04

24.30

mmol/l

0.37

137

681

Benign neoplasm of brain and other parts of central nervous system

218

1267

1.79

13.73

9.2

7.4

25.33

24.56

mmol/l

2.58

209

1179

Benign neoplasm: Caecum

358

2356

1.58

13.72

8.2

6.7

24.74

24.56

mmol/l

0.48

344

2192

Viral pneumonia (unknown virus, not influenza)

208

1191

1.81

13.71

12.0

7.4

24.62

24.35

mmol/l

0.42

197

1110

Other secondary gonarthrosis

189

1056

1.87

13.70

7.5

7.3

24.64

24.54

mmol/l

0.13

175

983

Other diseases of liver

522

3687

1.45

13.67

8.7

7.1

23.96

24.66

mmol/l

3.70

484

3437

Other and unspecified disorders involving the immune mechanism, not elsewhere classified

107

490

2.32

13.64

10.1

8.2

23.33

24.42

mmol/l

1.57

101

459

Melanocytic naevi, other sites/unspecified

217

1258

1.78

13.63

7.2

24.39

24.57

mmol/l

0.30

205

1160

Suggestive for eosinophilic asthma

294

1852

1.64

13.51

5.5

7.1

24.32

24.49

mmol/l

0.32

272

1726

Fracture of foot, except ankle

645

4726

1.39

13.46

7.5

7.1

24.67

24.50

mmol/l

0.52

605

4382

Acute appendicitis

2119

16851

1.20

13.44

7.1

7.4

24.60

24.55

mmol/l

0.25

1989

15672

Injury of muscle and tendon at shoulder and upper arm level

1178

9390

1.27

13.41

6.9

7.6

24.61

24.57

mmol/l

0.16

1093

8754

Dementia in Alzheimer disease

603

3738

1.41

13.37

4.8

6.1

24.48

mmol/l

0.00

581

3493

Other and unspecified visual disturbances

294

1857

1.63

13.35

6.6

7.3

24.53

24.59

mmol/l

0.10

269

1722

Benign neoplasm of ovary

445

3065

1.48

13.30

5.9

6.3

24.79

24.93

mmol/l

0.32

420

2830

Immunodeficiency with predominantly antibody defects

393

2.45

13.28

17.2

9.1

25.25

24.79

mmol/l

0.49

368

Other noninflammatory disorders of uterus, except cervix

673

3371

1.39

13.24

6.2

6.6

25.10

24.87

mmol/l

0.93

634

3123

Benign paroxysmal vertigo

889

6856

1.32

13.21

5.7

6.9

24.73

24.65

mmol/l

0.31

844

6380

Specific development disorders of speech and language

141

691

2.02

13.20

7.1

6.8

24.36

24.26

mmol/l

0.09

123

639

Open wound of abdomen, lower back and pelvis

103

470

2.31

13.17

13.9

8.2

24.66

24.36

mmol/l

0.33

430

Papillary adenocarcinoma of thyroid gland, excluding all cancers (controls excluding all cancers)

186

1043

1.85

13.16

6.2

7.3

24.98

24.70

mmol/l

0.53

173

958

Dental pulpitis 1, only avohilmo

3761

17219

1.15

13.08

6.8

7.1

24.52

24.57

mmol/l

0.39

3499

16076

Parkinson's disease, strict definition

501

3555

1.45

13.03

5.6

6.6

25.68

24.46

mmol/l

12.39

466

3321

Complications of other internal prosthetic devices, implants and grafts

136

694

2.06

13.03

7.6

5.8

24.73

24.44

mmol/l

0.36

125

646

Coeliac disease

343

2252

1.56

13.02

7.7

6.4

24.60

24.52

mmol/l

0.15

322

2086

Other necrotizing vasculopathies (FG)

201

1160

1.80

13.00

9.2

7.0

24.18

24.48

mmol/l

0.48

193

1092

Appendicitis, broad definition

2263

17587

1.19

12.97

7.1

7.3

24.62

24.56

mmol/l

0.32

2125

16362

Alzheimer disease, including avohilmo

1207

6966

1.27

12.93

5.0

6.3

24.52

24.57

mmol/l

0.15

1139

6488

Diseases of appendix

2281

17683

1.18

12.93

7.1

7.3

24.63

24.56

mmol/l

0.40

2141

16451

Abnormal findings on diagnostic imaging of central nervous system

137

701

2.04

12.91

8.6

7.9

24.42

24.46

mmol/l

0.04

132

655

Enteropathic arthropathies

330

2.56

12.90

7.4

10.7

23.81

24.22

mmol/l

0.49

310

Use of levodopa decarboxylase inhibitor

468

3290

1.46

12.84

5.4

6.8

25.75

24.47

mmol/l

12.21

434

3068

Malignant neoplasm of small intestine, excluding all cancers (controls excluding all cancers)

118

577

2.18

12.84

6.1

6.7

24.03

24.52

mmol/l

0.76

105

543

Other inflammatory liver diseases

215

1270

1.76

12.77

7.9

7.0

23.91

24.59

mmol/l

1.51

200

1183

Generalized epilepsy

122

600

2.11

12.77

8.8

7.2

24.75

24.36

mmol/l

0.50

114

562

Vitamin deficiency, wide

156

838

1.94

12.76

7.6

7.2

23.92

24.37

mmol/l

0.66

148

779

Vitamin deficiency

156

838

1.94

12.76

7.6

7.2

23.92

24.37

mmol/l

0.66

148

779

Systemic atrophies primarily affecting the central nervous system

155

836

1.95

12.68

6.2

7.7

26.34

24.58

mmol/l

4.83

145

784

Crohn disease

357

2380

1.53

12.60

9.0

6.8

24.32

24.48

mmol/l

0.32

334

2217

Follicular cysts of skin and subcutaneous tissue

546

3944

1.41

12.60

7.8

7.2

24.60

24.54

mmol/l

0.13

509

3682

Infections of genitourinary tract in pregnancy

221

1314

1.72

12.58

6.4

7.0

24.19

24.59

mmol/l

0.92

209

1221

Benign neoplasm: Small intestine

153

826

1.96

12.54

9.5

7.2

24.12

24.51

mmol/l

0.48

144

769

Other intracranial haemorrhages

129

658

2.09

12.54

9.9

6.0

24.82

24.38

mmol/l

0.63

123

614

Benign neoplasm: Duodenum

111

538

2.22

12.51

11.3

6.5

24.04

24.46

mmol/l

0.47

106

504

Postpartum care and examination

262

1017

1.67

12.50

4.9

6.6

23.56

24.18

mmol/l

1.89

245

944

Nonhereditary hypogammaglobulinemia

155

3.40

12.45

20.5

10.8

24.68

24.87

mmol/l

0.10

146

Degenerative diseases of the nervous system

1172

7065

1.27

12.45

5.2

6.4

24.46

24.55

mmol/l

0.37

1107

6587

Diffuse large B-cell lymphoma, helper endpoint

160

878

1.92

12.41

12.7

6.4

24.80

24.48

mmol/l

0.42

149

822

Diffuse large B-cell lymphoma, excluding all cancers (controls excluding all cancers)

160

878

1.92

12.41

12.7

6.4

24.80

24.48

mmol/l

0.42

149

822

Mental and behavioural disorders due to cannabinoids

310

2.54

12.40

7.9

9.5

25.40

24.10

mmol/l

1.85

280

Lesion of sciatic nerve

174

980

1.86

12.35

8.2

6.0

24.66

24.36

mmol/l

0.55

164

908

Dislocation, sprain and strain of joints and ligaments of shoulder girdle

862

6685

1.31

12.23

7.8

7.6

24.45

24.56

mmol/l

0.43

814

6230

Olecranon bursitis

216

1295

1.73

12.22

9.9

7.6

24.73

24.56

mmol/l

0.28

205

1212

Other disorders of binocular movement

308

2.57

12.21

6.8

8.7

23.95

24.42

mmol/l

0.55

287

Alcoholic liver disease

340

2269

1.55

12.20

11.6

7.3

23.30

24.55

mmol/l

5.75

322

2132

Renal cell carcinoma of kidney, excluding all cancers (controls excluding all cancers)

136

713

2.02

12.17

6.9

6.7

24.33

24.51

mmol/l

0.23

131

665

Disorders of optic nerve and visual pathways

265

1670

1.63

12.12

7.6

7.4

23.87

24.46

mmol/l

1.54

242

1552

Enthesopathies of lower limb, excluding foot

572

4187

1.39

12.06

8.0

7.4

24.89

24.48

mmol/l

2.29

541

3909

Protozoal diseases

108

524

2.20

12.04

14.0

8.2

24.66

24.47

mmol/l

0.20

102

494

Hypertrophic disorders of skin

160

881

1.88

12.02

10.6

7.4

24.34

24.32

mmol/l

0.02

150

823

Alcoholic gastritis

283

2.69

12.02

8.5

7.2

24.80

24.52

mmol/l

0.24

265

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

945

11764

0.78

12.00

6.8

24.83

24.64

mmol/l

0.94

881

10930

Pre-eclampsia or poor fetal growth

618

4563

1.37

12.00

6.1

6.4

24.41

24.48

mmol/l

0.21

566

4221

Seborrhoeic dermatitis

305

1993

1.58

12.00

9.4

6.6

24.91

24.50

mmol/l

1.06

281

1865

Nummular dermatitis

267

1695

1.63

11.98

9.8

6.5

24.82

24.51

mmol/l

0.70

249

1576

Other and unspecified epidermal thickening

458

2.26

11.94

8.8

7.9

23.79

24.55

mmol/l

1.01

429

Presbycusis

474

3363

1.44

11.92

5.1

5.9

24.51

24.54

mmol/l

0.07

432

3134

IBD patients in KELA-register

619

4598

1.37

11.89

7.2

7.1

24.14

24.52

mmol/l

1.85

579

4277

Neuroendocrine tumor and carcinoma of pancreas, excluding all cancers (controls excluding all cancers)

4.30

11.88

11.4

6.5

25.35

24.87

mmol/l

0.38

Inflammatory disease of uterus

311

2037

1.55

11.86

5.8

6.5

24.22

24.54

mmol/l

0.86

295

1884

Benign neoplasm: Connective and other soft tissue of upper limb, including shoulder

153

838

1.91

11.86

8.2

7.5

24.15

24.57

mmol/l

0.81

143

787

Malignant neoplasm of stomach, excluding all cancers (controls excluding all cancers)

210

1260

1.73

11.84

8.0

6.1

24.72

24.51

mmol/l

0.33

196

1181

Malignant neoplasm of bronchus and lung, excluding all cancers (controls excluding all cancers)

715

4523

1.34

11.83

7.4

6.9

25.65

24.54

mmol/l

13.12

670

4223

Other specified/unspecified systemic involvement of connective tissue

180

1035

1.80

11.79

7.7

7.1

25.17

24.52

mmol/l

1.28

168

960

Other shoulder lesions

255

1603

1.63

11.77

5.7

7.5

24.91

24.50

mmol/l

1.09

235

1483

Redundant prepuce, phimosis and paraphimosis

610

4512

1.37

11.75

8.2

8.4

24.85

24.48

mmol/l

1.48

566

4234

Abnormal findings on examination of urine, without diagnosis

152

834

1.91

11.74

7.7

7.6

23.83

24.38

mmol/l

0.86

145

777

Other disorders of bone

546

3988

1.39

11.73

6.5

7.1

24.86

24.50

mmol/l

1.59

506

3712

Nail disorders

244

1522

1.65

11.71

9.2

7.4

24.55

24.45

mmol/l

0.13

231

1417

Use of ropinirole

147

804

1.94

11.68

6.2

7.7

25.61

24.60

mmol/l

3.20

137

749

Vitamin D deficiency

238

2.77

11.65

6.5

8.6

24.27

24.28

mmol/l

0.00

222

Agoraphobia

307

2.49

11.65

14.9

6.6

24.96

24.12

mmol/l

0.66

282

Complications of cardiac and vascular prosthetic devices, implants and grafts

400

2.37

11.63

10.4

5.8

23.89

24.34

mmol/l

0.46

374

Cluster headache, wide,, including avohilmo

149

813

1.90

11.58

6.5

8.4

24.59

24.42

mmol/l

0.24

140

759

Congenital malformations of the nervous system

250

2.68

11.52

11.1

9.1

24.31

24.16

mmol/l

0.11

231

Lifestyle-related condition

190

3.06

11.52

8.6

6.9

24.75

24.44

mmol/l

0.26

176

Meralgia paraesthetica

112

559

2.10

11.45

7.1

8.2

24.64

24.52

mmol/l

0.10

106

524

Other peripheral vascular diseases

234

1453

1.66

11.45

5.8

6.7

24.95

24.59

mmol/l

0.74

216

1350

Endometriosis of pelvic peritoneum

357

2391

1.50

11.44

5.7

7.2

24.31

24.67

mmol/l

1.35

337

2211

Cluster headache, strict, including avohilmo

137

732

1.94

11.37

6.9

8.8

24.53

24.44

mmol/l

0.12

128

681

Disorders resulting from impaired renal tubular function

129

680

2.00

11.37

13.0

8.1

22.88

24.45

mmol/l

3.67

123

640

Trigeminal neuralgia

178

1031

1.79

11.37

7.0

7.5

24.96

24.55

mmol/l

0.87

160

959

Polyarthritis, unspecified

127

664

2.00

11.37

7.3

6.9

24.85

24.40

mmol/l

0.52

116

623

Other infectious diseases

258

1646

1.62

11.35

9.8

6.7

24.09

24.51

mmol/l

0.93

238

1532

Amputation of foot

109

545

2.15

11.34

11.3

7.5

23.14

24.30

mmol/l

2.05

103

502

Systemic sclerosis (FG)

370

2.37

11.33

7.6

8.6

24.19

24.42

mmol/l

0.21

350

Abnormal weight loss

276

1789

1.59

11.33

7.1

6.9

24.96

24.50

mmol/l

0.89

250

1663

Myocardial infarction, unclassifiable

824

5725

1.31

11.32

8.0

6.4

24.17

24.48

mmol/l

1.46

773

5339

Polycystic ovarian syndrome, broad definition

189

1108

1.73

11.28

6.1

5.7

24.13

24.01

mmol/l

0.19

176

1030

Benign neoplasm: Descending colon

234

1468

1.66

11.19

9.2

6.7

24.26

24.51

mmol/l

0.44

221

1369

Intermittent heterotropia

137

734

1.92

11.18

7.2

7.3

24.48

24.24

mmol/l

0.26

128

684

Wet age-related macular degeneration

592

4346

1.37

11.16

6.9

6.0

24.37

24.61

mmol/l

0.75

556

4042

Non-follicular lymphoma

324

2188

1.53

11.05

10.9

6.8

24.87

24.52

mmol/l

0.79

302

2043

Acute myeloid leukaemia and myelodysplastic syndromes, excluding all cancers (controls excluding all cancers)

135

731

1.94

10.98

6.7

6.2

24.42

24.36

mmol/l

0.06

128

680

Benign neoplasm: Ascending colon

434

3101

1.44

10.94

8.2

6.7

24.67

24.60

mmol/l

0.14

415

2896

Chronic gastritis

891

7047

1.28

10.92

5.8

6.5

24.45

24.64

mmol/l

0.79

838

6567

Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)

511

3527

1.40

10.91

7.8

6.8

25.54

24.51

mmol/l

8.61

483

3290

Irritable bowel syndrome

712

5466

1.32

10.90

6.2

6.5

24.76

24.67

mmol/l

0.27

670

5067

Generalized anxiety disorder

316

2115

1.52

10.89

7.9

6.2

24.95

24.21

mmol/l

2.96

304

1961

Sequelae of injuries of head

170

986

1.79

10.88

17.9

7.3

24.83

24.55

mmol/l

0.47

154

921

Pain associated with micturition

341

2328

1.50

10.86

6.5

6.7

25.00

24.55

mmol/l

1.60

316

2151

Allergic conjunctivitis

1010

12345

0.80

10.85

6.9

6.8

24.81

24.63

mmol/l

0.97

943

11480

Recurrent dislocation of patella

111

559

2.03

10.84

5.6

8.3

24.26

24.08

mmol/l

0.19

100

529

Schizoid personality disorder

290

2.54

10.83

7.4

9.3

25.89

24.40

mmol/l

1.89

271

Squamous cell neoplasms and carcinomas of the skin, excluding all cancers (controls excluding all cancers)

415

2945

1.45

10.83

6.3

6.2

24.17

24.57

mmol/l

1.36

385

2744

Inflammatory bowel disease, strict (require KELA)

619

4670

1.34

10.77

7.2

24.14

24.51

mmol/l

1.75

579

4346

Injuries to the ankle and foot

1901

14748

1.18

10.72

7.5

7.2

24.61

24.54

mmol/l

0.41

1790

13722

Perichondritis of external ear

350

2.40

10.68

8.0

6.6

24.96

24.22

mmol/l

0.98

329

Fall on and from stairs and steps

736

5701

1.31

10.65

7.1

7.0

24.21

24.58

mmol/l

1.78

685

5312

Divergent concomitant strabismus

216

1339

1.66

10.64

8.9

7.0

24.83

24.53

mmol/l

0.52

204

1246

Spondylopathies (FG)

364

2522

1.47

10.63

7.0

7.4

24.78

24.43

mmol/l

1.10

340

2358

Vascular dementia (mixed)

307

2.51

10.62

6.7

5.6

25.29

24.29

mmol/l

0.90

285

Excessive vomiting in pregnancy

172

1002

1.75

10.61

4.6

7.0

24.79

24.49

mmol/l

0.49

161

933

Status post-ami

250

1308

1.61

10.61

6.5

5.3

24.32

24.55

mmol/l

0.42

236

1222

Vascular dementia

283

1806

1.56

10.60

5.3

5.7

24.91

24.46

mmol/l

1.00

265

1689

Encephalitis

460

2.17

10.57

10.0

8.3

25.04

24.32

mmol/l

1.05

432

Mental disorders, not otherwise specified

198

1203

1.68

10.49

7.5

24.91

24.32

mmol/l

1.17

187

1119

Thrombocytopenia, unspecified

223

1403

1.64

10.47

9.9

7.1

24.81

24.53

mmol/l

0.42

204

1309

Adenocarcinoma and ductal carcinoma of pancreas, excluding all cancers (controls excluding all cancers)

124

665

1.97

10.44

10.7

6.8

24.45

24.62

mmol/l

0.23

115

624

L01XE Protein kinase inhibitors

197

1206

1.70

10.44

5.5

6.7

24.89

24.55

mmol/l

0.65

183

1125

Spirochaetal infections, other/unspecified

1720

0.48

10.42

7.2

7.4

25.12

24.64

mmol/l

1.01

1603

Thyroiditis, ILD-related definition

296

1979

1.53

10.40

7.6

6.7

24.41

24.55

mmol/l

0.26

282

1825

Open wound of ankle and foot

292

1950

1.53

10.39

10.6

7.0

24.66

24.38

mmol/l

0.65

274

1813

Hypertrophic scar

144

806

1.84

10.33

11.1

7.6

24.38

24.37

mmol/l

0.01

134

751

Mixed connective tissue disease

190

1152

1.70

10.31

7.2

25.15

24.50

mmol/l

1.40

177

1074

Renal cell carcinoma of kidney

136

756

1.89

10.23

6.9

6.3

24.33

24.35

mmol/l

0.02

131

709

Monoclonal gammopathy of undetermined significance (MGUS), excluding all cancers (controls excluding all cancers)

169

1000

1.77

10.21

6.2

25.32

24.55

mmol/l

1.26

157

934

Generalized skin eruption due to drugs and medicaments

127

689

1.92

10.20

8.3

7.4

24.64

24.48

mmol/l

0.21

117

649

Abnormalities of gait and mobility

375

2648

1.45

10.11

6.0

6.6

24.88

24.49

mmol/l

1.02

347

2469

Keratitis

997

8058

1.25

10.07

7.7

7.1

24.76

24.58

mmol/l

0.78

932

7511

Female genital prolapse

830

3756

1.29

10.04

5.8

6.6

24.85

24.84

mmol/l

0.02

765

3479

Benign neoplasm of urinary organs

146

831

1.83

10.04

6.0

6.6

24.28

24.51

mmol/l

0.28

137

777

Other arterial embolism and thrombosis

107

553

2.04

10.04

14.0

6.0

24.09

24.64

mmol/l

0.69

101

521

Dissection of aorta

121

652

1.95

10.04

19.7

6.3

25.15

24.58

mmol/l

1.05

116

607

Lichen planus

394

2812

1.43

9.97

6.0

7.1

24.26

24.68

mmol/l

1.32

367

2610

Polymyalgia rheumatica

438

3186

1.41

9.96

6.6

6.2

25.14

24.62

mmol/l

2.20

415

2974

Acute generalized exanthematous pustulosis

140

789

1.84

9.94

8.1

7.3

24.71

24.49

mmol/l

0.32

130

741

Neuroendocrine tumor and carcinoma of pancreas

104

3.74

9.84

11.4

7.8

25.35

24.85

mmol/l

0.41

Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)

1550

8952

1.20

9.82

6.5

7.0

24.38

24.63

mmol/l

2.09

1449

8336

Haemorrhage in early pregnancy

578

4268

1.34

9.78

5.4

6.9

24.43

24.71

mmol/l

1.16

539

3952

Other disorders of gingiva or/and edentulous alveolar ridge

153

889

1.78

9.76

7.7

6.4

24.55

24.45

mmol/l

0.11

141

826

Abnormal blood-pressure reading, without diagnosis

120

648

1.91

9.70

7.9

6.6

25.19

24.62

mmol/l

0.88

109

597

Acute laryngitis and tracheitis

242

1545

1.56

9.68

7.3

6.5

24.62

24.40

mmol/l

0.41

228

1430

Sequelae of injuries of upper limb

281

1892

1.52

9.66

7.5

7.3

24.85

24.50

mmol/l

0.82

253

1762

Mixed conductive and sensorineural hearing loss

388

2779

1.43

9.64

6.8

7.0

24.66

mmol/l

0.00

365

2582

Other specified/unspecified soft tissue disorders

158

930

1.76

9.63

6.8

24.55

24.57

mmol/l

0.02

152

866

Vitamin B12 deficiency anaemia

354

2497

1.45

9.59

6.2

6.3

24.28

24.58

mmol/l

0.72

332

2326

Conjunctivitis (acute, non atopic)

731

5716

1.29

9.55

7.4

6.9

24.57

24.52

mmol/l

0.13

685

5315

Other and unspecified mononeuropathies of upper limb

492

2.06

9.54

7.6

9.3

24.52

mmol/l

0.01

463

1362

10751

1.21

9.51

6.5

6.7

24.53

24.62

mmol/l

0.40

1275

10036

Benign neoplasm: Pituitary gland, craniopharyngeal duct

157

927

1.75

9.48

9.2

7.4

24.64

24.51

mmol/l

0.19

141

862

Diabetes mellitus in pregnancy

549

2661

1.35

9.47

6.2

6.6

23.60

24.31

mmol/l

4.38

510

2466

Benign neoplasm: Skin of other and unspecified parts of face

316

2188

1.48

9.45

6.0

6.8

24.47

24.59

mmol/l

0.25

295

2028

Primary open-angle glaucoma

1047

8358

1.24

9.44

6.2

6.6

24.44

24.67

mmol/l

1.19

976

7802

Other specified/unspecified spondylopathies

461

2.10

9.44

7.7

6.5

25.25

24.39

mmol/l

1.24

434

Marasmic kwashiorkor

6.69

9.43

10.2

7.5

24.27

24.45

mmol/l

0.06

Congenital malformations of the urinary system

160

950

1.74

9.41

10.5

8.1

23.20

24.44

mmol/l

4.30

146

882

Perforation of tympanic membrane

291

1985

1.50

9.40

6.1

6.9

24.40

24.50

mmol/l

0.17

267

1849

Fracture at wrist and hand level

949

7686

1.25

9.37

7.1

7.6

24.69

24.55

mmol/l

0.55

875

7151

Other and unspecified mononeuropathies, also in other diseases

102

531

2.01

9.35

8.5

6.6

25.48

24.29

mmol/l

2.14

498

Injuries to unspecified part of trunk, limb or body region

282

1914

1.51

9.34

10.0

7.1

24.60

24.49

mmol/l

0.18

271

1772

Benign neoplasm: Kidney

114

617

1.94

9.33

6.2

6.6

24.10

24.54

mmol/l

0.51

107

577

Other/unspecified synovitis and tenosynovitis

319

2215

1.47

9.33

7.9

7.2

24.58

mmol/l

0.00

302

2052

Infarction of spleen

108

3.61

9.32

14.6

6.2

23.83

24.37

mmol/l

0.22

100

Alzheimer disease

1017

6252

1.24

9.31

4.9

6.1

24.53

mmol/l

0.01

963

5821

Symptoms and signs involving speech and voice

951

7723

1.25

9.29

7.1

6.9

24.84

24.58

mmol/l

1.43

888

7188

Psoriatic and enteropathic arthropathies

316

2193

1.47

9.27

7.0

7.4

24.79

24.46

mmol/l

0.90

295

2050

Malignant neoplasm of skin, excluding all cancers (controls excluding all cancers)

1687

9824

1.18

9.25

6.6

7.0

24.39

24.63

mmol/l

1.99

1573

9145

Other diseases of peritoneum

145

845

1.78

9.22

6.3

6.4

24.36

24.56

mmol/l

0.26

131

791

Infective bursitis

110

592

1.96

9.21

10.5

8.0

24.61

24.56

mmol/l

0.04

104

550

Systemic sclerosis

404

2.16

9.20

7.6

8.0

24.19

24.53

mmol/l

0.35

383

Barrett oesophagus

167

1014

1.72

9.19

9.2

6.9

24.58

24.53

mmol/l

0.06

157

950

Third [oculomotor] nerve palsy

340

2.30

9.17

11.5

6.6

25.14

24.55

mmol/l

0.58

320

Other necrotizing vasculopathies

230

1506

1.58

9.17

8.9

6.9

24.19

24.56

mmol/l

0.73

219

1402

Glaucoma, exfoliation

375

2699

1.43

9.13

5.2

6.1

24.44

24.62

mmol/l

0.41

350

2526

Other specified/unspecified inflammatory spondylopathies

121

668

1.86

9.11

8.0

8.7

24.90

24.57

mmol/l

0.58

116

629

Embolic stroke

169

1030

1.70

9.10

7.3

6.1

24.54

24.44

mmol/l

0.14

153

951

Hypoparathyroidism

119

658

1.89

9.10

6.9

6.7

25.81

24.54

mmol/l

2.51

108

612

Other abnormal findings in urine

290

2.41

9.07

7.4

6.5

24.48

24.65

mmol/l

0.11

276

Diffuse large B-cell lymphoma

160

966

1.73

9.06

12.7

6.6

24.80

24.49

mmol/l

0.40

149

899

Biological medication for rheuma

375

2693

1.41

9.05

7.4

7.3

24.52

24.48

mmol/l

0.09

353

2505

Fracture of forearm

1560

12436

1.18

9.05

6.8

24.77

24.68

mmol/l

0.42

1453

11587

Supervision of normal pregnancy

184

1679

0.62

9.02

4.7

6.8

23.63

24.40

mmol/l

2.44

172

1567

Metatarsalgia

248

1650

1.54

9.02

7.2

7.4

24.92

24.70

mmol/l

0.51

230

1530

Injury of nerves and spinal cord at neck level

415

2.15

9.02

9.7

6.8

26.09

24.40

mmol/l

3.91

389

Benign neoplasm: Choroid

173

1063

1.68

9.02

8.3

6.9

24.35

24.65

mmol/l

0.43

162

981

Other encephalitis

441

2.09

9.00

10.5

8.5

25.22

24.30

mmol/l

1.48

413

Other hammer toe(s) (acquired)

511

3616

1.35

8.99

6.7

24.87

24.77

mmol/l

0.25

471

3385

Neovascular glaucoma

140

816

1.79

8.95

9.5

6.6

23.93

24.50

mmol/l

0.89

134

761

Tumor necrosis factor alpha inhibitors

335

2364

1.44

8.94

7.4

24.39

24.42

mmol/l

0.05

314

2207

Benign lipomatous neoplasm of skin and subcutaneous tissue of head, face and neck

192

1212

1.63

8.94

5.6

7.0

24.62

24.48

mmol/l

0.18

178

1133

Multiple myeloma and malignant plasma cell neoplasms

158

953

1.73

8.94

7.8

6.4

24.00

24.53

mmol/l

0.89

147

887

Arthropathies in other diseases classified elsewhere

118

654

1.88

8.92

10.9

8.7

24.64

24.47

mmol/l

0.15

108

617

Gestational [pregnancy-induced] oedema and proteinuria without hypertension

208

1335

1.59

8.90

6.5

7.0

24.53

24.65

mmol/l

0.18

196

1232

Systemic sclerosis, icd10

403

2.14

8.88

7.6

8.1

24.21

24.72

mmol/l

0.61

385

Necrotizing fasciitis

3.99

8.85

18.5

11.9

26.01

24.62

mmol/l

1.00

Bell's palsy

326

2298

1.45

8.84

8.9

7.1

24.44

24.53

mmol/l

0.18

303

2132

Seronegative rheumatoid arthritis

334

2365

1.44

8.83

8.3

7.0

24.84

24.61

mmol/l

0.51

307

2214

Herpesviral [herpes simplex] infections

315

2207

1.46

8.83

7.5

7.1

24.25

24.48

mmol/l

0.48

305

2050

Glaucoma secondary to other eye disorders

140

819

1.78

8.83

9.5

7.3

23.93

24.51

mmol/l

0.91

134

764

Polyhydramnios

475

2.01

8.83

4.8

6.5

23.65

24.26

mmol/l

0.76

440

Mouth breathing

1196

9977

1.21

8.83

6.7

7.7

24.85

24.57

mmol/l

1.82

1110

9288

Urticaria

731

5794

1.28

8.80

6.8

6.7

24.61

24.53

mmol/l

0.25

678

5386

Juvenile arthritis (FINNGEN)

504

1.97

8.76

6.1

8.5

24.47

24.09

mmol/l

0.44

471

Squamous cell neoplasms and carcinomas of the skin

415

3059

1.39

8.76

6.3

24.17

24.51

mmol/l

1.07

385

2860

Dislocation, sprain and strain of joint and ligaments of hip

121

681

1.86

8.75

6.3

7.0

24.86

24.46

mmol/l

0.63

113

638

Nontoxic multinodular goitre

585

4524

1.31

8.72

6.7

6.5

24.93

24.79

mmol/l

0.42

547

4208

Other female pelvic inflammatory diseases

401

2932

1.39

8.72

6.4

6.5

24.46

24.81

mmol/l

1.29

374

2718

Meningitis

152

911

1.72

8.71

10.6

7.9

25.05

24.49

mmol/l

1.33

141

848

Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk

344

2455

1.43

8.69

6.5

7.1

24.64

24.55

mmol/l

0.19

321

2267

Other specified/unspecified hearing loss

251

1692

1.52

8.69

7.5

6.6

24.58

24.56

mmol/l

0.02

237

1562

Acute lymphadenitis

159

964

1.69

8.65

9.7

7.5

24.47

24.40

mmol/l

0.09

150

897

Abscess of anal and rectal regions

237

1578

1.54

8.63

7.9

7.3

24.37

24.59

mmol/l

0.44

220

1471

Malignant neoplasm of pancreas

212

1384

1.58

8.63

9.7

6.5

24.54

24.50

mmol/l

0.06

201

1289

Malignant neoplasm of endocrine gland

208

1349

1.59

8.62

6.3

7.5

25.12

24.60

mmol/l

1.48

192

1257

Ingrowing nail

155

936

1.71

8.61

8.5

7.5

24.53

24.43

mmol/l

0.11

150

875

Other juvenile arthritis

404

2.08

8.61

6.3

9.5

24.23

23.97

mmol/l

0.24

374

Localized swelling, mass and lump of skin and subcutaneous tissue

898

7314

1.24

8.56

7.1

24.63

24.55

mmol/l

0.25

848

6813

Collagenous colitis

253

1715

1.51

8.51

8.9

6.6

24.15

24.62

mmol/l

1.10

240

1586

Malignant neoplasm of mesothelium and soft tissue, excluding all cancers (controls excluding all cancers)

207

1347

1.58

8.50

7.1

6.8

25.03

24.55

mmol/l

1.27

197

1247

Other disorders of central nervous system

174

2.77

8.49

10.9

9.5

25.72

24.65

mmol/l

1.18

164

Seropositive rheumatoid arthritis, strict definition

436

3249

1.37

8.49

7.3

7.0

24.38

24.66

mmol/l

0.74

402

3022

Monoamine oxidase A inhibitors

333

2374

1.43

8.48

8.1

7.2

25.42

24.46

mmol/l

6.01

321

2191

Disorders of magnesium metabolism

125

3.23

8.47

12.2

6.8

25.37

25.11

mmol/l

0.13

115

Haemangioma, any site

209

1361

1.57

8.45

6.8

7.2

24.52

24.63

mmol/l

0.17

200

1254

Tooth eruption problems

247

1643

1.51

8.44

7.1

7.0

24.29

23.93

mmol/l

0.70

222

1537

Lichen simplex chronicus

116

652

1.86

8.43

9.2

6.9

24.49

24.53

mmol/l

0.04

106

610

Myeloid leukaemia

482

2.01

8.38

9.8

7.9

24.51

24.59

mmol/l

0.08

454

Convalescence

153

928

1.70

8.37

20.8

6.2

25.18

24.46

mmol/l

1.55

142

869

Haemangioma and lymphangioma, any site

224

1484

1.54

8.36

6.7

7.2

24.52

24.61

mmol/l

0.14

215

1362

Multiple myeloma, excluding all cancers (controls excluding all cancers)

157

963

1.70

8.35

7.8

6.3

24.02

24.52

mmol/l

0.82

146

895

Acquired absence of organs, not elsewhere classified

206

2.62

8.34

13.1

6.0

23.90

24.45

mmol/l

0.45

191

Other benign neoplasms of connective and other soft tissue

287

2003

1.47

8.29

7.8

7.2

24.40

24.55

mmol/l

0.32

271

1866

Other enthesopathy of foot (+metatarsalgia)

260

1778

1.49

8.29

7.0

7.3

24.87

24.62

mmol/l

0.62

241

1646

Secondary uncertain malignant neoplasm

398

2939

1.38

8.29

7.3

6.5

24.83

24.47

mmol/l

1.07

369

2737

TMD related pain

446

2.02

8.28

6.8

9.7

24.29

24.60

mmol/l

0.44

415

Other disorders starting during childhood or adolecense, excluding more controls

279

2.25

8.25

9.0

5.4

24.02

23.71

mmol/l

0.23

259

Cramp and spasm

136

804

1.75

8.24

6.9

8.4

24.73

24.44

mmol/l

0.44

131

744

Exposure to unspecified factor

2986

20724

1.12

8.21

7.9

7.0

24.81

24.54

mmol/l

3.37

2785

19315

Parodontitis or/and operation codes

2031

10525

1.16

8.20

7.8

7.3

24.53

24.64

mmol/l

0.69

1885

9805

Dislocation, sprain and strain of joints and ligaments of knee

1647

13183

1.17

8.18

6.6

7.1

24.57

24.55

mmol/l

0.06

1532

12254

CR(E)ST syndrome

245

2.44

8.16

8.1

8.7

23.92

25.09

mmol/l

1.47

235

Polycystic ovarian syndrome

488

1.94

8.16

7.2

5.7

24.21

23.88

mmol/l

0.48

453

Congenital malformations of cardiac septa

162

968

1.66

8.15

9.6

7.4

24.70

24.45

mmol/l

0.39

150

904

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

1078

10543

0.83

8.15

5.9

7.0

24.60

24.55

mmol/l

0.18

1001

9791

Tuberculosis, IBD comorbidity

242

1643

1.51

8.13

8.6

6.4

24.97

24.52

mmol/l

0.94

228

1536

Chronic tubulo-interstitial nephritis

116

658

1.82

8.11

6.5

6.2

23.74

24.70

mmol/l

1.62

105

617

Benign lipomatous neoplasm

872

7127

1.24

8.11

6.5

7.1

24.64

24.63

mmol/l

0.03

815

6631

Other and unspecified vascular occlusions

312

2225

1.44

8.10

5.7

6.4

24.57

24.62

mmol/l

0.06

291

2073

Other specified disorders of muscle

522

1.94

8.10

11.2

7.7

24.68

24.39

mmol/l

0.25

488

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder

162

1011

1.67

8.07

8.2

6.6

23.43

24.60

mmol/l

3.55

151

945

Nosocomial condition (hospital)

107

3.36

8.04

6.2

5.4

25.89

24.26

mmol/l

1.57

Disturbance of activity and attention

160

973

1.64

8.03

5.4

7.1

24.23

23.96

mmol/l

0.48

151

907

Parodontitis, under 40 years

155

949

1.66

8.00

6.7

7.3

23.33

23.94

mmol/l

0.92

141

872

Parodontitis, under 40 years and operation codes

147

888

1.68

8.00

6.9

23.25

23.91

mmol/l

0.97

133

818

Parodontitis, operation under 40 years and operation codes

147

888

1.68

8.00

6.9

23.25

23.91

mmol/l

0.97

133

818

Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)

405

3011

1.37

7.98

7.7

6.8

24.00

24.41

mmol/l

1.10

378

2817

Malignant neoplasm of thyroid gland

194

1262

1.58

7.98

6.3

7.5

25.07

24.61

mmol/l

1.18

180

1180

Malignant neoplasm of head and neck, excluding all cancers (controls excluding all cancers)

308

2194

1.44

7.98

10.0

6.6

25.35

24.49

mmol/l

3.85

284

2044

Disorders of refraction and accommodation

624

4897

1.28

7.96

7.7

6.7

24.65

24.46

mmol/l

0.63

584

4536

Parodontitis, under 40 years, or operation codes

155

951

1.65

7.94

6.7

7.3

23.33

23.93

mmol/l

0.92

141

874

Femoral hernia

146

890

1.70

7.94

8.4

6.5

24.52

24.57

mmol/l

0.06

135

823

Gout due to impairment of renal function

200

2.63

7.93

9.4

6.1

23.79

24.31

mmol/l

0.37

187

Endometriosis ASRM stages 1,2

366

2677

1.38

7.93

5.9

6.5

24.31

24.59

mmol/l

0.97

345

2477

Peritonsillar abscess

530

4093

1.31

7.92

6.9

7.4

24.83

24.41

mmol/l

2.29

498

3803

Tuberculosis, wide

250

1718

1.49

7.91

8.5

6.6

24.97

24.48

mmol/l

1.10

236

1603

Use of memantine

838

5951

1.25

7.91

4.1

6.1

24.57

24.52

mmol/l

0.15

787

5547

Use of other anti-dementia drugs

838

5951

1.25

7.91

4.1

6.1

24.57

24.52

mmol/l

0.15

787

5547

Clefts and syndromes for tooth agenesis exclusion, including avohilmo

336

2.14

7.90

9.2

8.5

25.33

24.42

mmol/l

1.30

316

Paraplegia, diplegia of upper limbs

402

2.07

7.85

11.7

7.0

26.03

24.31

mmol/l

2.70

376

Kela reimbursement Agammaglobulinemia (D80-84)

102

3.27

7.84

15.7

11.7

25.55

24.90

mmol/l

0.43

Osteonecrosis

176

1127

1.61

7.81

9.0

7.3

24.71

24.60

mmol/l

0.14

167

1047

Drug-induced cataract

424

2.04

7.79

9.7

7.4

24.51

24.59

mmol/l

0.07

397

Malignant neoplasm of oral cavity, excluding all cancers (controls excluding all cancers)

144

879

1.70

7.79

11.4

6.6

25.42

24.61

mmol/l

2.12

136

822

Non-small cell lung cancer

511

3950

1.32

7.77

7.8

6.7

25.54

24.41

mmol/l

10.32

483

3694

Adenocarcinoma and ductal carcinoma of pancreas

124

731

1.78

7.76

10.7

6.3

24.45

24.56

mmol/l

0.14

115

687

Infection of intervertebral disc (pyogenic)

239

2.44

7.76

10.1

6.8

24.80

24.17

mmol/l

0.54

232

Post-traumatic wound infection, not elsewhere classified

445

2.00

7.75

10.4

8.0

24.26

24.56

mmol/l

0.22

410

Acute nephritic syndrome

383

2.09

7.75

6.7

7.9

23.93

24.55

mmol/l

0.53

354

Retinal breaks without detachment

251

3588

0.69

7.75

7.2

24.76

24.66

mmol/l

0.17

223

3347

In situ neoplasms

950

7497

1.22

7.73

6.2

6.6

24.46

24.58

mmol/l

0.45

883

6965

Other symptoms and signs involving the urinary system

320

2309

1.42

7.73

6.6

6.8

24.78

24.46

mmol/l

0.89

306

2158

Myelodysplastic syndrome, excluding all cancers (controls excluding all cancers)

104

583

1.87

7.73

5.9

6.2

24.36

24.37

mmol/l

0.00

545

Drug-induced osteoporosis

208

2.54

7.72

7.2

7.4

24.46

24.89

mmol/l

0.41

192

Cyst of kidney

220

1486

1.53

7.68

9.1

7.1

24.89

24.59

mmol/l

0.58

201

1390

Other diseases of jaws

194

1272

1.56

7.67

11.0

6.5

24.81

24.46

mmol/l

0.70

184

1182

Other maternal disorders predominantly related to pregnancy

1236

6550

1.19

7.65

5.9

6.8

24.33

24.73

mmol/l

3.50

1155

6084

Sicca syndrome [Sjögren]

241

1655

1.49

7.64

6.9

7.0

24.74

24.70

mmol/l

0.06

228

1531

Other/unspecified disorders of vestibular function

128

763

1.75

7.63

4.8

7.3

24.43

24.54

mmol/l

0.14

123

713

Septal defects

150

906

1.66

7.62

9.8

7.9

24.73

24.45

mmol/l

0.43

139

849

Right bundle-branch block

102

568

1.86

7.62

7.6

6.4

25.09

24.35

mmol/l

0.89

521

Malignant neoplasm of other and unspecified parts of biliary tract, excluding all cancers (controls excluding all cancers)

380

2.09

7.61

8.0

7.3

23.94

24.57

mmol/l

0.81

358

Other and unspecified rosacea

234

1599

1.50

7.60

7.3

24.46

24.53

mmol/l

0.11

216

1491

Malignant neoplasm of breast, HER2-negative, excluding all cancers (controls excluding all cancers)

1037

5632

1.21

7.57

5.7

6.3

25.23

24.83

mmol/l

3.38

970

5205

Dislocation, sprain and strain of joints and ligaments of thorax

541

1.88

7.56

6.8

7.5

24.47

24.43

mmol/l

0.04

505

Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)

1037

5633

1.21

7.56

5.7

6.3

25.23

24.83

mmol/l

3.38

970

5206

Traumatic ischaemia of muscle

216

2.47

7.52

15.5

9.8

24.81

24.39

mmol/l

0.33

201

Endometriosis

862

4183

1.24

7.51

5.9

6.6

24.46

24.66

mmol/l

0.92

805

3875

Panniculitis affecting regions of neck and back

111

637

1.80

7.49

10.3

7.4

24.98

24.63

mmol/l

0.50

100

602

Acute suppurative otitis media

536

3893

1.30

7.48

7.6

6.8

24.10

24.30

mmol/l

0.65

500

3614

Melanocytic naevi, other sites/unspecified

217

1466

1.52

7.47

7.2

7.4

24.39

24.48

mmol/l

0.14

205

1363

Spontaneous rupture of synovium and tendon

240

1656

1.48

7.44

7.3

24.40

24.68

mmol/l

0.63

230

1539

Lichen simplex chronicus and prurigo

188

1236

1.56

7.41

9.1

6.6

24.51

24.58

mmol/l

0.10

169

1141

Fibroblastic disorders

707

5709

1.25

7.41

7.2

24.48

24.51

mmol/l

0.09

667

5326

Dystonia

154

967

1.64

7.41

7.3

7.8

24.93

24.45

mmol/l

0.91

148

904

Actinic keratosis

1242

10047

1.19

7.40

6.5

24.50

24.61

mmol/l

0.52

1159

9377

Fistulae involving female genital tract

269

2.28

7.37

9.4

8.1

24.39

24.95

mmol/l

0.52

258

Burns and corrosions

359

2655

1.37

7.37

8.2

7.3

24.45

24.40

mmol/l

0.08

341

2468

Dental caries 1 and operation codes, only avohilmo

716

4460

0.80

7.36

7.5

7.9

24.59

24.55

mmol/l

0.11

678

4134

Residual foreign body in soft tissue

140

860

1.67

7.34

8.2

25.07

24.59

mmol/l

1.00

132

800

Other neurotic disorders

157

994

1.63

7.33

6.3

6.6

25.24

24.47

mmol/l

1.15

142

921

Skin changes due to chronic exposure to nonionizing radiation

1270

10267

1.18

7.30

6.5

6.6

24.48

24.62

mmol/l

0.62

1186

9586

Corneal ulcer

482

3723

1.31

7.30

7.1

6.9

24.61

24.54

mmol/l

0.18

451

3469

Contact with machinery

339

2498

1.39

7.24

6.1

7.5

24.06

24.51

mmol/l

1.46

318

2334

Benign neoplasm of middle ear and respiratory system

225

1542

1.49

7.24

6.5

6.7

24.81

24.52

mmol/l

0.55

215

1434

Other maltreatment syndromes

447

1.94

7.23

6.0

8.7

24.32

24.62

mmol/l

0.27

420

Generalized epilepsy, mode (most common among epilepsy diagnosis)

440

1.95

7.22

7.9

7.1

24.62

24.28

mmol/l

0.29

414

Salpingitis and oophoritis

434

3310

1.33

7.21

8.3

6.6

25.09

24.88

mmol/l

0.59

404

3050

Atrial septal defect

530

1.85

7.19

9.9

8.0

24.76

24.54

mmol/l

0.23

499

Adverse effects, not elsewhere classified

460

3539

1.32

7.15

7.1

6.8

24.49

24.46

mmol/l

0.07

430

3284

Melanocytic naevi of trunk

283

2026

1.42

7.11

6.6

7.0

24.66

24.37

mmol/l

0.62

267

1881

Multiple myeloma and malignant plasma cell neoplasms

158

1013

1.62

7.09

7.8

6.3

24.00

24.46

mmol/l

0.75

147

947

Ulcerative colitis (strict definition, require KELA, min 2 HDR)

413

3136

1.34

7.09

6.2

7.5

24.21

24.42

mmol/l

0.58

385

2919

Sixth [abducent] nerve palsy

111

651

1.78

7.07

9.8

6.7

25.03

24.44

mmol/l

1.08

102

607

Benign neoplasm of eye and adnexa

271

1931

1.43

7.06

7.7

6.9

24.32

24.63

mmol/l

0.64

251

1788

Basal cell carcinoma, excluding all cancers (controls excluding all cancers)

1463

8712

1.17

7.02

6.3

6.9

24.45

24.63

mmol/l

1.23

1366

8108

Diffuse brain injury

516

1.85

7.00

21.3

6.1

25.12

24.00

mmol/l

1.95

473

Other congenital malformations

192

1280

1.53

6.98

7.8

7.3

24.80

24.37

mmol/l

0.86

178

1192

Hypermetropia

173

1131

1.56

6.95

6.9

24.28

24.41

mmol/l

0.16

160

1050

Pedal cyclist injured in transport accident

574

4561

1.27

6.94

7.0

24.74

24.50

mmol/l

0.80

521

4252

Oral leukoplakia

359

2.07

6.92

7.7

7.3

24.47

24.58

mmol/l

0.07

340

Other abnormal uterine and vaginal bleeding

608

3451

1.27

6.92

6.7

6.5

25.11

24.82

mmol/l

1.00

573

3198

Internal derangement of knee

1046

8805

1.19

6.92

6.8

7.3

24.57

mmol/l

0.01

979

8228

Acne vulgaris

138

854

1.64

6.91

7.6

7.4

23.85

23.84

mmol/l

0.01

128

792

Melanocytic naevi

754

6176

1.23

6.90

7.4

7.0

24.44

24.52

mmol/l

0.22

703

5735

Viral infections of the central nervous system

193

1295

1.52

6.89

7.9

7.4

25.38

24.47

mmol/l

2.77

184

1212

Hyperkinetic disorders

166

1061

1.56

6.83

5.3

7.3

24.25

23.93

mmol/l

0.64

157

984

Other specified/unspecified dorsopathies

102

588

1.79

6.82

5.9

8.3

24.72

24.49

mmol/l

0.30

559

Benign neoplasm of other and unspecified intrathoracic organs

189

2.50

6.78

15.4

6.9

26.08

24.65

mmol/l

1.75

179

Hydrocele

384

2914

1.34

6.74

8.3

7.7

24.47

24.37

mmol/l

0.21

354

2734

498

1.88

6.73

9.1

6.7

26.03

24.29

mmol/l

2.56

473

Other benign neoplasms of skin

1109

9439

1.19

6.73

6.8

6.9

24.56

24.60

mmol/l

0.15

1035

8782

Other and unspecified urticaria

465

3616

1.30

6.70

7.3

6.7

24.70

24.51

mmol/l

0.53

436

3366

Tuberculosis

210

1445

1.49

6.69

8.1

6.7

25.19

24.43

mmol/l

1.79

200

1349

Basal cell carcinoma, including avohilmo, excluding all cancers (controls excluding all cancers)

1477

8813

1.16

6.68

6.3

6.9

24.45

24.64

mmol/l

1.23

1379

8202

Ovarian dysfunction

128

785

1.66

6.68

6.9

6.2

24.45

24.26

mmol/l

0.30

120

733

Speech therapy

521

6557

0.79

6.66

4.8

7.1

25.02

24.62

mmol/l

1.22

478

6124

Drug-induced osteoporosis with pathological fracture

282

2.19

6.65

11.2

6.7

26.03

24.73

mmol/l

1.64

266

Burns and corrosions of external body surface, specified by site

280

2027

1.41

6.63

7.7

7.4

24.46

24.42

mmol/l

0.06

265

1897

Ganglion

510

4018

1.28

6.61

6.6

7.0

24.69

24.56

mmol/l

0.39

478

3734

Other specified disorders of kidney and ureter

103

603

1.77

6.60

9.1

7.0

24.81

24.49

mmol/l

0.42

568

Mucosal proctocolitis

318

2351

1.37

6.59

7.6

7.0

24.07

24.42

mmol/l

1.05

299

2183

Erythema multiforme

392

1.97

6.58

8.9

8.0

25.19

24.67

mmol/l

0.70

368

Papillary adenocarcinoma of thyroid gland

144

918

1.61

6.57

6.9

7.1

25.01

24.64

mmol/l

0.64

134

860

Other diseases of stomach and duodenum

188

1271

1.52

6.55

10.7

6.5

24.52

24.70

mmol/l

0.22

174

1186

Thyroiditis

181

1214

1.52

6.50

7.5

24.77

24.58

mmol/l

0.36

173

1138

Benign neoplasm: Kidney

114

690

1.72

6.50

6.2

6.9

24.10

24.65

mmol/l

0.70

107

652

Haemolytic anaemias

109

651

1.74

6.50

11.1

7.5

24.18

24.50

mmol/l

0.34

104

610

Lichen planus, including avohilmo

510

4035

1.28

6.50

5.9

7.1

24.43

24.68

mmol/l

0.77

474

3755

Exposure to excessive natural cold

206

2.41

6.50

14.6

9.5

25.38

24.10

mmol/l

1.00

193

Postmenopausal bleeding

777

3502

1.23

6.49

6.2

6.7

25.25

24.90

mmol/l

2.10

718

3244

Pilonidal cyst

202

1384

1.48

6.47

6.8

7.6

24.75

24.39

mmol/l

0.72

193

1289

Hyperfunction of pituitary gland

116

702

1.69

6.47

7.1

7.7

25.39

24.47

mmol/l

1.85

104

655

Bronchitis, not specified as acute or chronic

234

1651

1.44

6.45

8.6

6.9

24.95

24.25

mmol/l

2.07

219

1533

Burn and corrosion of trunk

503

1.84

6.43

9.2

8.1

24.98

24.35

mmol/l

0.75

470

Cystic kidney disease

570

1.78

6.43

12.1

7.8

23.00

24.47

mmol/l

4.20

536

Primary open-angle glaucoma, strict

820

6822

1.22

6.39

6.3

6.6

24.42

24.67

mmol/l

1.09

765

6358

Blepharochalasis

864

7238

1.21

6.37

6.7

6.8

25.05

24.73

mmol/l

2.06

795

6732

Psoriasis

792

6577

1.22

6.37

8.4

7.4

25.16

24.56

mmol/l

4.65

740

6120

Prepatellar bursitis

142

910

1.61

6.37

7.2

7.9

23.89

24.56

mmol/l

1.22

127

849

Hepatocellular carcinoma, excluding all cancers (controls excluding all cancers)

582

1.78

6.33

8.7

6.9

23.24

24.60

mmol/l

2.56

541

Need for immunization against other single viral diseases

354

0.24

6.32

2.8

8.9

24.01

24.52

mmol/l

—

336

Effects of foreign body entering through natural orifice

659

5379

1.24

6.31

9.2

7.5

24.81

24.45

mmol/l

1.91

611

5013

Plantar fascial fibromatosis

246

1759

1.42

6.29

6.6

7.3

24.80

24.62

mmol/l

0.36

231

1628

Lesion of plantar nerve

167

1112

1.54

6.27

6.3

7.1

24.61

24.66

mmol/l

0.06

157

1035

Diseases of tongue

183

1242

1.51

6.26

8.6

6.6

25.15

24.56

mmol/l

1.44

167

1154

Postmenopausal atrophic vaginitis

444

3422

0.77

6.26

4.8

6.9

24.50

24.91

mmol/l

1.66

418

3171

Other disorders of pigmentation

127

797

1.64

6.23

4.8

7.3

24.37

24.55

mmol/l

0.20

120

745

Injury of eye and orbit

360

2735

1.33

6.23

8.5

7.4

24.69

24.40

mmol/l

0.79

341

2529

Crohn's disease NAS

165

1096

1.54

6.22

6.7

7.0

24.41

24.51

mmol/l

0.13

157

1021

Sequelae of injuries of lower limb

248

1781

1.42

6.21

8.0

7.3

24.85

24.50

mmol/l

0.75

230

1657

Nonalcoholic fatty liver disease

242

1732

1.43

6.20

8.5

7.4

23.97

24.59

mmol/l

1.60

227

1616

Gingival hyperplasia

561

1.77

6.19

7.6

6.6

24.27

24.55

mmol/l

0.23

522

Scabies

118

729

1.66

6.13

9.9

8.0

25.25

24.43

mmol/l

1.75

113

679

Myeloid leukaemia

535

1.80

6.13

9.8

7.3

24.51

24.43

mmol/l

0.07

503

Central retinal artery occlusion

462

1.87

6.11

7.2

6.3

24.06

24.44

mmol/l

0.40

432

Unspecified event, undetermined intent

373

1.95

6.10

7.1

8.6

24.56

24.48

mmol/l

0.05

349

Pure hyperglyceridaemia

403

1.92

6.09

13.0

6.5

24.69

24.27

mmol/l

0.38

377

Chronic hepatitis, not elsewhere classified

587

1.75

6.07

7.2

7.7

23.33

24.62

mmol/l

2.29

547

Noninflammatory disorders of female genital tract

1039

4423

1.19

6.06

6.0

6.5

24.32

24.58

mmol/l

1.30

964

4100

Ulcerative proctitis

156

1032

1.55

6.02

5.8

7.2

24.42

24.54

mmol/l

0.16

150

959

Other vitreous opacities

122

767

1.65

6.00

6.3

7.3

25.43

24.41

mmol/l

2.34

115

717

Benign neoplasm of ovary

445

3499

1.29

5.98

5.9

6.5

24.79

24.86

mmol/l

0.15

420

3242

Benign neoplasm of urinary organs

146

957

1.58

5.98

6.0

6.8

24.28

24.44

mmol/l

0.18

137

895

Voice disturbances

717

5940

1.22

5.96

6.7

6.9

24.79

24.60

mmol/l

0.79

668

5531

Open wound of forearm

250

1812

1.41

5.96

6.3

6.9

24.25

24.44

mmol/l

0.32

240

1687

Ulcerative colitis (strict definition, require KELA)

420

3279

1.30

5.95

6.4

7.5

24.22

24.42

mmol/l

0.54

391

3052

Other specified and unspecified retinal disorders

111

685

1.68

5.90

7.5

6.9

24.04

24.49

mmol/l

0.72

102

640

UC patients in KELA-register ( KELA 208 prior to 1994, or ICD K51)

453

3574

1.28

5.89

6.3

7.5

24.19

24.46

mmol/l

0.90

424

3328

Entropion and trichiasis of eyelid

272

2007

1.39

5.89

6.8

6.5

25.11

24.57

mmol/l

1.67

262

1868

Other disorders of patella

407

3167

1.30

5.89

6.5

7.5

24.46

24.55

mmol/l

0.19

390

2956

Injury of unspecified body region

203

1423

1.46

5.88

9.7

7.3

24.77

24.51

mmol/l

0.47

195

1320

Left hemicolectomy

506

1.80

5.83

9.8

7.1

23.82

24.52

mmol/l

1.24

475

Psoriasis vulgaris

511

4100

1.26

5.80

8.7

7.4

25.17

24.55

mmol/l

3.12

477

3825

Restless leg syndrome

328

2493

1.34

5.76

6.7

6.9

24.88

24.60

mmol/l

0.71

313

2311

Inguinal of femoral hernia, unilateral

514

1.78

5.76

8.6

6.8

24.20

24.60

mmol/l

0.50

481

Femoral hernia, unilateral

514

1.78

5.76

8.6

6.8

24.20

24.60

mmol/l

0.50

481

Inguinal hernia, unilateral

514

1.78

5.76

8.6

6.8

24.20

24.60

mmol/l

0.50

481

Coxibs

927

4162

1.20

5.75

5.1

7.5

24.51

24.38

mmol/l

0.45

856

3880

Other and unspecified follicular disorders

109

673

1.67

5.74

6.7

8.2

24.63

24.50

mmol/l

0.12

100

628

Bulimia nervosa (incl. atypical)

288

2.02

5.71

5.6

10.0

24.77

23.79

mmol/l

0.98

263

Adalimumab

206

1454

1.44

5.71

6.3

7.8

24.29

24.48

mmol/l

0.35

193

1359

Diabetic neuropathy

399

3110

1.31

5.70

8.1

8.6

24.00

24.25

mmol/l

0.59

369

2917

Vasomotor rhinitis (mode)

201

1416

1.45

5.70

5.1

7.5

24.51

24.52

mmol/l

0.01

189

1314

Benign neoplasm of other and unspecified intrathoracic organs

205

2.30

5.67

15.4

7.0

26.08

24.23

mmol/l

2.63

192

Carbimazole or st.post thyroidectomy, condition for graves disease

505

4056

1.26

5.66

5.7

6.9

24.90

24.64

mmol/l

1.09

464

3768

Erectile dysfunction

278

2076

1.37

5.64

7.6

7.2

24.34

24.32

mmol/l

0.02

252

1940

Lymphoid leukaemia

158

1067

1.52

5.61

7.7

6.9

24.77

24.49

mmol/l

0.43

147

994

Malignant neoplasm of bladder

233

1691

1.41

5.61

8.3

6.4

23.93

24.41

mmol/l

0.90

220

1582

Toxic liver disease

252

2.13

5.60

6.7

8.3

23.34

24.51

mmol/l

1.05

236

Glucosamine medication

1608

11360

1.14

5.60

6.1

6.8

24.95

24.68

mmol/l

2.34

1509

10590

Use of levodopa decarbox-comt-inhibitor

114

721

1.65

5.57

5.7

6.5

25.91

24.41

mmol/l

5.14

107

671

Other specified/unspecified disorders of synovium and tendon +Other specified/unspecified bursopathies

119

755

1.61

5.56

8.1

24.33

24.57

mmol/l

0.32

113

702

Other contact dermatitis

208

1479

1.43

5.56

8.3

6.5

24.77

24.43

mmol/l

0.64

189

1367

Secondary and unspecified malignant neoplasm of lymph nodes

244

1788

1.39

5.53

7.7

6.7

24.79

24.45

mmol/l

0.66

224

1664

Benign neoplasm: Skin of other and unspecified parts of face

316

2406

1.34

5.52

6.0

6.8

24.47

24.57

mmol/l

0.21

295

2232

Carcinoma in situ of other and unspecified digestive organs

484

1.79

5.52

6.3

6.9

24.93

24.47

mmol/l

0.60

454

Disorders of vitreous body and globe

1485

12787

1.14

5.50

7.1

24.83

24.69

mmol/l

0.85

1388

11924

Other Crohn's disease

169

1160

1.49

5.47

6.4

7.0

23.97

24.53

mmol/l

1.08

159

1083

Hypermobility syndrome

105

648

1.65

5.46

5.3

8.1

24.18

24.41

mmol/l

0.25

603

Chronic nephritic syndrome

119

762

1.61

5.43

8.7

7.6

23.09

24.61

mmol/l

3.66

113

712

Achilles tendinitis

260

1929

1.37

5.38

8.8

7.8

25.02

24.51

mmol/l

1.71

247

1799

Medial epicondylitis

101

622

1.67

5.37

7.4

8.4

24.79

24.69

mmol/l

0.12

575

Assault by other specified means

126

2.60

5.37

9.8

11.6

24.51

24.27

mmol/l

0.15

115

Secondary malignant neoplasm of respiratory and digestive organs

286

2.06

5.36

5.1

6.2

24.97

24.38

mmol/l

0.47

270

Other diseases of gallbladder

130

852

1.57

5.35

7.0

6.2

24.05

24.64

mmol/l

1.09

124

793

Vasomotor and allergic rhinitis

917

7720

1.18

5.33

7.3

7.0

24.36

24.50

mmol/l

0.63

855

7186

Crohn's disease of large intestine

130

851

1.56

5.32

10.3

7.3

24.08

24.51

mmol/l

0.65

121

794

Superficial injury of forearm

229

1668

1.39

5.32

8.2

7.3

24.68

24.42

mmol/l

0.51

218

1553

Malignant melanoma

268

3548

0.74

5.28

7.0

6.8

24.97

24.58

mmol/l

0.99

247

3309

Orthopaedic devices associated with adverse incidents

381

0.25

5.27

6.3

6.7

26.21

24.74

mmol/l

—

362

Necrobiosis lipoidica, not elsewhere classified

3.22

5.27

8.2

13.4

24.66

24.52

mmol/l

0.06

Other inflammation of eyelid

339

2624

1.31

5.24

6.6

6.9

24.47

24.67

mmol/l

0.45

318

2433

UC patients in KELA-register (code 208), prior to 1994

139

931

1.54

5.20

7.0

7.1

23.92

24.58

mmol/l

1.46

131

868

Rare circulating lymphoid malignancy, excluding all cancers (controls excluding all cancers)

552

1.71

5.20

8.4

7.8

24.51

24.35

mmol/l

0.15

520

Injury of blood vessels at abdomen, lower back and pelvis level

3.37

5.19

12.5

12.3

24.84

24.64

mmol/l

0.10

Phantom limb syndrome with pain

4.18

5.17

12.4

8.4

24.63

25.33

mmol/l

0.37

Injury of muscle and tendon at wrist and hand level

373

2929

1.29

5.16

6.9

7.6

24.60

24.55

mmol/l

0.09

348

2735

Maternal care for known or suspected fetal abnormality and damage

113

1550

0.64

5.15

7.0

6.4

23.91

24.15

mmol/l

0.26

104

1442

Endometriosis diagnosis and infertility diagnosis occurring together

191

1355

1.43

5.14

5.4

6.8

23.63

24.52

mmol/l

3.93

179

1266

Vaginitis/vulvovaginitis/vulvitis/abscess of vulva

315

2417

1.32

5.12

6.8

6.2

24.32

24.49

mmol/l

0.47

302

2236

Exposure to other and unspecified inanimate mechanical forces

177

1244

1.45

5.11

8.6

7.8

25.24

24.47

mmol/l

1.82

164

1160

Oral leukoplakia, including avohilmo

533

1.72

5.10

6.9

8.4

24.59

24.65

mmol/l

0.05

500

Benign neoplasm: Skin of eyelid, including canthus

395

3129

1.28

5.09

7.4

6.8

24.62

24.66

mmol/l

0.08

368

2890

Hyperhidrosis

352

1.86

5.06

5.0

7.1

24.70

24.46

mmol/l

0.21

327

Simple and mucopurulent chronic bronchitis

120

782

1.57

5.06

6.7

6.6

25.21

24.19

mmol/l

2.79

114

731

Pedal cyclist injured in other and unspecified transport accidents

283

2149

1.34

5.04

6.8

7.3

24.86

24.42

mmol/l

1.07

250

2008

Struck by thrown, projected or falling objec

128

847

1.55

5.04

6.0

7.6

24.58

24.42

mmol/l

0.22

120

793

Malignant neoplasm of small intestine

453

1.78

5.02

6.0

6.8

24.28

24.45

mmol/l

0.16

427

Acne

166

1152

1.46

5.01

7.1

7.2

24.05

23.93

mmol/l

0.14

155

1066

Dissection of cerebral arteries, nonruptured

113

2.65

4.98

9.6

7.1

24.10

24.40

mmol/l

0.18

107

Ectropion of eyelid

130

868

1.55

4.98

5.7

5.9

24.93

24.47

mmol/l

0.61

123

807

Persons with potential health hazards related to communicable diseases

573

6862

0.82

4.97

4.8

6.9

24.53

24.37

mmol/l

0.50

539

6367

Other keratitis

273

2067

1.34

4.96

9.2

7.2

24.84

24.54

mmol/l

0.66

256

1931

Campylobacter enteritis

460

1.75

4.96

6.0

8.1

23.73

24.60

mmol/l

1.10

430

Acute pharyngitis

300

2281

1.32

4.96

6.7

7.0

24.73

24.40

mmol/l

0.92

279

2129

Crystal arthropathies, rheuma endpoint

373

1.86

4.94

4.3

7.4

24.67

24.20

mmol/l

0.37

348

Atopic conjunctivitis

104

659

1.61

4.93

7.1

7.5

24.77

24.47

mmol/l

0.45

619

Suppurative and unspecified otitis media

801

6034

1.18

4.93

7.2

6.9

24.31

24.39

mmol/l

0.26

745

5616

Benign lipomatous neoplasm of skin and subcutaneous tissue of head, face and neck

192

1381

1.42

4.93

5.6

7.3

24.62

24.48

mmol/l

0.18

178

1292

Lichen ruber planus, wide definition including periferal and oral lichen planus

568

4701

1.22

4.89

5.8

7.0

24.40

24.68

mmol/l

0.99

529

4374

Nephrotic syndrome

546

1.68

4.88

11.0

8.1

23.33

24.46

mmol/l

1.45

515

Melanoma in situ of trunk

284

0.27

4.87

3.5

6.6

23.78

24.36

mmol/l

—

268

Other menopausal disorders

454

3241

0.80

4.85

5.6

7.2

25.09

24.89

mmol/l

0.73

426

3000

Left bundle-branch block

170

1198

1.45

4.85

4.9

6.0

24.77

24.55

mmol/l

0.34

163

1108

Bullous disorders

166

1168

1.46

4.84

8.4

6.5

24.95

24.46

mmol/l

0.94

158

1086

Other/unspecified enthesopathies of lower limb, excluding foot

161

1125

1.46

4.79

7.1

8.0

24.73

24.50

mmol/l

0.47

154

1055

Inflammatory diseases of prostate (prostatitis)

402

3220

1.27

4.78

6.8

8.2

24.43

24.40

mmol/l

0.05

371

3031

Other and unspecified intracranial injuries

534

1.68

4.77

10.4

7.4

24.79

24.29

mmol/l

0.61

496

Unspecified urinary incontinence

121

1795

0.66

4.76

6.5

25.38

24.77

mmol/l

0.99

114

1657

Degeneration of the brain due to alcohol

483

1.73

4.76

9.5

8.8

23.59

24.32

mmol/l

0.74

448

Bursitis of shoulder

428

1.76

4.75

6.0

7.5

25.40

24.63

mmol/l

1.22

399

Hypertrophic cardiomyopathy

127

853

1.54

4.75

9.0

7.5

24.22

24.43

mmol/l

0.26

121

797

Ankylosing spondylitis

216

1590

1.38

4.75

6.7

7.9

24.91

24.35

mmol/l

1.43

199

1497

Benign neoplasm: Choroid

173

1232

1.44

4.74

8.3

7.0

24.35

24.50

mmol/l

0.19

162

1145

Other facial nerve disorders

451

1.74

4.72

6.4

8.4

24.45

24.63

mmol/l

0.22

420

Impacted cerumen

153

2166

0.69

4.69

5.8

6.7

24.65

24.44

mmol/l

0.34

142

2009

Heart failure and hypertrophic cardiomyopathy

373

1.84

4.67

10.6

6.8

23.84

24.53

mmol/l

0.66

348

Rosacea

278

2132

1.32

4.65

7.3

7.2

24.54

24.51

mmol/l

0.05

257

1983

Contact with heat and hot substances

134

911

1.50

4.65

6.8

7.8

24.42

24.37

mmol/l

0.06

125

851

Atrophic disorders of skin

345

2720

1.28

4.65

6.1

6.9

24.69

24.77

mmol/l

0.17

315

2518

Alcohol-induced acute pancreatitis

115

761

1.56

4.63

16.0

7.1

24.53

24.57

mmol/l

0.03

109

708

Degeneration of nervous system due to alcohol

487

1.72

4.62

9.5

8.4

23.59

24.40

mmol/l

0.86

454

Carcinoma in situ of cervix uteri

140

958

1.48

4.61

6.2

6.4

24.39

24.11

mmol/l

0.37

129

881

conjunctival haemorrhage

217

1612

1.38

4.60

8.1

6.9

24.82

24.65

mmol/l

0.26

196

1500

Polyp of the female genital tract

784

3879

1.18

4.59

6.3

6.8

24.84

24.80

mmol/l

0.13

739

3593

Other abnormal findings of blood chemistry

119

793

1.54

4.59

8.1

7.5

24.41

24.43

mmol/l

0.02

113

744

Disorder of external ear, unspecified

587

1.64

4.59

6.3

8.0

23.99

24.45

mmol/l

0.61

550

Injuries to the wrist and hand

2944

19665

1.09

4.57

6.9

7.2

24.51

24.58

mmol/l

0.54

2754

18319

Disorders of vitreous body

1424

12431

1.13

4.56

7.3

7.1

24.82

24.69

mmol/l

0.76

1331

11588

Benign neoplasm of major salivary glands

254

1931

1.34

4.56

9.1

6.9

24.93

24.60

mmol/l

0.68

235

1783

Other disorders of prostate

118

788

1.55

4.56

7.7

6.7

24.13

24.17

mmol/l

0.05

111

736

Family history of certain disabilities and chronic diseases leading to disablement

546

1.64

4.55

5.8

7.1

24.34

24.39

mmol/l

0.04

499

Ulcerative rectosigmoiditis

209

1543

1.38

4.55

6.8

7.1

24.59

24.52

mmol/l

0.10

196

1435

Other coagulation defects

176

1264

1.42

4.54

11.3

7.2

24.87

24.36

mmol/l

1.03

164

1179

Ehlers-Danlos syndrome

2.72

4.49

4.5

6.8

23.79

24.42

mmol/l

0.47

Ulcerative colitis (strict definition, all Crohn cases excluded)

350

2776

1.28

4.49

6.2

7.2

24.22

24.41

mmol/l

0.49

329

2581

Respiratory tuberculosis

173

1244

1.42

4.49

8.4

7.0

24.92

24.47

mmol/l

0.73

163

1165

Respiratory tuberculosis, confirmed and not-confirmed

173

1244

1.42

4.49

8.4

7.0

24.92

24.47

mmol/l

0.73

163

1165

Use of anticholinesterases

1032

7305

1.15

4.48

4.6

6.3

24.62

24.57

mmol/l

0.18

967

6811

N06DA Anticholinesterases

1032

7305

1.15

4.48

4.6

6.3

24.62

24.57

mmol/l

0.18

967

6811

Other crystal arthropathies

385

1.80

4.47

4.3

7.3

24.67

24.26

mmol/l

0.31

359

Cysts of oral region, not elsewhere classified

122

822

1.52

4.46

5.8

6.7

24.37

24.58

mmol/l

0.29

112

765

Other and unspecified injuries of lower leg

172

1236

1.41

4.42

6.1

7.0

24.93

24.42

mmol/l

1.11

164

1163

Melanoma in situ of trunk

274

0.28

4.42

3.5

6.3

23.77

24.50

mmol/l

—

257

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

812

6974

1.17

4.41

6.6

6.9

24.59

24.45

mmol/l

0.54

765

6472

Etanercept

142

987

1.47

4.40

8.6

8.3

24.33

24.54

mmol/l

0.28

133

919

Primary biliary cholangitis (PBC)

341

1.82

4.38

11.6

6.4

24.18

24.62

mmol/l

0.44

316

Special screening examination for other diseases and disorders

188

1372

1.39

4.37

6.2

6.0

24.11

24.34

mmol/l

0.30

172

1279

Hallux rigidus

376

3020

1.26

4.37

7.5

7.2

24.80

24.69

mmol/l

0.24

355

2836

Epidermolysis bullosa

8.08

4.37

21.7

9.7

22.80

24.58

mmol/l

—

Other and unspecified corneal deformities and disorders

563

1.63

4.35

8.0

7.5

24.95

24.63

mmol/l

0.38

528

Crohn's disease of small intestine

162

1156

1.43

4.35

7.7

7.0

24.62

24.49

mmol/l

0.19

153

1075

Benign neoplasm: Bronchus and lung

250

1.98

4.30

9.1

6.7

25.34

24.65

mmol/l

0.82

232

Muscle strain

494

1.66

4.29

4.4

7.8

24.17

24.39

mmol/l

0.27

459

Acute myeloid leukaemia, helper endpoint

174

2.19

4.29

9.4

6.6

24.81

24.83

mmol/l

0.01

164

Acute myeloid leukaemia, excluding all cancers (controls excluding all cancers)

174

2.19

4.29

9.4

6.6

24.81

24.82

mmol/l

0.01

164

Other and unspecified disorders of skin and subcutaneous tissue

1245

0.62

4.20

7.4

7.0

24.95

24.46

mmol/l

0.50

1154

Sequelae of infectious and parasitic diseases

203

1513

1.36

4.20

6.9

6.8

25.34

24.41

mmol/l

2.72

195

1412

Dislocation, sprain and strain of joints and ligaments at wrist and hand level

663

5641

1.18

4.20

6.8

7.3

24.57

24.50

mmol/l

0.20

627

5247

Speech disturbances, not elsewhere classified

241

1847

1.33

4.15

8.1

6.8

24.96

24.52

mmol/l

0.87

227

1721

Isolated proteinuria

516

1.64

4.13

8.1

7.9

23.31

24.41

mmol/l

1.72

480

Dental caries 3 and operation codes, only avohilmo

846

4908

0.86

4.13

7.1

7.8

24.69

24.54

mmol/l

0.55

799

4557

Supervision of high-risk pregnancy

343

1642

1.27

4.12

5.1

6.8

23.75

24.44

mmol/l

3.33

322

1530

Malignant neoplasm of stomach

154

1105

1.43

4.10

8.2

6.3

24.86

24.51

mmol/l

0.58

143

1031

Endometriosis of rectovaginal septum and vagina

186

1373

1.38

4.09

7.6

6.5

24.71

24.77

mmol/l

0.09

180

1278

Unspecified dementia

318

2275

1.28

4.09

3.7

5.8

24.54

24.43

mmol/l

0.14

297

2119

Unspecified/other endometriosis

155

1109

1.41

4.06

5.3

6.3

24.00

24.45

mmol/l

1.07

149

1033

Noise effects on inner ear

133

933

1.47

4.05

6.6

7.7

24.67

24.40

mmol/l

0.34

122

869

Haemangioma and lymphangioma, any site

224

1706

1.33

4.02

6.7

7.3

24.52

24.54

mmol/l

0.03

215

1585

Selective deficiency of immunoglobulin G [IgG] subclasses

2.59

4.02

10.2

12.8

26.10

24.91

mmol/l

0.95

Leiomyoma of uterus

1025

5062

1.15

4.01

6.7

6.4

24.72

24.73

mmol/l

0.05

951

4681

Other and unspecified mental retardation

157

2.17

4.01

6.9

10.2

25.27

24.28

mmol/l

0.60

142

Nontoxic goitre/thyroid nodule

799

6931

1.16

4.01

6.7

6.6

24.90

24.75

mmol/l

0.56

746

6448

Myopia

254

1965

1.31

4.00

7.1

6.8

24.69

24.33

mmol/l

0.73

236

1827

Pustular psoriasis

121

835

1.48

3.98

6.5

7.9

25.44

24.57

mmol/l

1.36

114

782

Congenital obstructive defects of renal pelvis and congenital malformations of ureter

234

1.93

3.96

11.8

8.4

23.04

24.49

mmol/l

1.83

218

Psoriatic arthropathies

248

1919

1.31

3.95

7.1

7.8

25.07

24.62

mmol/l

1.18

231

1793

Embedded and impacted teeth

445

3116

1.22

3.94

5.9

6.9

24.21

24.15

mmol/l

0.12

413

2902

Dermatographic urticaria

143

1018

1.43

3.92

5.5

7.4

24.40

24.43

mmol/l

0.03

130

951

Rare circulating lymphoid malignancy

595

1.58

3.92

8.4

7.3

24.51

24.34

mmol/l

0.15

557

Atopic dermatitis

1014

9799

0.88

3.91

6.7

6.8

24.46

24.51

mmol/l

0.15

952

9109

Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs

188

1403

1.36

3.89

5.4

7.1

24.76

24.69

mmol/l

0.09

173

1291

Open bite

529

1.59

3.89

8.6

8.1

24.66

24.20

mmol/l

0.51

493

Effects of other external causes

384

1.71

3.86

4.5

7.9

24.41

24.40

mmol/l

0.01

355

Dermatopolymyositis (FG)

223

1.96

3.86

11.7

6.5

24.89

24.25

mmol/l

0.40

211

Benign neoplasm: Bronchus and lung

260

1.90

3.85

9.1

6.9

25.34

24.47

mmol/l

1.16

245

Adjustment and management of implanted device

390

4741

0.81

3.84

5.1

6.3

24.36

24.52

mmol/l

0.32

367

4432

Maternal care for other conditions predominantly related to pregnancy

323

2551

1.26

3.83

6.9

6.6

23.88

24.42

mmol/l

2.20

299

2367

Use of rasagiline

553

1.60

3.81

5.8

6.3

25.84

24.46

mmol/l

3.45

517

Haemangioma, any site

209

1590

1.34

3.81

6.8

7.4

24.52

24.54

mmol/l

0.03

200

1477

Benign neoplasm of middle ear and respiratory system

225

1731

1.32

3.81

6.5

6.9

24.81

24.54

mmol/l

0.51

215

1612

Pustulosis palmaris et plantaris

108

736

1.50

3.80

6.5

8.1

25.54

24.59

mmol/l

1.45

102

691

Vasculitis limited to skin, not elsewhere classified

481

1.63

3.79

8.8

7.7

24.41

24.45

mmol/l

0.02

447

Bullous pemphigoid

459

1.66

3.79

6.1

6.3

24.94

24.56

mmol/l

0.35

434

Other retinal artery occlusion

490

1.63

3.78

6.5

6.4

24.08

24.25

mmol/l

0.13

458

Failed induction of labour

517

1.59

3.77

3.6

5.7

24.39

24.08

mmol/l

0.42

477

Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk

344

2788

1.25

3.76

6.5

7.1

24.64

24.53

mmol/l

0.24

321

2589

Atypical facial pain

122

853

1.46

3.75

5.7

7.6

25.02

24.54

mmol/l

0.98

116

797

Other interventions on the root canals of the tooth

261

1.86

3.75

5.1

8.3

23.96

24.72

mmol/l

0.62

242

Abnormal findings in peritoneal fluid saliva

2.90

3.74

6.5

14.6

25.72

25.13

mmol/l

0.19

Contusion of other and unspecified parts of foot

100

672

1.51

3.73

6.1

7.9

24.38

24.43

mmol/l

0.05

622

Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers

115

798

1.48

3.72

10.5

6.2

25.35

24.47

mmol/l

1.29

104

742

Non-Hodgkin lymphoma, all

122

857

1.46

3.72

9.4

6.6

25.09

24.43

mmol/l

0.85

111

802

Other and unspecified vasculitis limited to skin

437

1.66

3.70

9.3

7.6

24.53

24.46

mmol/l

0.04

407

Cardiomyopathy in other diseases

2.76

3.69

6.8

5.1

23.32

24.29

mmol/l

0.42

Faecal incontinence

214

1641

1.32

3.69

7.2

6.2

24.81

24.87

mmol/l

0.10

198

1524

Benign neoplasm: Heart

2.90

3.67

15.2

6.1

26.07

24.23

mmol/l

0.94

Torticollis

212

1.94

3.67

5.7

8.4

24.61

24.65

mmol/l

0.02

200

Lymphoid leukaemia

158

1162

1.39

3.66

7.7

6.9

24.77

24.49

mmol/l

0.46

147

1085

Benign neoplasm of eye and adnexa

271

2148

1.28

3.64

7.7

6.7

24.32

24.58

mmol/l

0.53

251

1998

Nonspecific lymphadenitis

142

1025

1.41

3.64

6.0

7.5

24.69

24.54

mmol/l

0.20

129

947

Disorders of optic nerve, not elsewhere classified

401

1.68

3.63

7.0

8.3

24.05

24.57

mmol/l

0.52

379

Malignant neoplasm of liver and intrahepatic bile ducts

102

697

1.51

3.61

8.1

6.5

23.13

24.46

mmol/l

3.02

652

Pyogenic granuloma

272

1.83

3.61

8.3

7.1

23.84

24.62

mmol/l

0.35

255

Toxic effect of other gases, fumes and vapours

2.58

3.61

4.0

13.0

25.20

24.55

mmol/l

0.37

Non-small cell lung cancer, squamous, excluding all cancers (controls excluding all cancers)

137

987

1.42

3.59

9.8

6.5

25.73

24.28

mmol/l

3.89

130

930

Carcinoma in situ of other and unspecified digestive organs

545

1.58

3.59

6.3

6.9

24.93

24.49

mmol/l

0.57

514

Other and specified injuries of hip and thigh

394

1.68

3.58

4.8

7.6

24.67

24.54

mmol/l

0.09

369

Hordeolum and other deep inflammation of eyelid

133

953

1.42

3.58

8.6

7.2

24.71

24.44

mmol/l

0.37

122

883

Bacterial meningitis

640

1.52

3.58

10.7

8.5

24.77

24.46

mmol/l

0.35

600

Aspergillosis

153

2.16

3.57

8.1

6.7

24.97

24.09

mmol/l

0.77

144

Propionic acid derivatives

954

4217

1.14

3.56

7.2

7.5

24.42

24.37

mmol/l

0.14

889

3933

Gangrene, not elsewhere classified

126

2.27

3.56

8.1

5.6

24.21

23.84

mmol/l

0.19

114

Single delivery by forceps and vacuum extractor

123

1057

0.70

3.56

4.0

6.8

23.27

24.23

mmol/l

2.29

118

983

Urolithiasis

966

8565

1.14

3.56

7.6

7.4

24.35

24.50

mmol/l

0.59

897

8001

Other articular cartilage disorders

465

1.62

3.55

4.5

8.0

24.55

24.38

mmol/l

0.18

436

Amblyopia ex anopsia

583

1.54

3.54

5.8

7.5

24.14

24.45

mmol/l

0.34

545

Acute myeloid leukaemia

188

2.02

3.54

9.4

6.0

24.81

24.42

mmol/l

0.28

177

Calcification and ossification of muscle

3.46

3.53

8.8

7.3

24.55

23.67

mmol/l

0.35

Flatulence and related conditions

153

2.12

3.52

8.5

7.5

24.75

24.41

mmol/l

0.18

145

Other malignant neoplasms of skin (=non-melanoma skin cancer)

1756

12675

1.10

3.51

6.2

7.0

24.51

24.64

mmol/l

0.77

1642

11825

Benign neoplasm of bone and articular cartilage

178

1341

1.35

3.48

6.8

7.3

24.78

24.45

mmol/l

0.71

168

1246

Tongue abnormality

162

1207

1.37

3.47

8.0

7.1

25.32

24.59

mmol/l

1.86

146

1128

Other benign neoplasm of uterus: Other parts/unspecified

955

0.61

3.47

4.9

5.6

25.26

24.87

mmol/l

0.42

886

Disease of hard tissues of teeth, NOS

147

2.13

3.46

7.1

6.8

24.49

25.08

mmol/l

0.39

139

Fissure and fistula of anal and rectal regions

626

5398

1.17

3.45

6.9

24.52

24.64

mmol/l

0.39

587

4999

Other melanin hyperpigmentation

438

1.63

3.45

5.3

6.7

24.31

24.65

mmol/l

0.27

411

Inflammatory disorders of breast

119

841

1.44

3.44

4.2

6.9

24.26

24.56

mmol/l

0.38

111

786

Vascular dementia (undefined)

107

736

1.47

3.44

3.9

5.7

25.04

24.36

mmol/l

0.82

687

Stenosis and insufficiency of lacrimal passages

248

1959

1.28

3.44

6.1

6.9

24.97

24.76

mmol/l

0.43

231

1819

Superficial injury of ankle and foot

243

1911

1.28

3.44

6.6

7.0

24.52

24.31

mmol/l

0.42

232

1769

Chromosomal abnormalities, not elsewhere classified

209

1.91

3.43

9.0

9.5

24.34

24.44

mmol/l

0.07

196

Other and unspecified injuries of shoulder and upper arm

509

1.57

3.41

7.1

7.4

24.91

24.44

mmol/l

0.60

473

Melanocytic naevi of trunk

283

2274

1.26

3.38

6.6

7.2

24.66

24.49

mmol/l

0.33

267

2114

134

1824

0.72

3.38

11.6

6.7

22.87

24.42

mmol/l

3.02

129

1713

Deep endometriosis

209

1619

1.31

3.36

7.4

6.6

24.62

24.67

mmol/l

0.09

202

1502

Oral lichen ruber planus wide, hypothyreosis or thyroxin

137

1000

1.40

3.36

6.6

6.5

24.18

24.72

mmol/l

0.90

129

936

122

2.22

3.35

3.3

10.5

23.80

24.20

mmol/l

0.29

112

Synovial cyst of popliteal space [Baker]

189

1448

1.33

3.33

6.9

7.2

25.03

24.71

mmol/l

0.50

181

1344

Benign neoplasm: Endocrine pancreas

117

2.30

3.33

11.8

6.0

24.96

24.89

mmol/l

0.04

112

Chronic periodontitis, complicated

261

2085

1.27

3.33

9.4

6.9

24.52

mmol/l

0.01

245

1950

Superficial frostbite

110

2.31

3.31

8.4

12.3

25.23

24.04

mmol/l

0.59

102

Prolapse and hernia of ovary and fallopian tube

125

893

1.42

3.31

5.1

5.2

24.75

24.78

mmol/l

0.03

113

847

Degenerative conditions of globe

2.47

3.31

3.5

6.9

25.22

24.09

mmol/l

0.67

Pathological/recurrent dislocation and subluxation of joint, not elsewhere classified

170

1283

1.34

3.29

6.7

8.0

24.43

24.46

mmol/l

0.04

161

1206

Lichen sclerosus et atrophicus

241

1909

1.28

3.28

6.1

6.7

24.79

24.81

mmol/l

0.02

223

1755

LeFortI or BSSRO operation

537

1.53

3.27

3.6

9.3

24.06

24.58

mmol/l

0.53

494

Malignant neoplasm of other connective and soft tissue, excluding all cancers (controls excluding all cancers)

113

803

1.44

3.26

6.7

7.3

24.98

24.59

mmol/l

0.60

106

751

Endometriosis of ovary

352

2896

1.22

3.25

6.4

6.9

24.70

24.75

mmol/l

0.09

323

2674

Preparatory care for dialysis

854

0.61

3.24

6.4

7.9

22.36

24.51

mmol/l

2.91

800

Use of selegiline

140

1035

1.38

3.21

5.5

6.6

25.73

24.50

mmol/l

5.39

130

968

Other disorders of bladder

345

2852

1.23

3.20

6.5

7.3

25.04

24.52

mmol/l

1.73

329

2653

Polypectomy (DHB20)

194

1503

1.31

3.19

5.4

7.4

24.64

24.45

mmol/l

0.27

177

1405

Superficial injury of shoulder and upper arm

276

2229

1.25

3.17

6.3

6.8

24.80

24.46

mmol/l

0.89

262

2077

Other disorders of optic disc

195

1.92

3.17

7.5

10.1

24.07

24.68

mmol/l

0.37

187

Hypersomnia

224

1.85

3.17

6.3

8.7

25.77

24.72

mmol/l

1.08

211

Malignant neoplasm of retroperitoneum and peritoneum

133

2.16

3.16

8.9

6.3

24.38

24.80

mmol/l

0.37

124

Crohn disease (strict definition, require KELA, min 2 HDR)

135

992

1.38

3.15

10.0

7.6

24.37

24.45

mmol/l

0.11

125

921

Benign neoplasm: Endocrine pancreas

120

2.24

3.14

11.8

6.6

24.96

24.63

mmol/l

0.23

114

Persons encountering health services in other circumstances

1011

9049

1.12

3.14

6.2

7.0

24.66

24.52

mmol/l

0.64

966

8400

Maxillary prognathism

2.82

3.14

8.6

8.8

24.55

24.93

mmol/l

0.25

Calculus of kidney and ureter

884

7867

1.13

3.12

7.3

7.4

24.31

24.50

mmol/l

0.87

821

7349

Endometriosis ASRM stages 3,4

489

4174

1.18

3.11

6.7

6.4

24.69

mmol/l

0.01

455

3874

Otitis externa

537

4620

1.17

3.11

6.4

7.0

24.57

24.47

mmol/l

0.24

500

4291

Injury of nerves and spinal cord at thorax level

2.50

3.10

23.2

7.7

26.92

24.64

mmol/l

1.63

Reactive arthropathies

212

1666

1.29

3.09

10.1

7.6

24.55

24.50

mmol/l

0.08

197

1561

Benign leiomyoma with endometriosis

262

3235

0.80

3.08

5.8

6.6

24.67

24.86

mmol/l

0.38

246

3010

Inguinal hernia, bilateral

318

2622

1.23

3.06

6.0

7.0

24.56

24.45

mmol/l

0.23

304

2443

Malignant melanoma of skin

209

2640

0.78

3.05

7.6

6.7

24.90

24.48

mmol/l

0.92

195

2460

Inguinal or femoral hernia, bilateral

323

2668

1.23

3.05

6.1

7.0

24.57

24.44

mmol/l

0.26

309

2485

Chronic iridocyclitis

124

906

1.39

3.04

7.3

6.9

24.35

24.57

mmol/l

0.23

110

843

Nasal polyp

542

4679

1.17

3.03

5.8

7.6

24.48

24.50

mmol/l

0.04

504

4348

Other disorders of conjunctiva

393

3307

1.20

3.03

7.9

6.9

24.76

24.61

mmol/l

0.32

361

3074

Malignant neoplasm of breast, ER-positive, excluding all cancers (controls excluding all cancers)

708

5042

1.15

3.01

5.5

6.3

25.27

24.89

mmol/l

2.31

660

4667

Deviated nasal septum

948

8487

1.12

2.98

7.2

7.7

24.71

24.52

mmol/l

0.90

883

7895

Crohn's disease patients in KELA-register (KELA code 209, or 208 with ICD K50)

145

1088

1.35

2.98

10.1

7.5

24.30

24.45

mmol/l

0.19

135

1011

Otitis externa, unspecified

251

2022

1.26

2.98

6.0

7.2

24.17

24.46

mmol/l

0.61

232

1883

Use of rivastigmine

407

3437

1.20

2.96

4.3

5.9

24.68

24.53

mmol/l

0.37

378

3220

Episcleritis

119

868

1.39

2.95

6.6

7.6

24.32

24.62

mmol/l

0.43

112

813

Primary angle-closure glaucoma

128

947

1.38

2.95

4.4

6.9

24.39

24.62

mmol/l

0.25

117

874

Chondropathies

362

3029

1.21

2.94

6.3

7.2

24.83

24.44

mmol/l

1.23

331

2819

Crohn disease (strict definition, require KELA)

136

1013

1.36

2.94

10.0

7.5

24.28

24.45

mmol/l

0.22

126

942

Syndrome of inappropriate secretion of antidiuretic hormone

117

2.22

2.94

5.8

5.9

24.37

24.35

mmol/l

0.01

109

Adenocarcinoma and papillary adenocarcinoma of stomach, excluding all cancers (controls excluding all cancers)

546

1.50

2.91

7.3

6.6

25.49

24.36

mmol/l

1.73

508

Disorders of urea cycle metabolism

10.07

2.88

10.4

6.2

22.00

24.37

mmol/l

—

SLE (Finngen)

521

1.51

2.88

5.6

6.3

24.50

24.59

mmol/l

0.09

482

Carcinoma in situ of oesophagus

4.50

2.88

5.8

6.3

23.28

24.88

mmol/l

—

Other behavioural and emotional disorders with onset usually occurring in childhood and adolescence

504

1.50

2.87

8.5

7.1

24.08

24.11

mmol/l

0.02

470

Anti-inflammatory and antirheumatic products, non-steroids

940

4217

1.13

2.86

6.9

7.5

24.40

24.37

mmol/l

0.08

872

3933

Pemphigoid

566

1.49

2.85

6.1

24.78

24.51

mmol/l

0.24

531

Ptosis of eyelid

298

2462

1.23

2.84

8.7

6.9

24.59

24.67

mmol/l

0.14

276

2291

Hepatomegaly and splenomegaly, not elsewhere classified

138

2.04

2.84

6.5

6.9

24.02

24.38

mmol/l

0.15

132

Complications associated with artificial fertilization

144

1.98

2.83

5.8

10.2

23.35

23.88

mmol/l

0.49

134

Other disorders starting during childhood or adolescence

413

1.55

2.82

9.0

7.3

24.02

23.80

mmol/l

0.16

383

Caught, crushed, jammed or pinched in or between objects

112

816

1.40

2.82

7.1

7.4

24.19

24.49

mmol/l

0.43

102

760

Carcinoma in situ of skin of other and unspecified parts of face

147

1915

0.75

2.81

6.1

6.0

23.84

24.51

mmol/l

1.28

136

1786

Ménière disease

259

2112

1.24

2.80

6.1

7.0

24.88

24.65

mmol/l

0.53

240

1963

Pedestrian injured in transport accident

169

1310

1.31

2.80

6.5

7.5

24.59

24.51

mmol/l

0.10

159

1221

Varus deformity, not elsewhere classified

160

1.94

2.79

7.5

24.80

24.74

mmol/l

0.03

149

Hypertrophy of breast in women and men

414

3525

1.18

2.76

7.1

7.0

24.57

24.56

mmol/l

0.02

391

3264

Conjunctivitis

1682

15855

0.92

2.75

7.2

7.0

24.67

24.60

mmol/l

0.32

1576

14765

Other benign neoplasm of uterus: Other parts/unspecified

903

0.65

2.75

4.9

5.8

25.26

24.95

mmol/l

0.30

840

Hyperprolactinaemia

437

1.54

2.74

7.4

8.0

25.49

24.43

mmol/l

1.60

406

Carcinoma in situ of breast, intraductal

166

1287

1.31

2.74

5.8

7.0

25.10

24.98

mmol/l

0.16

152

1186

Perforation of oesophagus

2.30

2.73

10.3

6.9

24.92

24.27

mmol/l

0.36

Other and unspecified psoriasis

172

1342

1.30

2.73

9.5

7.8

25.31

24.54

mmol/l

2.07

162

1249

Melanocytic naevi of other and unspecified parts of face

124

924

1.36

2.71

5.3

7.3

24.68

24.56

mmol/l

0.13

114

853

Crushed, pushed or stepped on by crowd or human stampede

138

1044

1.34

2.70

8.0

7.9

24.49

24.35

mmol/l

0.20

127

970

Atopic dermatitis, strict definition with reimbursement

583

4942

1.15

2.70

6.9

6.6

24.57

24.33

mmol/l

0.82

551

4590

Labour and delivery complicated by intrapartum haemorrhage, not elsewhere classified

107

781

1.39

2.67

6.7

6.4

25.33

24.85

mmol/l

0.98

102

727

Hemiplegia

127

953

1.35

2.67

8.8

7.1

24.51

24.48

mmol/l

0.03

118

889

Scleritis and episcleritis

139

1057

1.33

2.66

6.6

7.2

24.33

24.59

mmol/l

0.43

131

978

Pediculosis, acariasis and other infestations

138

1049

1.34

2.65

9.2

7.3

25.17

24.43

mmol/l

1.63

132

984

Other osteochondropathies

169

1320

1.30

2.65

7.5

24.77

24.47

mmol/l

0.42

153

1238

Otalgia

167

1302

1.30

2.65

5.2

7.5

24.97

24.54

mmol/l

1.02

158

1208

Astigmatism

128

961

1.35

2.65

11.1

6.5

24.98

24.32

mmol/l

1.29

121

894

Conductive hearing loss, unspecified

203

1622

1.27

2.65

5.6

7.2

24.92

24.65

mmol/l

0.43

186

1505

Arthropathy in ulcerative colitis

200

1.81

2.64

6.5

9.5

23.86

24.56

mmol/l

0.60

184

Striking against or struck by other objects

775

6915

1.13

2.63

7.9

7.4

24.69

24.46

mmol/l

0.98

721

6440

Disorders of synovium and tendon in diseases classified elsewhere

387

1.57

2.62

5.8

7.9

25.00

24.43

mmol/l

0.50

358

Opening and dilatation of root channel of tooth

138

1051

1.33

2.61

6.7

7.4

24.64

24.44

mmol/l

0.23

132

977

Benign neoplasm: other/unspecified salivary gland

518

1.48

2.60

9.7

6.3

24.77

24.60

mmol/l

0.12

488

Respiratory tuberculosis, not confirmed

123

925

1.36

2.59

7.9

6.9

25.10

24.38

mmol/l

1.16

117

864

Benign neoplasm: Parotid gland

190

1513

1.27

2.57

8.7

6.9

25.01

24.60

mmol/l

0.76

178

1398

Basal cell carcinoma

1761

13028

1.08

2.56

6.1

7.0

24.49

24.65

mmol/l

1.12

1648

12148

malignant neoplasm of male genital organs, excluding all cancers (controls excluding all cancers)

1008

5569

1.11

2.56

6.6

7.7

24.45

24.40

mmol/l

0.15

926

5228

Lactose intolerance

421

1.52

2.54

6.4

8.0

24.43

24.60

mmol/l

0.12

393

Pain and other conditions associated with female genital organs and menstrual cycle

343

2778

1.19

2.52

5.3

6.8

24.06

24.51

mmol/l

1.63

321

2575

Other and unspecified bullous disorders

174

1.86

2.52

7.4

5.9

24.62

24.61

mmol/l

0.01

164

Other lesions of median nerve

530

1.47

2.52

8.1

7.4

24.34

24.51

mmol/l

0.17

493

Defects in the complement system

2.18

2.50

21.6

7.0

25.74

24.75

mmol/l

0.50

Traumatic amputation of wrist and hand

125

949

1.34

2.49

7.6

7.8

24.45

24.57

mmol/l

0.14

119

878

Basal cell carcinoma, including avohilmo

1800

13193

1.08

2.46

6.1

7.0

24.51

24.65

mmol/l

0.92

1685

12304

Contact with and exposure to communicable diseases

451

5178

0.86

2.46

5.0

7.0

24.39

24.26

mmol/l

0.34

422

4814

Contact with other and unspecified heat and hot substances

2.16

2.45

3.9

6.5

23.33

24.08

mmol/l

0.24

Family history of mental and behavioural disorders

5.33

2.45

8.5

5.7

27.10

24.89

mmol/l

—

Mandibular retrognathia

116

867

1.35

2.45

6.6

8.3

24.53

24.47

mmol/l

0.05

105

811

Female infertility, tubal origin

606

1.42

2.44

5.7

7.2

24.55

24.69

mmol/l

0.15

561

Dermatopolymyositis

259

1.67

2.44

11.7

7.0

24.89

24.58

mmol/l

0.17

245

Thyrotoxicosis

595

5258

1.14

2.44

6.2

6.7

24.64

24.67

mmol/l

0.06

556

4890

Oral leukoplakia and related diseases

150

1171

1.30

2.43

9.1

7.2

24.58

24.52

mmol/l

0.06

144

1095

Bilateral sagittal split ramus osteotomy operation

442

1.49

2.42

3.8

10.0

23.88

24.61

mmol/l

0.69

409

Crohn disease (strict definition, all UC cases excluded)

108

804

1.36

2.42

10.1

7.5

24.37

24.49

mmol/l

0.13

102

742

Malignant neoplasm of oral cavity

730

1.39

2.41

11.7

7.2

25.56

24.48

mmol/l

2.74

684

Ocular pain

171

1356

1.28

2.40

5.7

7.3

24.12

24.46

mmol/l

0.62

164

1262

Respiratory TBC, ICD-8 codes not specifying whether confirmed bacteriologically or histologically

662

1.41

2.40

7.1

6.1

24.74

24.47

mmol/l

0.29

621

Bicipital tendinitis

120

910

1.34

2.39

5.9

7.2

25.07

24.65

mmol/l

0.81

110

846

Disorders of tooth development and eruption

593

1.41

2.37

6.9

5.9

24.81

24.27

mmol/l

0.68

558

Thyrotoxicosis, other and/or unspecified

453

3939

1.16

2.37

5.8

6.7

24.55

24.64

mmol/l

0.23

423

3662

Juvenile osteochondrosis

436

1.49

2.37

4.7

8.4

24.85

24.30

mmol/l

0.60

404

Non-small cell lung cancer, adenocarcinoma, excluding all cancers (controls excluding all cancers)

165

1310

1.28

2.34

6.9

6.3

25.37

24.43

mmol/l

3.14

153

1215

Progressive external ophthalmoplegia

6.66

2.33

11.2

13.6

27.22

24.80

mmol/l

—

Female infertility

573

3116

1.14

2.31

5.9

7.2

23.99

24.57

mmol/l

3.45

526

2887

Contact with sharp glass

539

1.43

2.29

10.8

8.6

24.34

24.51

mmol/l

0.16

503

Benign neoplasm: Middle ear, nasal cavity and accessory sinuses

701

1.38

2.29

6.6

7.4

24.86

24.53

mmol/l

0.39

649

Malignant neoplasm of skin

1956

13785

1.07

2.29

6.4

7.1

24.55

24.65

mmol/l

0.59

1829

12857

Pregnancy examination and test

229

1168

1.23

2.28

7.4

6.6

23.89

24.28

mmol/l

0.94

216

1083

Other and unspecified acquired haemolytic anaemias

165

1.83

2.28

9.0

10.1

24.11

24.61

mmol/l

0.25

156

Other acquired deformities of musculoskeletal system and connective tissue

119

909

1.33

2.28

7.2

7.5

24.74

24.54

mmol/l

0.30

112

851

Disorders of eyelid in diseases classified elsewhere

583

1.42

2.27

7.5

7.3

24.29

24.47

mmol/l

0.23

550

Persons encountering health services for specific procedures, not carried out

160

1269

1.27

2.27

13.1

6.3

24.88

24.40

mmol/l

0.93

160

1184

HSIL lesion of the cervix uteri, vagina or vulva

316

2681

1.19

2.26

5.1

6.3

24.20

24.40

mmol/l

0.44

297

2484

Convergent concomitant strabismus

113

856

1.34

2.26

13.4

7.2

24.52

24.53

mmol/l

0.01

104

794

Haemorrhagic disorder due to circulating anticoagulants

258

1.66

2.26

10.0

7.0

25.29

24.08

mmol/l

0.98

240

Retinal haemorrhage

485

1.46

2.24

9.8

6.9

24.66

24.40

mmol/l

0.27

454

Antenatal screening

257

1740

0.83

2.24

4.4

6.7

23.81

24.39

mmol/l

1.87

247

1623

Injury of muscle and tendon at lower leg level

387

3346

1.17

2.23

7.0

7.4

24.65

24.47

mmol/l

0.51

371

3132

Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)

988

5400

1.10

2.23

6.5

7.6

24.47

24.40

mmol/l

0.24

906

5068

Congenital malformations of eye, ear, face and neck

122

937

1.32

2.22

7.2

7.8

25.18

24.30

mmol/l

1.82

110

874

Single delivery by caesarean section

281

1358

1.20

2.22

7.5

6.8

23.81

24.34

mmol/l

1.49

266

1258

Non-small cell lung cancer, squamous, helper endpoint

137

1072

1.30

2.21

9.8

6.4

25.73

24.33

mmol/l

3.69

130

1006

Non-small cell lung cancer, squamous

137

1072

1.30

2.21

9.8

6.4

25.73

24.33

mmol/l

3.69

130

1006

Personality and behavioural disorders due to brain disease, damage and dysfunction

274

1.62

2.21

8.0

6.8

25.83

24.43

mmol/l

1.53

256

Autoimmune hyperthyroidism

124

957

1.31

2.19

6.5

24.62

24.60

mmol/l

0.03

114

878

Adenocarcinoma and papillary adenocarcinoma of stomach

581

1.41

2.16

7.3

6.4

25.49

24.31

mmol/l

1.85

541

Myeloproliferative diseases

220

1820

1.22

2.16

8.2

6.8

24.13

24.58

mmol/l

0.87

206

1694

Postpartum hemorraghe, parous women as controls

301

3099

0.85

2.16

5.3

6.1

23.60

24.32

mmol/l

4.08

283

2873

Open bite that required surgery (Lefort1 or BSSRO)

2.10

2.15

3.0

12.8

24.43

24.81

mmol/l

0.10

Ovarian hyperstimulation (induction)

152

1.81

2.15

6.0

9.3

23.24

23.88

mmol/l

0.59

140

Medical treatment for female infertility

294

2485

1.19

2.15

5.8

6.4

23.84

24.25

mmol/l

1.53

270

2303

Retinal detachments and breaks

1011

9268

1.10

2.14

6.7

7.0

24.39

24.62

mmol/l

1.19

938

8629

Carcinoma in situ of skin of other and unspecified parts of face

147

1842

0.79

2.14

6.1

6.3

23.84

24.61

mmol/l

1.59

136

1721

Disorders of puberty, all

116

1.93

2.13

4.0

11.8

24.93

23.49

mmol/l

0.91

104

Anomalies of dental arch relationship, including avohilmo

365

2828

1.17

2.12

6.8

6.9

24.65

24.33

mmol/l

1.09

344

2640

Diseases of middle ear and mastoid

1405

10678

1.08

2.12

7.0

24.42

24.46

mmol/l

0.14

1310

9942

Multiple myeloma, Monoclonal gammopathy of undetermined significance (MGUS)

542

1.42

2.12

7.0

5.9

23.95

24.32

mmol/l

0.27

510

Multiple myeloma

542

1.42

2.12

7.0

5.9

23.95

24.32

mmol/l

0.27

510

Diastasis of muscle

2.05

2.11

6.4

7.4

24.00

24.23

mmol/l

0.11

Reactive arthropathies, FINNGEN

158

1265

1.26

2.10

10.5

7.5

24.53

24.43

mmol/l

0.12

144

1180

Degenerative macular diseases

345

2977

1.17

2.09

6.9

6.3

24.74

24.65

mmol/l

0.18

327

2777

Liposarcoma, excluding all cancers (controls excluding all cancers)

185

1.74

2.09

6.6

6.7

24.83

24.30

mmol/l

0.59

172

Viral meningitis

533

1.41

2.08

7.3

9.1

25.23

24.63

mmol/l

0.90

500

Other hereditary haemolytic anaemias

2.09

2.07

10.7

7.5

24.95

25.00

mmol/l

0.02

Carcinoma in situ of rectum

171

1.78

2.07

5.4

6.9

24.36

24.56

mmol/l

0.13

164

Other puerperal infections

807

0.69

2.07

4.5

7.3

23.89

24.11

mmol/l

0.25

748

Presence of other devices

627

5622

1.12

2.06

7.0

6.1

24.44

24.63

mmol/l

0.62

588

5232

Other and unspecified types of non-Hodgkin lymphoma, hilmo

115

890

1.32

2.06

10.5

6.5

25.35

24.49

mmol/l

1.24

104

829

Undefined dementia

320

2524

1.18

2.06

3.7

5.5

24.58

24.46

mmol/l

0.18

299

2357

Background retinopathy and retinal vascular changes

394

1.48

2.04

12.1

7.0

23.54

24.68

mmol/l

1.52

372

Other disorders of white blood cells

136

1075

1.28

2.04

7.8

7.3

24.74

24.43

mmol/l

0.38

125

1004

Occupant of special vehicle mainly used on industrial premises injured in transport accident

2.10

2.04

8.4

7.5

24.28

24.41

mmol/l

0.04

Other disorders of penis

252

2124

1.20

2.04

7.5

8.0

24.41

24.37

mmol/l

0.06

232

1989

Neuroendocrine tumor and carcinoma of small intestine, excluding all cancers (controls excluding all cancers)

265

1.60

2.03

4.8

7.0

24.04

24.61

mmol/l

0.53

251

Pedal cyclist injured in collision with motor vehicle

502

1.42

2.03

4.9

8.5

25.00

24.39

mmol/l

0.81

469

Dislocation, sprain and strain of joints and ligaments of lumbar spine and pelvis

435

1.45

2.03

8.5

9.2

24.82

24.67

mmol/l

0.13

401

Exposure to controlled fire, not in building or structure

2.52

2.03

8.6

17.4

25.67

24.13

mmol/l

1.02

Uterine polyps

205

1697

1.22

2.00

4.8

6.8

24.96

24.85

mmol/l

0.17

192

1580

Vestibular neuronitis

224

1874

1.21

1.98

7.2

7.3

24.77

24.55

mmol/l

0.43

208

1741

Giant cell arteritis

113

878

1.31

1.98

7.7

6.1

24.62

24.47

mmol/l

0.18

108

814

Visual impairment including blindness (binocular or monocular)

164

1331

1.25

1.96

9.1

6.3

25.05

24.54

mmol/l

1.09

155

1243

Other obstructed labour

133

1054

1.27

1.94

6.6

6.2

24.44

24.59

mmol/l

0.18

121

977

Injury of nerves at wrist and hand level

661

1.35

1.94

8.3

7.8

23.75

24.54

mmol/l

1.50

615

Golimumab

456

1.42

1.93

4.7

9.3

24.05

24.75

mmol/l

0.76

424

Malignant neoplasm of nasal cavity and sinuses, excluding all cancers (controls excluding all cancers)

182

1.71

1.92

6.8

7.2

25.22

24.38

mmol/l

0.59

173

Other/unspecified enthesopathies, not elsewhere classified

213

1779

1.21

1.92

5.9

7.2

24.80

24.62

mmol/l

0.31

198

1646

Polyuria

616

5552

1.12

1.90

6.6

7.2

25.04

24.51

mmol/l

3.01

576

5155

Injury of muscle and tendon at ankle and foot level

408

1.45

1.90

6.9

8.5

24.46

24.55

mmol/l

0.08

380

Benign neoplasm of major salivary glands

254

2158

1.19

1.90

9.1

7.0

24.93

24.60

mmol/l

0.68

235

2008

Vulvovaginal ulceration/inflammation in other diseases

705

1.33

1.90

4.7

7.2

24.70

24.46

mmol/l

0.33

654

Malignant neoplasm of head and neck

223

1874

1.20

1.90

9.5

6.7

25.50

24.50

mmol/l

4.09

204

1754

Pedal cyclist injured in noncollision transport accidents

250

2120

1.19

1.89

8.7

7.4

24.79

24.40

mmol/l

0.91

237

1976

Disorders of vagus nerve

3.43

1.89

14.0

9.9

26.01

24.20

mmol/l

—

Rash and other nonspecific skin eruption

230

1938

1.20

1.88

7.9

7.1

24.81

24.56

mmol/l

0.57

221

1809

Occupant of heavy transport vehicle injured in other and unspecified transport accidents

101

1.97

1.88

9.3

12.2

25.12

24.06

mmol/l

0.86

Unspecified lump in breast

254

2980

0.85

1.87

8.2

6.6

25.09

24.79

mmol/l

0.64

231

2763

Other diseases of blood and blood-forming organs

168

1376

1.24

1.87

8.4

7.3

25.31

24.49

mmol/l

1.63

163

1274

Vascular dementia (other)

116

1.90

1.87

6.5

6.2

23.26

23.72

mmol/l

0.18

108

Benign neoplasm: Skin of trunk

692

1.33

1.85

5.9

7.2

24.53

24.47

mmol/l

0.05

648

Carcinoma in situ of cervix uteri

140

1124

1.25

1.84

6.2

6.6

24.39

24.33

mmol/l

0.07

129

1043

Pollen allergy

224

2625

0.84

1.83

5.9

7.0

24.12

24.26

mmol/l

0.27

207

2454

Lactose intolerance, other/unspecified

386

1.45

1.82

6.3

7.8

24.24

24.61

mmol/l

0.29

363

Idiopathic thrombocytopenic purpura

565

1.37

1.82

8.7

7.2

25.30

24.46

mmol/l

1.11

534

Bitten or struck by other mammals

213

1789

1.20

1.81

6.7

7.2

24.59

24.33

mmol/l

0.48

193

1671

Ulcerative enterocolitis

506

1.38

1.79

7.2

23.47

24.52

mmol/l

1.31

467

Other and unspecified disorders of white blood cells

767

1.31

1.79

8.8

7.8

25.28

24.38

mmol/l

1.27

719

Ectopic pregnancy

324

2817

1.16

1.78

5.9

6.8

24.55

24.76

mmol/l

0.49

305

2611

Oral lichen ruber planus

431

1.42

1.78

5.5

8.6

24.46

24.81

mmol/l

0.43

408

Personal history of other diseases and conditions

172

1410

1.22

1.78

7.9

6.1

24.53

24.32

mmol/l

0.27

165

1307

Corneal scars and opacities

499

1.39

1.78

7.8

6.6

26.00

24.43

mmol/l

2.27

467

Cellulitis of external ear

178

1.67

1.78

8.2

6.8

24.47

24.43

mmol/l

0.02

165

Other and unspecified hypertrophic disorders of skin

103

1.92

1.78

10.9

11.4

24.24

24.85

mmol/l

0.24

Foreign body in respiratory tract

114

900

1.28

1.77

7.6

7.4

25.04

24.50

mmol/l

0.81

107

843

Excessive attrition of teeth

1044

5233

1.09

1.76

7.8

6.9

24.63

24.59

mmol/l

0.16

989

4854

Endometriosis of intestine

147

1.73

1.76

6.6

10.1

24.22

24.49

mmol/l

0.17

137

Cleft palate

110

1.86

1.76

4.4

11.7

24.99

24.23

mmol/l

0.57

101

Follicular lymphoma

101

787

1.30

1.75

7.0

6.5

25.46

24.42

mmol/l

1.66

732

Spermatocele

224

1900

1.19

1.75

6.1

7.8

24.37

24.29

mmol/l

0.14

212

1778

Malignant neoplasm of anus and anal canal

2.00

1.73

7.5

6.8

24.22

24.84

mmol/l

0.40

Sacrococcygeal disorders, not elsewhere classified

442

1.40

1.71

6.8

8.5

25.10

24.57

mmol/l

0.57

420

Normotensive glaucoma

228

1942

1.19

1.71

5.5

6.4

24.26

24.74

mmol/l

1.32

211

1803

Benign neoplasm: Skin of scalp and neck

443

1.40

1.71

7.3

8.7

24.96

24.45

mmol/l

0.56

417

Acetic acid derivatives and related substances

866

4141

1.09

1.69

5.5

7.5

24.37

24.38

mmol/l

0.03

806

3859

Other, unspecified and serous retinal detachments

608

1.34

1.69

7.8

6.9

24.54

24.53

mmol/l

0.00

567

Neuroendocrine tumor and carcinoma of small intestine

278

1.52

1.69

4.8

6.5

24.04

24.58

mmol/l

0.49

262

Benign neoplasm of thyroid gland

547

1.36

1.68

7.2

6.2

24.99

24.60

mmol/l

0.39

514

Other bursitis of elbow

151

1.72

1.66

4.2

6.7

25.22

23.96

mmol/l

0.73

138

Disorders of glycoprotein metabolism

3.90

1.66

8.6

7.4

25.36

26.53

mmol/l

—

Melanocytic naevi of lower limb, including hip

643

1.32

1.66

6.5

7.7

24.07

24.55

mmol/l

0.63

598

Fall on and from ladder

211

1791

1.19

1.66

6.6

7.3

24.41

24.44

mmol/l

0.05

197

1669

Malignant neoplasm of other and unspecified parts of mouth, excluding all cancers (controls excluding all cancers)

159

1.70

1.65

14.1

5.5

25.27

24.60

mmol/l

0.49

154

Malignant neoplasm of respiratory system and intrathoracic organs

633

5302

1.11

1.65

7.4

6.7

25.58

24.41

mmol/l

13.16

589

4953

Benign neoplasm: other/unspecified salivary gland

567

1.35

1.65

9.7

7.1

24.77

24.67

mmol/l

0.07

536

All dysplastic lesions of the vulva

653

1.32

1.64

6.7

7.1

24.70

24.83

mmol/l

0.13

603

Superficial injury of wrist and hand

403

3581

1.13

1.63

7.1

7.2

24.54

24.45

mmol/l

0.20

384

3315

Polycythaemia vera

708

1.31

1.63

9.6

7.3

23.71

24.50

mmol/l

0.90

663

Benign neoplasm of breast

191

2259

0.84

1.61

5.4

6.7

25.25

24.84

mmol/l

0.84

186

2091

Malignant neoplasm of bronchus and lung

541

4580

1.11

1.60

7.5

6.6

25.59

24.39

mmol/l

11.74

506

4282

Allergic rhinitis

609

5486

1.10

1.59

6.7

7.0

24.24

24.42

mmol/l

0.69

565

5088

Scar conditions and fibrosis of skin

630

1.32

1.59

5.3

8.3

24.51

24.57

mmol/l

0.05

580

Disturbances of smell and taste

736

1.29

1.59

6.8

7.7

25.16

24.57

mmol/l

1.10

687

Varicose veins of other sites

156

1293

1.22

1.59

7.1

7.4

24.85

24.40

mmol/l

0.93

150

1207

Other disorders of cornea

227

1945

1.18

1.59

6.9

6.8

24.82

24.62

mmol/l

0.40

210

1809

Unspecified privation

186

2200

0.84

1.58

7.8

7.0

24.58

24.49

mmol/l

0.11

174

2046

Benign neoplasm: Skin of eyelid, including canthus

395

3519

1.13

1.57

7.4

6.9

24.62

24.66

mmol/l

0.09

368

3270

Allergic urticaria

161

1339

1.21

1.57

6.1

7.0

24.50

24.41

mmol/l

0.13

146

1244

Transient global amnesia

240

2069

1.17

1.57

6.1

6.8

24.71

24.64

mmol/l

0.13

224

1922

Ankylosing spondylitis, ICD10

204

1734

1.19

1.57

6.8

7.6

24.97

24.45

mmol/l

1.19

187

1623

Ethmoidectomy

296

2590

1.15

1.55

5.4

7.7

24.51

24.48

mmol/l

0.04

273

2414

FESS (DNB20)

284

2478

1.15

1.55

5.5

7.7

24.59

24.44

mmol/l

0.33

262

2310

L01XX Other antineoplastic agents

147

1217

1.22

1.54

7.3

6.9

24.03

24.48

mmol/l

0.87

136

1138

Disorders of puberty

100

1.82

1.54

3.9

11.9

24.98

23.51

mmol/l

0.76

Mild or no visual impairment, binocular

2.03

1.54

7.7

5.9

24.66

24.55

mmol/l

0.05

Exposure to uncontrolled fire, not in building or structure

2.40

1.54

3.0

6.4

23.08

24.46

mmol/l

—

Effects of heat and light

124

1.75

1.52

12.0

9.9

23.23

24.50

mmol/l

0.63

112

Contact with hot air and gases

109

1.81

1.52

8.8

6.9

24.97

24.36

mmol/l

0.34

102

Benign lipomatous neoplasm of other sites/unspecified

209

1787

1.18

1.51

7.7

6.4

24.61

24.65

mmol/l

0.05

200

1652

Benign neoplasm: Skin of scalp and neck

454

1.37

1.50

7.3

8.8

24.96

24.47

mmol/l

0.54

426

Chronic suppurative otitis media, including avohilmo

176

1484

1.20

1.50

7.2

7.5

24.23

24.50

mmol/l

0.38

164

1373

Alzheimer’s disease (Late onset)

632

4955

1.10

1.50

4.4

6.0

24.52

24.51

mmol/l

0.03

607

4631

Other noninflammatory disorders of vulva and perineum

169

1419

1.20

1.50

5.9

6.3

24.70

24.72

mmol/l

0.02

161

1321

Benign neoplasm: Liver/bile ducts (ICD-9)

3.49

1.49

9.2

10.4

24.34

26.40

mmol/l

—

Hypertrophy of tongue papillae

212

1.55

1.48

11.2

9.0

25.31

24.33

mmol/l

0.82

200

Liposarcoma

149

1.68

1.47

7.8

7.3

24.58

23.99

mmol/l

0.60

140

Other and unspecified disorders of psychological development

2.06

1.44

11.2

15.9

25.24

23.77

mmol/l

0.70

Congenital malformations of genital organs

144

1189

1.21

1.43

9.9

7.2

24.49

24.39

mmol/l

0.11

132

1103

Other congenital malformations of face and neck

397

1.38

1.43

6.2

8.4

25.18

24.51

mmol/l

0.56

374

Benign neoplasm of mouth and pharynx

245

2131

1.16

1.43

6.9

6.8

24.63

24.60

mmol/l

0.05

228

1977

Other osteochondrodysplasias

111

1.76

1.42

8.1

11.2

24.85

24.80

mmol/l

0.02

104

Atopic dermatitis, strict definition

540

4819

1.10

1.42

6.7

6.8

24.48

24.29

mmol/l

0.59

510

4487

Systemic lupus erythematosus

598

1.30

1.42

5.6

8.4

24.50

24.60

mmol/l

0.10

560

Motorcycle rider injured in other and unspecified transport accidents

113

918

1.24

1.42

10.1

7.7

24.91

24.32

mmol/l

1.46

102

859

Benign neoplasm: Liver/bile ducts (ICD-9)

3.27

1.41

9.2

5.0

24.34

25.36

mmol/l

—

In situ neoplasms

950

8868

1.08

1.40

6.2

6.6

24.46

24.60

mmol/l

0.53

883

8262

Prurigo nodularis

469

1.35

1.40

10.5

6.7

24.45

24.63

mmol/l

0.16

440

Use of donepezil

566

4979

1.10

1.40

4.4

6.1

24.67

24.53

mmol/l

0.40

530

4649

Oral leukoplakia and related diseases, including avohilmo

217

1876

1.17

1.40

7.8

7.0

24.62

24.61

mmol/l

0.00

209

1752

Hypertension, portal

2.16

1.38

10.8

7.7

22.75

25.28

mmol/l

0.72

Malignant neoplasm of other and unspecified urinary organs, excluding all cancers (controls excluding all cancers)

160

1.62

1.38

7.6

5.8

23.61

24.35

mmol/l

0.47

154

Other specified/unspecified bacterial intestinal infections

152

1278

1.20

1.37

6.6

6.9

23.92

24.50

mmol/l

0.97

146

1186

Alzheimer’s disease (Early onset)

922

0.77

1.36

9.7

6.0

24.69

24.41

mmol/l

0.26

856

Other disorders of eye and adnexa

292

2580

1.14

1.36

6.5

6.9

24.43

24.44

mmol/l

0.02

275

2393

Fractures involving multiple body regions

2.24

1.36

32.7

7.3

26.90

24.24

mmol/l

—

Acute appendicitis, with complications

503

4582

1.10

1.36

7.0

24.56

24.49

mmol/l

0.15

471

4272

Hyperkinetic disorders (excl. ADHD)

119

1.68

1.35

5.1

11.8

24.46

24.24

mmol/l

0.13

107

Spontaneous abortion

925

5866

1.08

1.34

5.9

6.8

24.47

24.72

mmol/l

1.51

851

5456

Premature rupture of membranes

235

1982

0.87

1.33

10.0

6.3

23.90

24.25

mmol/l

0.77

216

1834

Perineal laceration during delivery

154

1625

0.84

1.33

6.0

5.8

24.00

24.12

mmol/l

0.19

145

1507

Squamous cell neoplasms and carcinoma of cervix

1.81

1.32

7.1

6.3

25.28

24.72

mmol/l

0.34

Postpartum hemorraghe, all women as controls

301

3376

0.88

1.32

5.3

6.3

23.60

24.32

mmol/l

4.03

283

3123

Haemorrhagic and haematological disorders of fetus and newborn

1.83

1.32

9.5

3.2

24.77

23.03

mmol/l

0.71

Recurrent dislocation and subluxation of joint

129

1072

1.21

1.31

7.3

8.1

24.31

24.48

mmol/l

0.22

124

1010

Deficiency of other B group vitamins

396

1.36

1.31

7.9

7.6

23.73

24.38

mmol/l

0.84

375

Other deformities of toe(s)

633

1.28

1.30

6.2

7.6

24.74

24.52

mmol/l

0.22

593

Other and unspecified iridocyclitis

767

1.25

1.30

6.3

7.2

23.71

24.65

mmol/l

1.63

716

Biomechanical lesions, not elsewhere classified

114

939

1.23

1.30

7.1

24.22

24.57

mmol/l

0.69

106

876

Fenamates

339

2557

0.89

1.30

5.3

7.5

24.57

24.47

mmol/l

0.20

316

2386

Wilms' tumor, excluding all cancers (controls excluding all cancers)

115

1.72

1.30

2.5

5.4

22.88

24.33

mmol/l

0.89

107

Benign neoplasm: salivary glands, exclude unknown (D119)

217

1890

1.16

1.29

8.7

7.1

24.90

24.62

mmol/l

0.51

203

1758

Galactorrhea

107

1.72

1.28

4.3

7.3

24.95

24.92

mmol/l

0.01

102

Calculus of lower urinary tract

145

1226

1.20

1.27

10.3

7.3

24.37

24.40

mmol/l

0.02

137

1147

Unspecified abortion

733

1.25

1.27

6.5

7.4

24.50

24.76

mmol/l

0.35

674

Bacterial, viral and other infectious agents

185

1594

1.17

1.26

7.4

7.8

24.62

24.47

mmol/l

0.24

174

1495

Palmar fascial fibromatosis [Dupuytren]

439

3992

1.11

1.26

6.7

7.0

24.17

24.51

mmol/l

1.26

413

3723

Allergic colitis

162

1.56

1.26

22.1

5.1

24.13

23.73

mmol/l

0.22

150

Postpartum haemorrhage

301

2942

0.89

1.26

5.3

6.5

23.60

24.44

mmol/l

5.20

283

2704

Psoriatic arthropathies, ICD10

239

2100

1.15

1.25

7.0

7.6

25.03

24.51

mmol/l

1.41

224

1958

Other injuries of spine and trunk, level unspecified

132

1.64

1.24

11.3

7.0

24.76

24.39

mmol/l

0.13

125

Adenocarcinoma of pancreas, excluding all cancers (controls excluding all cancers)

541

1.30

1.23

7.4

6.5

24.51

24.50

mmol/l

0.00

512

Poor fetal growth

155

1318

1.18

1.23

7.6

6.4

24.01

24.10

mmol/l

0.14

142

1222

Antepartum haemorrhage, not elsewhere classified

113

935

1.21

1.22

5.9

6.1

24.45

24.26

mmol/l

0.23

107

873

Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs

188

1629

1.16

1.21

5.4

7.5

24.76

24.62

mmol/l

0.20

173

1519

Contraceptive management

903

5942

1.07

1.21

7.2

7.8

24.51

24.63

mmol/l

0.49

835

5553

Postpartum haemorrhage due to retained placenta

129

1532

0.84

1.20

5.7

6.3

23.21

24.31

mmol/l

4.13

121

1421

Other disorders of the genitourinary system

301

2693

1.13

1.19

7.1

6.7

24.64

24.83

mmol/l

0.42

276

2493

Malignant neoplasm of breast, HER-negative

409

4490

0.91

1.19

5.9

6.4

25.16

24.84

mmol/l

1.09

385

4173

Otitis media, unspecified

187

1490

1.16

1.19

6.5

7.0

25.23

24.12

mmol/l

3.22

169

1397

Malignant neoplasm of thymus

1.95

1.18

4.3

6.9

25.36

24.69

mmol/l

0.39

Crystalline deposits in vitreous body

183

1.52

1.18

6.8

5.9

25.26

24.51

mmol/l

0.66

174

Malignant neoplasm of placenta, excluding all cancers (controls excluding all cancers)

2.67

1.18

9.0

5.6

26.96

25.32

mmol/l

—

Melanocytic naevi of other and unspecified parts of face

124

1041

1.20

1.18

5.3

7.3

24.68

24.47

mmol/l

0.24

114

973

Malignant neoplasm of lip, excluding all cancers (controls excluding all cancers)

216

1.47

1.18

8.2

5.2

23.84

24.39

mmol/l

0.31

203

Chalazion

253

2242

1.14

1.17

7.4

7.1

24.49

24.53

mmol/l

0.05

238

2085

Injury of muscle and tendon at hip and thigh level

213

1867

1.15

1.17

6.7

7.3

24.75

24.50

mmol/l

0.51

197

1737

Keratitis and keratoconjunctivitis in other diseases classified elsewhere

697

1.25

1.17

7.7

6.7

24.99

24.61

mmol/l

0.46

653

Failed attempted abortion

110

1.66

1.17

2.2

9.9

24.01

23.89

mmol/l

0.07

102

Carcinoma in situ, bladder

709

1.25

1.15

7.3

6.8

24.23

24.58

mmol/l

0.32

660

Colonic or urogenital fistula

686

6387

1.08

1.15

7.8

7.2

24.52

24.57

mmol/l

0.13

645

5943

Chronic suppurative otitis media

152

1302

1.18

1.15

7.3

24.26

24.49

mmol/l

0.28

141

1206

Disorders of amino-acid transport

2.41

1.14

12.0

5.6

24.20

24.90

mmol/l

—

Mature T/NK-cell lymphomas, hilmo, excluding all cancers

251

1.43

1.14

7.3

8.6

24.28

24.47

mmol/l

0.10

238

Disorders of orbit

753

1.23

1.14

7.4

7.2

24.28

24.56

mmol/l

0.30

704

Myeloproliferative diseases (CML excluded)

188

1640

1.16

1.13

8.6

6.8

24.14

24.57

mmol/l

0.74

177

1522

Retained placenta and membranes, without haemorrhage

217

1909

1.14

1.13

5.1

6.4

24.53

24.73

mmol/l

0.36

210

1764

Non-small cell lung cancer, adenocarcinoma

165

1427

1.17

1.13

6.9

6.6

25.37

24.48

mmol/l

2.92

153

1335

Non-small cell lung cancer, adenocarcinoma, helper endpoint

165

1427

1.17

1.13

6.9

6.6

25.37

24.48

mmol/l

2.92

153

1335

Diving or jumping into water causing injury other than drowning or submersion

1.79

1.12

6.1

14.7

25.92

24.50

mmol/l

1.16

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8, excluding more controls

1129

0.82

1.12

5.8

7.1

24.84

24.45

mmol/l

0.53

1056

Other acute skin changes due to ultraviolet radiation

683

1.25

1.12

6.4

7.9

24.85

24.51

mmol/l

0.32

641

Other congenital malformations of skull and face bones

2.33

1.12

2.6

19.5

25.84

24.88

mmol/l

—

Cyst of Bartholin Gland

539

1.27

1.12

4.1

7.2

24.32

24.77

mmol/l

0.56

499

Other appendicitis

192

1678

1.15

1.12

7.3

7.0

24.80

24.54

mmol/l

0.46

182

1565

Diseases of external ear

850

7984

1.07

1.11

6.5

7.1

24.61

24.52

mmol/l

0.30

793

7434

Sexual dysfunction

244

1.42

1.10

5.2

9.1

23.48

24.33

mmol/l

0.47

229

Benign neoplasm of bone and articular cartilage

178

1549

1.16

1.10

6.8

7.5

24.78

24.49

mmol/l

0.59

168

1444

Acquired atrophy of ovary and fallopian tube

2.27

1.10

13.6

5.9

26.57

25.80

mmol/l

—

All dysplastic lesions of the cervix uteri, vagina or vulva

470

4290

1.09

6.1

6.5

24.39

24.47

mmol/l

0.20

439

3963

Erosion of teeth, including avohilmo

432

3822

1.10

1.09

9.3

6.9

24.98

24.56

mmol/l

1.63

407

3535

Triptan medication for migraine, min. 3 purchases

1140

8520

1.06

1.08

7.4

6.9

24.35

24.55

mmol/l

1.20

1067

7906

Thyrotoxicosis with toxic multinodular goitre

138

1181

1.18

1.08

6.7

6.6

25.11

24.58

mmol/l

1.16

131

1101

Hypertrophy of bone

2.08

1.08

4.8

7.8

25.16

23.55

mmol/l

—

Burn and corrosion of ankle and foot

237

1.42

1.07

7.2

9.2

23.90

24.24

mmol/l

0.20

222

Other and unspecified injuries of wrist and hand

597

1.25

1.06

6.6

8.0

24.74

24.53

mmol/l

0.18

551

Nontoxic single thyroid nodule

115

1358

0.84

1.06

5.5

6.4

24.35

24.63

mmol/l

0.41

103

1249

Cleft lip, lip and palate or palate

187

1.46

1.05

3.9

9.3

25.28

24.44

mmol/l

0.87

173

Hypertrophy of breast

311

2810

1.11

1.05

6.3

6.8

24.63

24.68

mmol/l

0.10

291

2606

Sudden idiopathic hearing loss

245

2187

1.13

1.05

8.5

7.0

24.65

24.64

mmol/l

0.01

234

2023

Peripheral retinal degeneration

590

1.25

1.05

7.2

7.1

24.38

24.54

mmol/l

0.13

554

Use of galantamine

190

1671

1.15

1.04

4.7

5.6

24.30

24.51

mmol/l

0.35

182

1559

Radiodermatitis

1.98

1.04

5.3

7.5

25.84

25.36

mmol/l

—

Acute epiglottitis

264

1.39

1.04

7.7

7.6

24.97

24.50

mmol/l

0.50

251

Disorders of conjunctiva

2014

17530

0.96

1.04

7.2

7.0

24.69

24.59

mmol/l

0.57

1882

16327

Benign neoplasm: Parotid gland

190

1671

1.15

1.04

8.7

7.1

25.01

24.60

mmol/l

0.76

178

1555

Aphakia

247

1.40

1.03

6.9

6.3

24.41

24.53

mmol/l

0.05

224

Benign neoplasm: Pelvic bones, sacrum and coccyx

1.93

1.02

5.4

5.0

24.50

24.55

mmol/l

—

Other psoriatic arthropathies

229

2039

1.13

1.02

7.0

7.5

25.01

24.50

mmol/l

1.33

216

1900

Crossbite

731

1.21

1.02

5.8

7.9

24.98

24.36

mmol/l

0.98

684

Malignant neoplasm of breast, ER-negative, excluding all cancers (controls excluding all cancers)

480

4257

1.09

1.02

6.0

6.3

25.07

24.89

mmol/l

0.54

453

3924

Superficial injury of neck

257

1.38

1.00

5.8

8.9

24.65

24.35

mmol/l

0.18

241

Acrodermatitis chronica atrophicans

0.00

1.00

0.0

7.5

—

24.39

—

Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue

165

1.49

1.00

9.4

9.3

25.15

24.43

mmol/l

0.54

156

Malignant neoplasm of breast, HER-positive

698

7338

0.93

1.00

5.6

6.5

25.30

24.91

mmol/l

2.53

650

6827

Female infertility, cervigal, vaginal, other or unspecified origin

490

3028

1.09

1.00

6.1

7.2

24.04

24.59

mmol/l

2.82

452

2802

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8

1113

0.83

1.00

5.8

7.1

24.84

24.42

mmol/l

0.58

1031

Motor- or nonmotor-vehicle accident in traffic area

100

1.64

0.99

6.7

11.8

24.87

24.82

mmol/l

0.02

Malignant neoplasm of gum, excluding all cancers (controls excluding all cancers)

174

1.47

0.98

11.5

5.8

25.91

24.89

mmol/l

0.86

165

Dislocation, sprain and strain of joints and ligaments of elbow

115

978

1.18

0.98

6.5

7.7

24.55

24.50

mmol/l

0.06

108

907

Other/unspecified reactive arthropathies

141

1220

1.16

0.98

10.8

7.8

24.52

24.51

mmol/l

0.01

129

1136

Osteitis due to dental implant

117

1.59

0.97

11.2

10.2

25.16

24.73

mmol/l

0.21

112

Ankle and foot

133

1.54

0.97

8.2

5.9

24.77

24.66

mmol/l

0.05

125

Additional codes for the location of defect, injury or illness

121

1036

1.18

0.97

5.3

7.4

24.87

24.48

mmol/l

0.58

111

961

Mature T/NK-cell lymphomas, hilmo

260

1.37

0.96

7.3

8.2

24.28

24.56

mmol/l

0.16

247

Other infective (teno)synovitis

1.78

0.96

6.1

7.9

24.00

24.65

mmol/l

0.23

SLE, ICD10

588

1.24

0.96

5.5

8.4

24.41

24.74

mmol/l

0.38

554

SLE, strict definition

588

1.24

0.96

5.5

8.4

24.41

24.74

mmol/l

0.38

554

Benign neoplasm: Middle ear, nasal cavity and accessory sinuses

798

1.20

0.96

6.6

7.7

24.86

24.46

mmol/l

0.52

747

Disorders of phosphorus metabolism and phosphatases

1.77

0.95

9.0

7.0

25.09

24.84

mmol/l

0.09

Torsion of testis

234

1.38

0.95

8.8

10.1

23.37

24.33

mmol/l

0.60

217

Tinnitus

568

5301

1.08

0.95

7.7

7.3

24.82

24.65

mmol/l

0.63

545

4914

Drowning and submersion while in natural water

1.66

0.95

4.1

12.7

23.22

24.12

mmol/l

0.61

Dacryoadenitis

134

1.53

0.94

5.6

7.4

24.23

24.48

mmol/l

0.11

123

Other congenital malformations of kidney

1.88

0.94

10.6

6.3

23.86

25.25

mmol/l

—

Carcinoma in situ of other and unspecified sites

755

1.21

0.93

7.4

6.9

24.33

24.54

mmol/l

0.18

704

Melanocytic naevi of scalp and neck

366

1.30

0.93

5.5

8.2

23.25

24.44

mmol/l

1.28

342

Meningococcal infection

102

0.48

0.91

14.0

6.2

28.02

24.44

mmol/l

—

Carcinoma in situ of skin

164

1857

0.88

0.91

5.8

6.2

23.96

24.54

mmol/l

1.05

151

1727

Benign leiomyoma with endometriosis

262

2892

0.90

5.8

6.4

24.67

24.90

mmol/l

0.49

246

2661

Otosclerosis

140

1602

0.87

0.90

6.3

7.3

24.74

24.56

mmol/l

0.20

129

1493

Mandibular hypoplasia

1.68

0.90

14.2

8.1

23.35

24.47

mmol/l

0.55

Persons encountering health services in circumstances related to reproduction

1332

8635

1.05

0.89

7.4

7.7

24.62

24.66

mmol/l

0.19

1226

8046

Other and/or unspecified nontoxic goitre

183

1626

1.13

0.89

6.6

6.7

25.30

24.74

mmol/l

1.54

175

1502

Use of antiglaucoma preparations and miotics

211

1893

1.12

0.88

5.8

6.1

24.37

24.63

mmol/l

0.38

191

1766

Macular hole

138

1206

1.16

0.88

6.2

6.4

24.78

24.60

mmol/l

0.27

132

1116

Nonsuppurative otitis media

425

3399

1.08

0.87

6.8

6.5

24.33

24.24

mmol/l

0.16

399

3148

Drug-induced systemic lupus erythematosus

112

1.56

0.87

5.7

7.2

25.14

25.29

mmol/l

0.08

105

Burn and corrosion, body region unspecified

104

1.58

0.87

11.8

8.4

23.86

24.49

mmol/l

0.36

Maternal care for known or suspected disproportion

486

1.24

0.86

4.8

6.3

23.70

24.35

mmol/l

0.61

458

Contact with other sharp object(s)

121

1048

1.16

0.85

7.4

7.9

24.43

24.40

mmol/l

0.03

114

973

Demyelinating diseases of the central nervous system

156

1377

1.14

0.84

6.7

7.9

24.35

24.39

mmol/l

0.05

142

1280

Other nonthrombocytopenic purpura

172

1.43

0.84

5.3

9.5

24.50

24.70

mmol/l

0.13

159

HSIL lesion of the cervix uteri

257

2334

1.10

0.83

5.3

6.4

24.22

24.32

mmol/l

0.16

242

2163

Benign neoplasm: Skin of trunk

774

1.19

0.82

5.9

7.7

24.53

mmol/l

0.00

729

Other and unspecified noninflammatory disorders of ovary, fallopian tube and broad ligament

355

1.28

0.82

7.8

8.2

24.40

24.77

mmol/l

0.25

333

Familial chondrocalcinosis

0.00

0.82

0.0

6.8

—

24.40

—

Other specified diseases with participation of lymphoreticular and reticulohistiocytic tissue

1.79

0.82

7.9

14.7

22.86

25.14

mmol/l

—

Malignant neoplasm of other and ill-defined digestive organs

156

1.45

0.82

3.7

6.6

25.91

24.59

mmol/l

0.78

144

Acute mastoiditis

131

1.48

0.80

11.9

6.7

23.98

24.86

mmol/l

0.68

122

Long labour

308

2926

0.92

0.79

5.8

6.5

24.04

24.45

mmol/l

1.38

289

2684

Systemic lupus erythematosus, unspecified

502

1.23

0.79

5.6

8.7

24.37

24.72

mmol/l

0.39

471

Obstructed labour due to maternal pelvic abnormality

289

2650

1.09

0.79

8.8

6.6

24.77

24.89

mmol/l

0.25

269

2446

Other demyelinating diseases of the central nervous system

502

1.22

0.78

9.1

9.0

24.29

24.38

mmol/l

0.07

470

Granuloma annulare

226

1.35

0.78

10.1

7.2

25.27

24.71

mmol/l

0.44

213

Severe mental retardation

1.82

0.78

1.5

8.0

23.38

23.94

mmol/l

—

Injury of blood vessels at ankle and foot level

2.23

0.77

3.8

24.9

24.80

23.89

mmol/l

—

Separation of retinal layers (serosa)

855

1.17

0.76

9.1

7.4

24.51

24.59

mmol/l

0.08

803

Other abnormal products of conception

499

3113

1.07

0.76

5.5

6.6

24.14

24.45

mmol/l

1.22

458

2882

Other and unspecified acne

158

1.41

0.75

6.3

9.7

24.52

24.29

mmol/l

0.08

145

Other disorders of Eustachian tube

487

1.22

0.75

5.2

7.0

25.08

24.53

mmol/l

0.85

455

Macular pucker

395

3682

1.08

0.75

7.0

6.8

24.46

24.66

mmol/l

0.56

369

3412

Tuberculosis of nervous system

2.10

0.75

43.6

7.8

26.70

23.76

mmol/l

—

Malignant melanoma, excluding all cancers (controls excluding all cancers)

362

3890

0.93

0.73

6.2

6.8

24.76

24.59

mmol/l

0.38

335

3613

Shoulder region

238

1.32

0.73

5.5

6.5

24.37

24.50

mmol/l

0.07

226

Allergic contact dermatitis due to drugs in contact with skin

390

1.25

0.72

5.5

6.8

24.64

24.53

mmol/l

0.09

363

Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue

178

1.38

0.71

9.4

9.5

25.15

24.38

mmol/l

0.61

168

Crushing injury of ankle and foot

1.65

0.71

12.7

13.3

25.48

24.47

mmol/l

0.45

Periodontal disease, other/unspecified

1.65

0.71

12.5

7.6

23.73

24.46

mmol/l

0.22

Benign neoplasm of thyroid gland

620

1.19

0.70

7.2

6.9

24.99

24.69

mmol/l

0.29

585

Pedestrian injured in collision with pedal cycle

583

1.19

0.70

5.6

8.1

25.22

24.58

mmol/l

0.76

544

Bus occupant injured in other and unspecified transport accidents

117

0.59

0.70

4.4

6.3

24.26

24.73

mmol/l

—

109

L04AC Interleukin inhibitors

778

1.16

0.70

5.8

8.7

24.89

24.73

mmol/l

0.17

723

Childhood allergy (age < 16)

157

1157

1.12

0.69

5.8

6.1

23.56

mmol/l

0.00

149

1070

Pregnancy with abortive outcome

1542

7784

1.04

0.69

5.9

6.3

24.61

24.71

mmol/l

0.49

1443

7232

Colitis, primary sclerosing, strict definition

144

1.41

0.69

14.8

11.5

23.32

24.47

mmol/l

0.75

132

Malignant neoplasm of gum

0.51

0.69

9.6

6.3

25.76

24.99

mmol/l

—

Infectious mononucleosis

115

1012

1.14

0.69

8.7

7.8

24.50

24.09

mmol/l

0.51

107

937

Carcinoma in situ, bladder

753

1.17

0.68

7.3

6.9

24.23

24.40

mmol/l

0.14

695

Abnormal findings on diagnostic imaging of breast

223

1.32

0.68

11.7

6.9

24.61

25.28

mmol/l

0.24

211

Benign neoplasm: Scapula and long bones of upper limb

136

1.42

0.68

4.5

7.5

25.35

24.98

mmol/l

0.18

127

Melanocytic naevi of scalp and neck

385

1.23

0.67

5.5

8.1

23.25

24.51

mmol/l

1.41

360

Other disorders of veins

874

9118

0.96

0.66

7.2

6.9

25.04

24.62

mmol/l

2.59

822

8478

Other peripheral vertigo

215

1968

1.10

0.66

6.1

6.8

24.84

24.64

mmol/l

0.30

200

1833

Other bursitis, not elsewhere classified

172

1.36

0.65

4.2

7.0

25.35

24.41

mmol/l

0.85

158

Other otitis externa (chronic)

137

1226

1.12

0.65

5.2

7.6

24.62

24.51

mmol/l

0.12

123

1137

Adenocarcinoma of pancreas

589

1.19

0.65

7.4

6.2

24.51

24.52

mmol/l

0.01

555

Other disorders of breast

190

2085

0.91

0.65

6.2

6.9

24.99

24.72

mmol/l

0.60

182

1931

Other congenital malformations of skin

635

1.17

0.64

6.1

8.6

24.55

24.51

mmol/l

0.04

592

Continuous positive airway pressure

214

1688

1.10

0.64

5.8

4.6

24.88

24.65

mmol/l

0.36

205

1553

Enteritis due to Yersinia enterocolitica

1.55

0.64

4.3

7.6

24.51

24.21

mmol/l

0.08

Melanocytic naevi of lower limb, including hip

729

1.16

0.64

6.5

8.1

24.07

24.67

mmol/l

0.87

681

Dysplasia of cervi uteri

414

3006

1.07

0.64

6.0

6.9

24.32

24.55

mmol/l

0.68

389

2782

Benign neoplasm: Ureter

0.00

0.63

0.0

4.0

—

25.41

—

Other specified disorders of external ear

825

0.85

0.63

7.9

25.36

24.44

mmol/l

1.31

770

Chorioretinal inflammation

507

1.19

0.63

7.5

7.6

24.46

24.55

mmol/l

0.06

474

Lymphocyte function antigen-1 [LFA-1] defect

0.00

0.62

0.0

5.1

—

24.27

—

Thyrotoxicosis with diffuse goitre

273

2532

1.08

0.62

5.9

6.8

24.77

24.63

mmol/l

0.29

251

2344

Arthropathic psoriasis

246

2274

1.09

0.61

7.0

7.5

25.00

24.50

mmol/l

1.41

229

2116

Localized adiposity

1.54

0.61

16.8

12.2

24.32

25.12

mmol/l

0.17

Other specified and unspecified disorders of choroid

1.58

0.61

13.7

7.2

26.09

24.79

mmol/l

0.84

Other protozoal intestinal diseases

198

0.70

0.61

4.1

9.0

23.16

24.48

mmol/l

0.59

189

Intrahepatic Cholestasis of Pregnancy (ICP) , excluding more controls

801

0.86

0.60

4.8

7.3

24.30

24.18

mmol/l

0.13

749

Acute poliomyelitis

255

1.27

0.60

4.3

6.8

25.72

24.75

mmol/l

1.09

240

Maternal care for known or suspected abnormality of pelvic organs

363

2347

1.07

0.59

5.6

6.3

23.91

24.35

mmol/l

1.93

343

2171

Impacted teeth

248

2137

1.08

0.58

5.6

6.9

23.94

23.99

mmol/l

0.07

236

1987

L02BG Aromatase inhibitors

599

6283

0.95

0.58

5.4

6.7

25.26

24.90

mmol/l

1.96

560

5833

Alzheimer’s disease, wide definition

672

5372

1.05

0.57

4.9

6.1

24.50

24.53

mmol/l

0.05

644

5008

Prolonged pregnancy

152

1527

0.91

0.57

5.5

6.3

24.13

24.11

mmol/l

0.02

143

1423

Toxic effect of organic solvents

1.58

0.57

10.0

15.5

26.93

23.98

mmol/l

—

Palindromic rheumatism

183

0.70

0.57

4.4

7.3

24.72

24.56

mmol/l

0.06

173

Benign lipomatous neoplasm of of intra-abdominal organs

1.55

0.56

3.8

8.1

24.37

24.88

mmol/l

—

Urethral stricture

148

1346

1.11

0.55

5.2

7.3

24.52

24.54

mmol/l

0.03

131

1254

Leiomyoma of uterus

1413

8287

0.97

0.55

6.5

6.4

24.82

24.84

mmol/l

0.08

1305

7709

Single spontaneous delivery

860

4763

0.96

0.55

6.1

6.4

24.64

24.79

mmol/l

0.50

811

4434

Follicular lymphoma, hilmo

101

900

1.13

0.55

7.0

6.7

25.46

24.43

mmol/l

1.67

836

Meningitis, viral

1.50

0.55

5.8

13.8

25.02

24.11

mmol/l

—

Rheumatic heart disease, other

1.59

0.54

2.5

5.2

23.22

23.59

mmol/l

—

Abscess of tendon sheath

100

1.43

0.53

5.1

6.8

26.54

24.77

mmol/l

2.06

Intentional self-harm by hanging, strangulation and suffocation

100

1.43

0.53

5.0

12.8

25.22

23.65

mmol/l

1.65

Other and unspecified pemphigus

1.44

0.53

8.2

6.0

22.94

24.09

mmol/l

—

Anogenital herpesviral [herpes simplex] infection

810

0.87

0.51

10.1

7.6

24.69

24.19

mmol/l

0.73

749

Crowding of teeth, including avohilmo

102

752

1.12

0.51

7.6

7.1

23.78

23.91

mmol/l

0.13

704

Other disorders of carbohydrate metabolism

1.41

0.51

2.9

13.4

22.08

24.38

mmol/l

—

Vascular dementia (sudden onset)

1.40

0.51

4.1

5.0

25.29

23.65

mmol/l

—

Other and unspecified degenerative diseases of nervous system

473

1.17

0.51

5.4

7.2

25.52

24.26

mmol/l

1.78

444

MS-disease / Multiple Sclerosis

123

1114

1.11

0.51

6.1

8.0

24.45

24.47

mmol/l

0.01

113

1032

Puerperal sepsis

233

2172

1.08

0.50

5.4

7.0

24.76

24.83

mmol/l

0.11

220

2011

Carcinoma in situ of skin

164

1781

0.92

0.50

5.8

6.3

23.96

24.63

mmol/l

1.30

151

1659

Benign neoplasm: Conjunctiva

539

1.16

0.50

7.5

7.2

25.02

24.45

mmol/l

0.72

508

All dysplastic lesions of the cervix uteri

375

3543

1.06

0.49

6.0

6.3

24.32

24.37

mmol/l

0.10

352

3271

Postinfectious hypothyroidism

1.42

0.49

14.4

7.8

23.03

24.82

mmol/l

0.70

Neonatal jaundice from other and unspecified causes

1.50

0.49

9.4

3.6

25.71

23.31

mmol/l

—

Other disorders of breast and lactation associated with childbirth

155

0.70

0.49

3.5

6.1

23.88

24.26

mmol/l

0.15

146

Disorder of carbohydrate metabolism, other/unspecified

1.52

0.48

2.4

15.1

21.70

24.40

mmol/l

—

Intrahepatic Cholestasis of Pregnancy (ICP)

784

0.88

0.48

4.8

7.2

24.30

24.29

mmol/l

0.00

728

Respiratory tuberculosis, clinically confirmed

264

1.23

0.47

11.2

7.8

25.82

24.26

mmol/l

1.00

252

Gilbert syndrome

118

0.67

0.47

4.1

10.4

24.80

24.30

mmol/l

—

112

Cholinergic urticaria

0.58

0.46

3.4

12.3

25.32

24.46

mmol/l

—

Bullous keratopathy

165

1.29

0.46

4.6

5.9

24.87

24.73

mmol/l

0.05

157

Macular cyst

526

1.15

0.45

6.1

6.8

24.27

24.55

mmol/l

0.21

499

Carcinoma in situ of breast, intraductal

166

1538

1.08

0.44

5.8

6.8

25.10

24.88

mmol/l

0.35

152

1423

Felty syndrome

113

1.35

0.44

14.0

6.5

21.51

24.54

mmol/l

1.26

108

Thyrotoxicosis with toxic single thyroid nodule

130

0.68

0.44

4.6

7.0

24.00

24.99

mmol/l

—

122

Small cell lung cancer, excluding all cancers (controls excluding all cancers)

479

0.85

0.44

5.0

6.7

25.90

24.37

mmol/l

1.42

453

Frontotemporal dementia, wide, incl. Pick's disease

122

1.34

0.43

27.9

6.6

25.44

24.55

mmol/l

0.52

116

Other noninflammatory disorders of vagina

140

1289

1.09

0.43

5.9

6.4

24.34

24.79

mmol/l

0.82

126

1208

Onychogryphosis

1.44

0.43

2.9

5.8

21.61

25.01

mmol/l

—

Hydrocephalus in other diseases

0.64

0.43

14.8

11.6

25.48

24.75

mmol/l

—

Vibratory urticaria

0.00

0.42

0.0

12.3

—

25.06

—

Fracture of spine, level unspecified

1.56

0.42

10.0

4.8

28.26

24.44

mmol/l

—

Small cell lung cancer, helper endpoint

477

0.85

0.42

5.0

5.8

25.90

24.29

mmol/l

1.53

451

Small cell lung cancer

477

0.85

0.42

5.0

5.8

25.90

24.29

mmol/l

1.53

451

Injury of blood vessels at lower leg level

1.42

0.42

23.4

6.2

25.31

24.13

mmol/l

0.92

Chronic diseases of tonsils and adenoids

2098

13011

1.02

0.41

6.6

7.4

24.62

24.56

mmol/l

0.35

1959

12111

Atypical virus infections of central nervous system

168

1.27

0.41

5.4

8.1

26.39

24.85

mmol/l

1.52

156

Covid-19 suspected case

374

3567

1.05

0.41

7.2

6.7

24.07

24.39

mmol/l

0.91

348

3308

Hypertrophy of (infrapatellar) fat pad

141

1.29

0.41

5.6

11.2

26.05

24.75

mmol/l

0.98

132

Foreign body granuloma of skin and subcutaneous tissue

1.45

0.40

6.6

5.6

24.37

24.44

mmol/l

—

Other and unspecified disorders of vitreous body

1008

10308

0.97

0.40

6.6

7.2

24.93

24.71

mmol/l

1.34

941

9592

Villonodular synovitis (pigmented)

124

1.31

0.39

6.7

11.5

23.93

24.58

mmol/l

0.20

117

Personal history of medical treatment

142

1.28

0.39

10.3

6.9

26.08

24.21

mmol/l

0.74

133

Chronic laryngitis and laryngotracheitis

319

3037

1.05

0.39

7.9

7.2

25.02

24.59

mmol/l

1.12

305

2823

Maternal care for known or suspected malpresentation of fetus

218

1528

1.07

0.39

5.6

6.2

23.97

24.12

mmol/l

0.29

202

1414

Varicella [chickenpox]

751

1.11

0.39

7.7

8.3

23.95

24.46

mmol/l

0.62

695

Polyarteritis with lung involvement [Churg-Strauss]/EGPA

1.42

0.38

9.4

7.7

24.88

25.37

mmol/l

—

Impaction of intestines

116

1.31

0.38

20.6

6.0

24.51

24.45

mmol/l

0.02

105

Undescended testicle

111

0.71

0.37

8.3

11.4

26.62

23.91

mmol/l

—

102

L02BA Anti-estrogens

306

3211

0.95

0.37

5.2

6.7

24.97

24.87

mmol/l

0.21

288

2980

Oral lichen ruber planus, including avohilmo

119

1099

1.09

0.37

4.5

7.6

24.12

24.73

mmol/l

1.56

111

1030

Other superficial injuries of ankle and foot

1.38

0.37

8.1

12.6

23.54

23.98

mmol/l

0.10

Carcinoma in situ of other and unspecified sites

822

1.10

0.37

7.4

6.9

24.33

24.48

mmol/l

0.12

762

Defect, injury or illness of lumbar spine

1.49

0.36

11.0

9.4

24.53

25.34

mmol/l

—

Non-seminoma of testis, excluding all cancers (controls excluding all cancers)

1.28

0.36

12.8

15.9

23.64

24.05

mmol/l

—

Foreign body or object entering through skin

125

1158

1.08

0.36

9.0

7.4

24.54

24.45

mmol/l

0.10

116

1083

Benign lipomatous neoplasm of other sites/unspecified

209

1973

1.06

0.36

7.7

6.8

24.61

24.63

mmol/l

0.04

200

1831

Eustachian salpingitis and obstruction

101

1096

0.92

0.34

6.7

8.1

25.45

24.41

mmol/l

1.45

1023

Malignant neoplasm of hypopharynx, excluding all cancers (controls excluding all cancers)

144

0.75

0.34

10.6

6.0

26.55

24.02

mmol/l

1.16

136

Medical abortion

1446

7693

1.02

0.34

6.4

6.3

24.59

24.71

mmol/l

0.66

1359

7149

Contact with nonpowered hand tool

864

1.09

0.34

8.1

7.6

24.25

24.53

mmol/l

0.32

800

Delivery, wide proxy

751

4114

0.97

0.34

6.6

6.1

24.38

24.78

mmol/l

1.95

708

3820

L02BX Other hormone antagonists and related agents

122

1309

0.93

0.33

5.4

6.8

23.82

24.28

mmol/l

0.46

114

1220

Ankyloglossia

109

1.29

0.33

6.1

10.9

22.42

23.43

mmol/l

0.46

Maze procedure for atrial fibrillation

101

1.31

0.33

8.9

7.3

22.68

24.15

mmol/l

1.00

Ankylosing spondylitis, strict definition

694

1.10

0.32

7.5

9.1

25.26

24.55

mmol/l

1.37

647

Chronic rhinitis, nasopharyngitis and pharyngitis

710

6906

1.03

0.31

7.4

7.2

24.69

24.56

mmol/l

0.49

671

6420

Benign neoplasm: Scapula and long bones of upper limb

156

1.23

0.31

4.5

7.3

25.35

24.93

mmol/l

0.22

144

Seminoma of testis

164

0.78

0.31

8.5

11.1

23.96

24.39

mmol/l

0.22

152

Other and unspecified atrophic disorders of skin

1.33

0.31

4.9

5.9

26.21

25.20

mmol/l

0.28

Benign neoplasm: Connective and other soft tissue of trunk, unspecified

108

0.73

0.29

3.5

6.5

24.82

24.99

mmol/l

—

Delivery

880

4768

0.98

0.29

6.6

6.4

24.60

24.78

mmol/l

0.70

831

4439

Accidental poisoning by and exposure to other and unspecified chemicals and noxious substances

555

1.10

0.28

7.8

8.9

24.91

24.47

mmol/l

0.43

515

Other disorders of amniotic fluid and membranes

160

1499

1.06

0.28

6.3

23.61

24.20

mmol/l

1.30

147

1395

Overexertion and strenuous or repetitive movements

185

1944

0.95

0.27

8.0

7.3

24.62

24.47

mmol/l

0.22

171

1814

Other noninflammatory disorders of cervix uteri

926

0.93

0.27

7.4

6.9

24.65

24.99

mmol/l

0.38

865

Other congenital malformations of male genital organs

1.22

0.27

3.8

13.8

23.02

24.28

mmol/l

—

Malignant neoplasm of breast, HER2-negative

1107

8294

0.98

0.27

5.7

6.4

25.25

24.87

mmol/l

3.37

1035

7716

Pedestrian injured in collision with two- or three-wheeled motor vehicle

0.68

0.27

8.0

12.9

25.22

24.25

mmol/l

—

L02BB Anti-androgens

240

2302

1.05

0.26

4.3

6.8

23.85

24.30

mmol/l

0.80

222

2154

Hereditary sideroblastic anaemia

1.27

0.26

8.6

5.7

26.32

24.28

mmol/l

—

Malaria

0.66

0.26

17.4

7.3

24.50

23.76

mmol/l

—

Unspecified renal colic

114

1.24

0.25

13.5

6.5

23.34

24.24

mmol/l

0.29

105

Testicular dysfunction, other/unspecified

1.21

0.25

15.3

14.6

26.37

24.14

mmol/l

—

Abrasion of teeth

629

4740

0.97

0.25

7.3

6.9

24.95

24.63

mmol/l

1.40

591

4400

Degenerative myopia

115

1.23

0.24

6.1

7.1

25.46

25.13

mmol/l

0.15

108

Seminoma of testis, excluding all cancers (controls excluding all cancers)

158

0.82

0.24

8.5

10.0

23.96

24.16

mmol/l

0.09

149

Cryoglobulinemia

1.35

0.24

4.4

21.2

22.92

24.68

mmol/l

—

Scissor bite

208

1.15

0.23

7.8

9.0

24.58

23.88

mmol/l

0.52

193

Other and unspecified glaucoma

148

1553

0.95

0.23

7.0

6.6

24.15

24.60

mmol/l

0.67

141

1444

Tonsillectomy and adenotomy

1150

7873

1.02

0.23

5.6

7.3

24.42

mmol/l

0.01

1065

7326

Infections with a predominantly sexual mode of transmission

514

5264

0.97

0.22

8.3

6.8

24.68

24.37

mmol/l

1.22

479

4882

Disorders of visual cortex

0.00

0.22

0.0

5.5

—

23.52

—

Plasmodium vivax malaria

0.00

0.22

0.0

8.1

—

23.71

—

Toxic effect of other inorganic substances

0.00

0.22

0.0

7.1

—

21.95

—

Hereditary factor IX deficiency

0.00

0.22

0.0

51.5

—

23.47

—

Congenital absence, atresia and stenosis of small intestine

0.00

0.21

0.0

3.2

—

23.66

—

Special screening examination for neoplasms

833

0.93

0.21

7.1

6.3

24.28

24.31

mmol/l

0.02

777

Adenomyosis (Endometriosis of uterus)

246

2547

0.96

0.21

5.3

6.7

24.60

24.85

mmol/l

0.50

231

2362

Unattended death

164

1.17

0.21

4.7

6.5

24.86

24.47

mmol/l

0.18

156

Glanders and melioidosis

0.00

0.20

0.0

5.6

—

24.29

—

Gestational diabetes (for exclusion)

491

3559

0.98

0.20

5.9

6.5

23.74

24.32

mmol/l

3.25

461

3290

Duodenal ulcer - Unspecified as acute or chronic, without haemorrhage or perforation, drug-induced

1.25

0.19

5.5

6.1

25.11

24.54

mmol/l

—

Benign neoplasm: Skin, unspecified

746

0.94

0.19

7.0

7.5

23.99

24.43

mmol/l

0.51

706

Benign neoplasm of mouth and pharynx

245

2374

1.03

0.18

6.9

7.0

24.63

24.53

mmol/l

0.18

228

2215

Rheumatic fever with heart involvement

100

1.21

0.18

17.8

6.4

25.29

24.72

mmol/l

0.22

Labyrinthine fistula

1.18

0.18

3.7

8.4

23.67

24.58

mmol/l

—

Pemphigus

119

1.19

0.18

12.1

5.6

24.01

24.63

mmol/l

0.24

114

Benign neoplasm of breast

191

1978

0.96

0.18

5.4

6.6

25.25

24.84

mmol/l

0.84

186

1829

Phlebitis and thrombophlebitis of superficial vessels of lower extremities, drug-induced

0.75

0.17

7.0

5.3

23.22

24.69

mmol/l

—

Labour and delivery complicated by fetal stress [distress]

273

1875

0.97

0.17

4.8

6.3

23.59

24.13

mmol/l

2.21

258

1728

Parapsoriasis

320

1.10

0.17

6.0

8.2

25.27

24.41

mmol/l

0.63

302

Maternal care for other known or suspected fetal problems

289

1802

1.03

0.17

5.8

6.2

23.67

24.12

mmol/l

1.69

267

1667

Other sideroblastic anaemias

0.73

0.17

6.4

5.6

24.92

24.42

mmol/l

—

Deep bite

176

1485

1.04

0.17

7.1

7.3

24.50

24.31

mmol/l

0.32

166

1389

Abnormal findings in secretions and smears from cervix uteri vagina vulva

896

6936

1.02

0.16

5.9

6.6

24.57

24.64

mmol/l

0.21

833

6434

Acute hepatitis B

0.79

0.16

4.5

7.8

24.53

24.24

mmol/l

—

Chronic mastoiditis

565

0.93

0.16

6.0

6.3

25.41

24.37

mmol/l

1.46

532

Foreign body entering into or through eye or natural orifice

154

1595

0.96

0.15

7.3

7.9

24.88

24.46

mmol/l

0.67

140

1496

Exposure to ignition of highly flammable material

1.15

0.15

11.0

13.5

25.90

24.53

mmol/l

—

Other specified transport accidents

1.15

0.15

7.2

12.8

26.03

24.97

mmol/l

—

Cleft lip and palate

1.14

0.15

2.8

13.0

25.98

24.20

mmol/l

—

Non-seminoma of testis

1.12

0.15

12.8

14.7

23.64

23.97

mmol/l

—

Contact with blunt object, undetermined intent

1.10

0.15

8.2

13.5

24.74

24.25

mmol/l

—

Benign neoplasm: Anus and anal canal

537

1.07

0.15

5.4

6.6

25.09

24.49

mmol/l

0.75

503

Supernumerary teeth EXCLUDE clefts and syndromes, including avohilmo

1.09

0.14

10.4

12.3

24.20

24.02

mmol/l

—

Contact with lifting and transmission devices, not elsewhere classified

333

1.09

0.14

8.0

9.0

25.63

24.36

mmol/l

1.62

309

Benign neoplasm: Other parts of oropharynx

141

1.14

0.14

7.6

10.3

26.33

25.01

mmol/l

0.83

132

Mandibular prognathia AND surgery (LeFortI or BSSO or LeFortI AND BSSO), including avohilmo

122

1.15

0.14

2.7

10.7

25.06

24.62

mmol/l

0.22

111

Congenital malformations of breast

170

1.12

0.13

4.1

6.3

24.73

24.82

mmol/l

0.05

161

Complications of labour and delivery

1235

6959

0.99

0.13

7.3

6.6

24.52

24.74

mmol/l

1.35

1162

6441

Benign neoplasm: Connective and other soft tissue of thorax

1.19

0.12

8.7

7.4

24.05

24.82

mmol/l

—

Retinal detachment with retinal break

305

3112

0.98

0.12

7.7

6.6

24.06

24.55

mmol/l

1.44

287

2908

malignant neoplasm of male genital organs

1308

8226

1.01

0.12

6.6

7.8

24.35

24.40

mmol/l

0.17

1207

7713

Complications predominantly related to the puerperium

411

4040

1.02

0.12

5.4

6.6

24.34

24.54

mmol/l

0.55

391

3744

Migraine, single triptan purchase ok & required. ICD-code if available is included

1793

12232

0.99

0.12

6.7

7.2

24.49

24.66

mmol/l

1.37

1686

11369

Triptan medication for migraine, single purchase ok

1793

12232

0.99

0.12

6.7

7.2

24.49

24.66

mmol/l

1.37

1686

11369

Malignant neoplasm of breast

1146

8348

0.99

0.12

5.6

6.4

25.20

24.86

mmol/l

2.85

1071

7768

Graves disease, strict definition

157

1613

0.97

0.11

4.6

7.3

24.79

24.51

mmol/l

0.55

144

1500

Alcohol induced polyneuropathy

192

1.10

0.11

25.3

7.6

26.34

24.11

mmol/l

2.16

179

Other predominantly sexually transmitted diseases, not elsewhere classified

255

2600

0.98

0.10

7.5

6.8

24.42

24.32

mmol/l

0.18

236

2416

Open wound of wrist and hand

1023

10219

0.99

0.10

6.6

7.6

24.32

24.52

mmol/l

1.13

956

9502

Allergic contact dermatitis

234

2386

0.98

0.10

6.7

6.4

24.71

24.53

mmol/l

0.32

216

2202

Inflammatory disease of cervix uteri

117

1204

0.97

0.10

6.7

6.5

24.74

24.77

mmol/l

0.03

108

1114

Disorders of breast

1008

9423

0.99

0.10

6.7

6.3

24.78

24.76

mmol/l

0.07

941

8763

Deaf mutism, not elsewhere classified

1.16

0.09

3.4

6.9

25.06

24.39

mmol/l

—

Injury of blood vessels at shoulder and upper arm level

1.05

0.09

5.4

5.7

26.06

24.76

mmol/l

—

Benign neoplasm: Skin, unspecified

674

1.04

0.09

7.0

7.3

23.99

24.48

mmol/l

0.58

636

Malignant neoplasm, without specification of site

655

0.96

0.09

7.4

6.0

24.84

24.48

mmol/l

0.34

609

Cleft lip and cleft lip and palate

1.14

0.09

2.7

12.2

25.55

24.19

mmol/l

1.12

Explosion of other materials

1.08

0.09

2.2

7.7

21.25

23.82

mmol/l

—

Other specified acquired deformities of limbs

1.05

0.08

6.2

24.62

23.79

mmol/l

—

Pedestrian injured in collision with heavy transport vehicle or bus

1.04

0.08

16.0

6.8

22.62

24.30

mmol/l

—

Mandibular prognathia AND surgery (LeFortI or BSSRO)

0.79

0.08

4.0

14.9

24.14

24.43

mmol/l

—

Premenstrual syndrome

123

0.89

0.08

6.3

12.2

25.15

24.68

mmol/l

0.18

116

Benign neoplasm: Epididymis

1.05

0.08

6.7

7.8

24.36

24.06

mmol/l

—

Phlebitis and thrombophlebitis of other deep vessels of lower extremities, drug-induced

1.03

0.08

13.4

8.5

26.74

24.66

mmol/l

—

Medicines for HER+ breast cancer

783

7688

0.99

0.07

5.6

6.5

25.17

24.88

mmol/l

1.74

733

7149

Malignant neoplasm of prostate

1285

8062

1.01

0.07

6.5

7.8

24.35

24.40

mmol/l

0.16

1184

7556

Acute thyroiditis

1.07

0.07

7.5

8.1

24.86

25.23

mmol/l

—

Unspecified transport accident

1.07

0.07

16.1

9.0

24.94

24.49

mmol/l

—

Other cestode infections

1.06

0.07

4.9

5.7

24.55

24.50

mmol/l

—

Obstructed labour due to malposition and malpresentation of fetus

299

2855

0.99

0.07

7.3

6.6

24.24

24.48

mmol/l

0.64

284

2615

Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)

314

3181

0.99

0.07

6.4

6.9

24.70

24.58

mmol/l

0.23

292

2940

Benign neoplasm: Other parts of oropharynx

147

1.09

0.07

7.6

10.3

26.33

24.89

mmol/l

0.96

138

Benign neoplasm: Scrotum

0.84

0.07

9.7

8.2

27.19

23.82

mmol/l

—

Peroneal tendinitis

194

0.93

0.07

3.4

9.2

25.42

24.96

mmol/l

0.21

188

Alzheimer’s disease (Early onset), excluding more controls

659

1.03

0.07

9.7

5.2

24.69

24.17

mmol/l

0.56

610

Other and unspecified disease of Bartholin gland

478

0.96

0.07

4.8

7.4

24.30

24.80

mmol/l

0.43

445

Carcinoma in situ of uteri, other/unspecified

0.84

0.07

8.6

6.3

26.46

25.28

mmol/l

—

Certain conditions originating in the perinatal period

769

1.03

0.06

7.2

7.5

24.30

23.99

mmol/l

0.32

716

Multiple gestation

109

1067

1.02

0.06

8.3

6.4

24.35

24.31

mmol/l

0.04

996

Frontotemporal dementia

109

1.11

0.06

35.9

6.6

25.44

24.58

mmol/l

0.42

104

Xanthelasma of eyelid

158

1.08

0.06

8.3

7.6

24.65

25.04

mmol/l

0.20

149

Benign neoplasm: Anus and anal canal

586

0.97

0.05

5.4

6.2

25.09

24.52

mmol/l

0.70

554

Persons encountering health services in other circumstances, wide

3724

19279

1.00

0.04

7.6

6.9

24.68

24.55

mmol/l

1.23

3528

17903

Follow-up examination after treatment for conditions other than malignant neoplasms

971

6387

1.00

0.04

7.6

6.4

24.49

24.47

mmol/l

0.08

921

5884

Urticaria due to cold and heat

109

0.91

0.04

4.0

7.2

25.03

25.02

mmol/l

—

102

Malignant neoplasm of testis

271

0.96

0.04

9.5

8.9

24.14

24.13

mmol/l

0.01

252

Foreign body on external eye

315

3174

0.99

0.04

8.2

7.9

24.67

24.52

mmol/l

0.42

290

2959

Other orthopaedic follow-up care

103

1015

1.02

0.03

5.5

6.3

25.15

24.45

mmol/l

1.20

946

Memory loss

208

2099

0.99

0.03

6.6

7.0

24.71

24.58

mmol/l

0.17

195

1952

Overjet

190

1.05

0.03

5.6

9.0

23.52

24.07

mmol/l

0.33

175

Injury of nerves at ankle and foot level

102

1.08

0.03

28.4

8.0

27.46

24.42

mmol/l

0.93

Maternal care related to the fetus and amniotic cavity and possible delivery problems

743

4357

1.00

0.03

6.5

6.6

24.29

24.56

mmol/l

1.19

691

4037

Twin gestation

104

1028

1.01

0.02

8.6

6.4

24.33

24.29

mmol/l

0.04

959

Malignant neoplasm of parotid gland, excluding all cancers (controls excluding all cancers)

182

1.05

0.02

5.8

6.1

24.80

24.33

mmol/l

0.40

171

Benign mammary dysplasia

288

2895

0.99

0.02

6.8

6.5

24.78

24.88

mmol/l

0.18

271

2691

Disorder of thyroid, unspecified

212

1.04

0.02

5.7

6.8

23.80

24.88

mmol/l

0.33

201

Other operation for atrial fibrillation

113

1.07

0.02

10.1

7.8

24.73

24.05

mmol/l

0.14

106

Follicular adenocarcinoma of thyroid gland

117

0.94

0.02

2.4

6.0

24.28

24.87

mmol/l

0.42

110

LSIL lesion of the cervix uteri

141

1420

0.99

0.01

7.4

6.7

24.52

24.38

mmol/l

0.21

133

1320

Loose body in joint

468

0.98

0.01

4.3

8.4

23.93

24.29

mmol/l

0.27

439

Early syphilis

217

0.97

0.01

7.1

9.5

24.88

24.95

mmol/l

0.04

200

Malignant neoplasm of base of tongue

114

1.06

0.01

7.8

8.8

25.55

24.23

mmol/l

0.51

106

Malignant neoplasm of testis, excluding all cancers (controls excluding all cancers)

306

0.98

0.00

9.1

8.4

24.18

24.20

mmol/l

0.01

285

Unspecified visual impairment (binocular)

235

1.02

0.00

2.8

9.0

25.25

24.90

mmol/l

0.15

224

Calcaneal spur

204

0.98

0.00

3.1

6.2

24.33

24.52

mmol/l

0.12

193

Other disorders of thyroid

234

0.98

0.00

5.6

7.1

23.87

24.89

mmol/l

0.33

222

Habitual aborter

168

1.01

0.00

2.7

8.8

22.05

24.16

mmol/l

0.88

155

Pregnancy, childbirth and the puerperium

703

3675

1.00

0.00

6.1

5.9

24.46

24.77

mmol/l

1.24

670

3397

LSIL lesion of the cervix uteri, vagina or vulva

191

1911

1.00

0.00

7.7

6.4

24.69

24.43

mmol/l

0.54

178

1775

Malignant neoplasm of base of tongue, excluding all cancers (controls excluding all cancers)

147

1.02

0.00

8.7

7.5

25.97

24.52

mmol/l

0.74

141

Mesial bite

1.05

0.00

3.6

11.7

23.86

24.25

mmol/l

—

Carcinoma in situ of breast, lobular

124

0.97

0.00

4.3

7.3

26.22

25.28

mmol/l

0.39

118

Malignant neoplasm of parotid gland

136

1.03

0.00

4.9

7.1

25.47

24.52

mmol/l

1.04

130

Ankylosis of joint

1.06

0.00

5.9

5.4

24.57

24.23

mmol/l

—

Carcinoma in situ of breast, lobular

115

1.05

0.00

4.3

7.7

26.23

25.42

mmol/l

0.32

109

Toxic effect of noxious substances eaten as seafood

0.00

0.0

5.6

—

26.82

—

Carcinoma in situ, other and unspecified urinary organs

0.00

0.0

3.6

—

24.03

—

Leptospirosis

0.00

0.0

3.7

—

23.38

—

Livedoid vasculitis

0.97

0.00

11.6

13.1

22.76

24.83

mmol/l

—

Melanoma in situ of lip

0.00

0.0

3.9

—

25.18

—

Benign neoplasm: Conjunctiva

620

1.00

0.00

7.5

7.6

25.02

24.60

mmol/l

0.49

579

Intracranial laceration and haemorrhage due to birth injury

0.00

0.0

10.6

—

23.88

—

Interstitial emphysema and related conditions originating in the perinatal period

0.00

0.0

4.3

—

24.25

—

Spotted fever [tick-borne rickettsioses]

0.00

0.0

9.4

—

22.48

—

Anthrax

0.00

0.0

7.1

—

27.44

—

Carcinoma in situ, other and unspecified urinary organs

0.00

0.0

3.8

—

26.30

—

Nutritional and metabolic disorders in diseases classified elsewhere

0.00

0.0

3.0

—

26.70

—

Other disorders of intestinal carbohydrate absorption

0.00

0.0

3.2

—

24.18

—

Chlamydia psittaci infection

0.00

0.0

3.0

—

24.12

—

Other disorders of blood and blood-forming organs in diseases classified elsewhere

0.00

0.0

7.8

—

25.16

—

Defect, injury or illness of skull

0.00

0.0

4.0

—

22.84

—

Hereditary factor XI deficiency

0.00

0.0

2.7

—

22.98

—

Carcinoma in situ of respiratory system, other/unspecified

0.00

0.0

2.3

—

25.30

—

Disorders of glycosaminoglycan metabolism, other/unspecified

0.00

0.0

4.5

—

20.55

—

Other chronic figurate erythema

0.00

0.0

4.8

—

24.32

—

Laboratory evidence of human immunodeficiency virus [HIV]

0.00

0.0

9.0

—

24.77

—

Acquired keratosis follicularis

0.00

0.0

6.0

—

24.52

—

Other fluke infections

0.00

0.0

15.2

—

25.46

—

Digestive system disorders of fetus and newborn

0.00

0.0

11.0

—

25.66

—

Pervasive developmental disorders excl. Autism + Asperger

1.01

0.00

3.0

12.5

23.73

24.22

mmol/l

—

Yellow nail syndrome

0.00

0.0

6.1

—

25.20

—

Apocrine sweat disorders, other sweat gland disorders

1.01

0.00

4.5

7.4

23.28

25.18

mmol/l

—

Pedal cyclist injured in collision with train or tram

0.00

0.0

7.8

—

23.38

—

Effects of air pressure and water pressure

0.84

0.00

7.0

16.4

24.96

24.94

mmol/l

—

Granuloma inguinale

0.00

0.0

6.4

—

25.70

—

Acute hepatitis A

0.91

0.00

14.3

7.8

25.03

24.64

mmol/l

—

Plasmodium malariae malaria

0.00

0.0

2.8

—

26.52

—

Hypercementosis

0.00

0.0

5.4

—

25.93

—

Presbyopia

116

1160

1.00

0.00

5.6

7.3

24.90

24.64

mmol/l

0.46

109

1083

Systemic disorders of connective tissue in diseases classified elsewhere

0.84

0.00

3.8

5.4

23.02

24.00

mmol/l

—

Benign neoplasm: Connective and other soft tissue of trunk, unspecified

0.90

0.00

3.5

6.8

24.83

25.04

mmol/l

—

Mastocytosis

0.91

0.00

7.3

11.9

24.65

24.62

mmol/l

—

Whooping cough

0.91

0.00

1.8

5.6

23.18

24.51

mmol/l

—

Other congenital malformations of peripheral vascular system

170

1.00

0.00

13.7

9.5

26.98

24.64

mmol/l

0.81

157

Degenerative macular diseases, drug-induced

0.99

0.00

6.0

5.7

23.74

24.50

mmol/l

—

Other specified disorders of eye and adnexa in diseases classified elsewhere

0.00

0.0

4.3

—

23.32

—

Other respiratory conditions originating in the perinatal period

0.00

0.0

1.8

—

24.58

—

Birth injury to scalp

0.00

-0.00

0.0

11.7

—

24.55

—

≡ Risteys

FG R12 + FR

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Bicarbonate [Moles/volume] in Arterial blood

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS